<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:94e9ae7f-e327-45ef-8c7f-35901a7703f2,g:94b3f782-9391-42c0-b657-b810092f8ef0-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.jazzpharma.com/role/Cover" xlink:type="simple" xlink:href="jazz-20210930.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_af927cdc-f991-4720-96bf-fe65f35b3838" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_0826da9d-fc86-4eac-8b66-e669a8cbd774" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_af927cdc-f991-4720-96bf-fe65f35b3838" xlink:to="loc_dei_DocumentType_0826da9d-fc86-4eac-8b66-e669a8cbd774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_465c7df9-a4f0-4d6c-8d29-6444c4a4228e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_af927cdc-f991-4720-96bf-fe65f35b3838" xlink:to="loc_dei_DocumentQuarterlyReport_465c7df9-a4f0-4d6c-8d29-6444c4a4228e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_ed173f73-e976-4b28-b7c9-a5c64bec8080" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_af927cdc-f991-4720-96bf-fe65f35b3838" xlink:to="loc_dei_DocumentPeriodEndDate_ed173f73-e976-4b28-b7c9-a5c64bec8080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_6385d895-dc49-4430-8e22-50b7bdc6398b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_af927cdc-f991-4720-96bf-fe65f35b3838" xlink:to="loc_dei_DocumentTransitionReport_6385d895-dc49-4430-8e22-50b7bdc6398b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_4437db1b-c3cd-4d34-a769-a95a8f006fe3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_af927cdc-f991-4720-96bf-fe65f35b3838" xlink:to="loc_dei_EntityFileNumber_4437db1b-c3cd-4d34-a769-a95a8f006fe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_45b1b5f1-b11a-4606-9a6e-277de6768c92" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_af927cdc-f991-4720-96bf-fe65f35b3838" xlink:to="loc_dei_EntityRegistrantName_45b1b5f1-b11a-4606-9a6e-277de6768c92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_d970a9dd-162e-4c09-bdeb-a60cb20e3f6e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_af927cdc-f991-4720-96bf-fe65f35b3838" xlink:to="loc_dei_EntityIncorporationStateCountryCode_d970a9dd-162e-4c09-bdeb-a60cb20e3f6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_a6a812db-32c6-4236-9981-f96fb71f5cf8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_af927cdc-f991-4720-96bf-fe65f35b3838" xlink:to="loc_dei_EntityTaxIdentificationNumber_a6a812db-32c6-4236-9981-f96fb71f5cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_64dbe036-3f6c-46d0-abd4-cc3657cafa3e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_af927cdc-f991-4720-96bf-fe65f35b3838" xlink:to="loc_dei_EntityAddressAddressLine1_64dbe036-3f6c-46d0-abd4-cc3657cafa3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_eec4a480-388a-4120-a64c-bf6a6cf171d5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_af927cdc-f991-4720-96bf-fe65f35b3838" xlink:to="loc_dei_EntityAddressAddressLine2_eec4a480-388a-4120-a64c-bf6a6cf171d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_c975321a-386c-4271-a436-801ed49b46c0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_af927cdc-f991-4720-96bf-fe65f35b3838" xlink:to="loc_dei_EntityAddressCityOrTown_c975321a-386c-4271-a436-801ed49b46c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_f933bf7f-ca1d-4542-a562-984317a4f6b2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_af927cdc-f991-4720-96bf-fe65f35b3838" xlink:to="loc_dei_EntityAddressCountry_f933bf7f-ca1d-4542-a562-984317a4f6b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_56f3184e-ed09-48d6-887c-e7b5d23f7d5a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_af927cdc-f991-4720-96bf-fe65f35b3838" xlink:to="loc_dei_EntityAddressPostalZipCode_56f3184e-ed09-48d6-887c-e7b5d23f7d5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion_97c56104-3a74-42a7-8861-bde8a10f0c34" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CountryRegion"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_af927cdc-f991-4720-96bf-fe65f35b3838" xlink:to="loc_dei_CountryRegion_97c56104-3a74-42a7-8861-bde8a10f0c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_2e2f6b76-2c5c-4a13-ace3-17d3c73934c2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_af927cdc-f991-4720-96bf-fe65f35b3838" xlink:to="loc_dei_CityAreaCode_2e2f6b76-2c5c-4a13-ace3-17d3c73934c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_ba5aa7a0-0993-46ea-9568-8e7e0687946d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_af927cdc-f991-4720-96bf-fe65f35b3838" xlink:to="loc_dei_LocalPhoneNumber_ba5aa7a0-0993-46ea-9568-8e7e0687946d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_c79d9ff1-4a51-4c92-891a-3a0ec488dbaf" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_af927cdc-f991-4720-96bf-fe65f35b3838" xlink:to="loc_dei_Security12bTitle_c79d9ff1-4a51-4c92-891a-3a0ec488dbaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_cf044ab0-1152-4db9-8712-97aafe8760aa" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_af927cdc-f991-4720-96bf-fe65f35b3838" xlink:to="loc_dei_TradingSymbol_cf044ab0-1152-4db9-8712-97aafe8760aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_1074d66d-4286-487e-b068-83d056d77ec6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_af927cdc-f991-4720-96bf-fe65f35b3838" xlink:to="loc_dei_SecurityExchangeName_1074d66d-4286-487e-b068-83d056d77ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_d7551110-597d-4760-953c-8c5551ede692" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_af927cdc-f991-4720-96bf-fe65f35b3838" xlink:to="loc_dei_EntityCurrentReportingStatus_d7551110-597d-4760-953c-8c5551ede692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_decb4013-a037-48ae-ab26-68e750ef2bc1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_af927cdc-f991-4720-96bf-fe65f35b3838" xlink:to="loc_dei_EntityInteractiveDataCurrent_decb4013-a037-48ae-ab26-68e750ef2bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_53051f06-428a-4c1b-a92c-3c08900b7c7e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_af927cdc-f991-4720-96bf-fe65f35b3838" xlink:to="loc_dei_EntityFilerCategory_53051f06-428a-4c1b-a92c-3c08900b7c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_0958e856-4ea4-47f5-a3a1-35c75bd385b7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_af927cdc-f991-4720-96bf-fe65f35b3838" xlink:to="loc_dei_EntitySmallBusiness_0958e856-4ea4-47f5-a3a1-35c75bd385b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_ddb4908d-cc67-4cec-a959-4f4dbca462d7" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_af927cdc-f991-4720-96bf-fe65f35b3838" xlink:to="loc_dei_EntityEmergingGrowthCompany_ddb4908d-cc67-4cec-a959-4f4dbca462d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_d5c8f05b-c37e-4384-ae81-fdd13a0e720a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_af927cdc-f991-4720-96bf-fe65f35b3838" xlink:to="loc_dei_EntityShellCompany_d5c8f05b-c37e-4384-ae81-fdd13a0e720a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_c0db86e1-ae5e-4adb-8bb9-ac0b5760c502" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_af927cdc-f991-4720-96bf-fe65f35b3838" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_c0db86e1-ae5e-4adb-8bb9-ac0b5760c502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_68c2a5a1-d928-4388-8162-46ac898e6b3c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_af927cdc-f991-4720-96bf-fe65f35b3838" xlink:to="loc_dei_AmendmentFlag_68c2a5a1-d928-4388-8162-46ac898e6b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_c20aa34d-8242-4924-a8f6-e2eed5d20282" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_af927cdc-f991-4720-96bf-fe65f35b3838" xlink:to="loc_dei_DocumentFiscalYearFocus_c20aa34d-8242-4924-a8f6-e2eed5d20282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_40a6a0eb-f687-463a-a88a-413952c11adb" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_af927cdc-f991-4720-96bf-fe65f35b3838" xlink:to="loc_dei_DocumentFiscalPeriodFocus_40a6a0eb-f687-463a-a88a-413952c11adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_dd9e4654-0cc7-4e57-8a97-74a62847eeb5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_af927cdc-f991-4720-96bf-fe65f35b3838" xlink:to="loc_dei_EntityCentralIndexKey_dd9e4654-0cc7-4e57-8a97-74a62847eeb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_42d17064-acc4-439e-8f05-5d4118f3b0b9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_af927cdc-f991-4720-96bf-fe65f35b3838" xlink:to="loc_dei_CurrentFiscalYearEndDate_42d17064-acc4-439e-8f05-5d4118f3b0b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CONDENSENEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="jazz-20210930.xsd#CONDENSENEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/CONDENSENEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_c85440cf-6dda-4e6a-8965-32bdff65946a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_e60d6cc6-7088-48a9-a47e-305d7a76a794" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c85440cf-6dda-4e6a-8965-32bdff65946a" xlink:to="loc_us-gaap_AssetsAbstract_e60d6cc6-7088-48a9-a47e-305d7a76a794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_ef50c64a-a461-4d57-ade6-c144f500d769" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e60d6cc6-7088-48a9-a47e-305d7a76a794" xlink:to="loc_us-gaap_AssetsCurrentAbstract_ef50c64a-a461-4d57-ade6-c144f500d769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1d27c0f9-eb77-4647-bba7-310104606f42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ef50c64a-a461-4d57-ade6-c144f500d769" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1d27c0f9-eb77-4647-bba7-310104606f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_edaab708-4dee-4d27-96a8-d7c1b554d593" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ef50c64a-a461-4d57-ade6-c144f500d769" xlink:to="loc_us-gaap_Investments_edaab708-4dee-4d27-96a8-d7c1b554d593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_94142eba-0936-4fd6-8727-b8d8d065694b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ef50c64a-a461-4d57-ade6-c144f500d769" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_94142eba-0936-4fd6-8727-b8d8d065694b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_7992ecc7-e111-4310-93a1-3025f845a613" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ef50c64a-a461-4d57-ade6-c144f500d769" xlink:to="loc_us-gaap_InventoryNet_7992ecc7-e111-4310-93a1-3025f845a613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_988bac96-1975-4c31-a888-3b7af1fd0aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ef50c64a-a461-4d57-ade6-c144f500d769" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_988bac96-1975-4c31-a888-3b7af1fd0aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_7ad9e134-ebba-426f-a995-8829bd345a72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ef50c64a-a461-4d57-ade6-c144f500d769" xlink:to="loc_us-gaap_OtherAssetsCurrent_7ad9e134-ebba-426f-a995-8829bd345a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_17f719c4-508c-4172-b426-82dd2904fb46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ef50c64a-a461-4d57-ade6-c144f500d769" xlink:to="loc_us-gaap_AssetsCurrent_17f719c4-508c-4172-b426-82dd2904fb46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_c43183e1-db05-4136-9634-06cbe6e01831" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e60d6cc6-7088-48a9-a47e-305d7a76a794" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_c43183e1-db05-4136-9634-06cbe6e01831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_dcea0f60-03b6-4ff8-9673-4eae175ed99c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e60d6cc6-7088-48a9-a47e-305d7a76a794" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_dcea0f60-03b6-4ff8-9673-4eae175ed99c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1ec10ea9-0643-4949-a52f-d744a7039404" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e60d6cc6-7088-48a9-a47e-305d7a76a794" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1ec10ea9-0643-4949-a52f-d744a7039404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_76f6c567-06a1-43ae-a980-055ec7b16ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e60d6cc6-7088-48a9-a47e-305d7a76a794" xlink:to="loc_us-gaap_Goodwill_76f6c567-06a1-43ae-a980-055ec7b16ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_3d9e7d9b-04cc-464e-b3b8-0d89786c4f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e60d6cc6-7088-48a9-a47e-305d7a76a794" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_3d9e7d9b-04cc-464e-b3b8-0d89786c4f6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_576e781d-fc9a-40f5-92b0-7d2f2ca5a8cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e60d6cc6-7088-48a9-a47e-305d7a76a794" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_576e781d-fc9a-40f5-92b0-7d2f2ca5a8cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_3fa3da3b-a5d2-436a-9ec9-69e7ae3545b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e60d6cc6-7088-48a9-a47e-305d7a76a794" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_3fa3da3b-a5d2-436a-9ec9-69e7ae3545b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_b4477890-8a40-4924-b61c-08053f413715" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e60d6cc6-7088-48a9-a47e-305d7a76a794" xlink:to="loc_us-gaap_Assets_b4477890-8a40-4924-b61c-08053f413715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_10b82d65-da8f-4f96-b0b7-af8dc7e56113" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c85440cf-6dda-4e6a-8965-32bdff65946a" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_10b82d65-da8f-4f96-b0b7-af8dc7e56113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_e1a98291-b206-439c-a943-a74788ec642f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_10b82d65-da8f-4f96-b0b7-af8dc7e56113" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_e1a98291-b206-439c-a943-a74788ec642f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_e5bfea7a-6f54-476a-a664-9ac633241af6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e1a98291-b206-439c-a943-a74788ec642f" xlink:to="loc_us-gaap_AccountsPayableCurrent_e5bfea7a-6f54-476a-a664-9ac633241af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_8053290e-83a2-44f2-950d-b32b8ca82ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e1a98291-b206-439c-a943-a74788ec642f" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_8053290e-83a2-44f2-950d-b32b8ca82ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_42ca8307-f8a2-4fba-8b83-f9663074dcf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e1a98291-b206-439c-a943-a74788ec642f" xlink:to="loc_us-gaap_LongTermDebtCurrent_42ca8307-f8a2-4fba-8b83-f9663074dcf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_05b70032-72d4-4aae-b0a8-f22856d55ac9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e1a98291-b206-439c-a943-a74788ec642f" xlink:to="loc_us-gaap_TaxesPayableCurrent_05b70032-72d4-4aae-b0a8-f22856d55ac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_0f1fe3bd-61e3-4025-9436-afcbbeceeeb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e1a98291-b206-439c-a943-a74788ec642f" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_0f1fe3bd-61e3-4025-9436-afcbbeceeeb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_136b705b-be80-408d-b7a3-4b4c87b4374c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e1a98291-b206-439c-a943-a74788ec642f" xlink:to="loc_us-gaap_LiabilitiesCurrent_136b705b-be80-408d-b7a3-4b4c87b4374c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_cd468388-4939-4c41-a052-ed24363cb2bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_10b82d65-da8f-4f96-b0b7-af8dc7e56113" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_cd468388-4939-4c41-a052-ed24363cb2bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_2636a45e-1c21-4af9-b750-fd795752d4a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_10b82d65-da8f-4f96-b0b7-af8dc7e56113" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_2636a45e-1c21-4af9-b750-fd795752d4a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_855ff441-6b8f-432c-9413-8c6ebf738595" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_10b82d65-da8f-4f96-b0b7-af8dc7e56113" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_855ff441-6b8f-432c-9413-8c6ebf738595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_2463911e-bc20-470a-873c-2fed324579d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_10b82d65-da8f-4f96-b0b7-af8dc7e56113" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_2463911e-bc20-470a-873c-2fed324579d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_f6a88da6-11a8-46d9-b226-0df7ceaaeafc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_10b82d65-da8f-4f96-b0b7-af8dc7e56113" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_f6a88da6-11a8-46d9-b226-0df7ceaaeafc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_ef6c5c9a-fa5b-4142-96a4-f76f9c9697c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_10b82d65-da8f-4f96-b0b7-af8dc7e56113" xlink:to="loc_us-gaap_CommitmentsAndContingencies_ef6c5c9a-fa5b-4142-96a4-f76f9c9697c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_6dd81f33-930f-4a55-b704-72b22f9f4dc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_10b82d65-da8f-4f96-b0b7-af8dc7e56113" xlink:to="loc_us-gaap_StockholdersEquityAbstract_6dd81f33-930f-4a55-b704-72b22f9f4dc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_ce51e362-4375-4663-a497-c4d5fe9eb7d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6dd81f33-930f-4a55-b704-72b22f9f4dc8" xlink:to="loc_us-gaap_CommonStockValue_ce51e362-4375-4663-a497-c4d5fe9eb7d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_NonvotingEuroDeferredShares_0ff6ba83-8fac-409f-b735-63b5d0871f0e" xlink:href="jazz-20210930.xsd#jazz_NonvotingEuroDeferredShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6dd81f33-930f-4a55-b704-72b22f9f4dc8" xlink:to="loc_jazz_NonvotingEuroDeferredShares_0ff6ba83-8fac-409f-b735-63b5d0871f0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_CapitalRedemptionReserve_836651c1-daf1-4b41-bf08-72f626f3f351" xlink:href="jazz-20210930.xsd#jazz_CapitalRedemptionReserve"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6dd81f33-930f-4a55-b704-72b22f9f4dc8" xlink:to="loc_jazz_CapitalRedemptionReserve_836651c1-daf1-4b41-bf08-72f626f3f351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_8fe65a86-4997-4e1d-9ee4-8e6b5292285f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6dd81f33-930f-4a55-b704-72b22f9f4dc8" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_8fe65a86-4997-4e1d-9ee4-8e6b5292285f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3be5ce05-ee20-4424-a25c-2a35b1546f64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6dd81f33-930f-4a55-b704-72b22f9f4dc8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3be5ce05-ee20-4424-a25c-2a35b1546f64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1df73104-b4fc-4a94-9749-b3f4997a6269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6dd81f33-930f-4a55-b704-72b22f9f4dc8" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1df73104-b4fc-4a94-9749-b3f4997a6269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_23f4a995-6ebf-4477-a564-1ac7f008a3c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6dd81f33-930f-4a55-b704-72b22f9f4dc8" xlink:to="loc_us-gaap_StockholdersEquity_23f4a995-6ebf-4477-a564-1ac7f008a3c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_16f4187a-3af2-4524-9b23-48764d107566" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_10b82d65-da8f-4f96-b0b7-af8dc7e56113" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_16f4187a-3af2-4524-9b23-48764d107566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS" xlink:type="simple" xlink:href="jazz-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_e5f92596-2cd8-43f9-8c99-290181c82cd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c5f3d0b5-529b-42db-a895-49a3a9460bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e5f92596-2cd8-43f9-8c99-290181c82cd0" xlink:to="loc_us-gaap_StatementTable_c5f3d0b5-529b-42db-a895-49a3a9460bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f6b5e54f-1bd1-4012-9fbf-18e02a9732a8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c5f3d0b5-529b-42db-a895-49a3a9460bf3" xlink:to="loc_srt_ProductOrServiceAxis_f6b5e54f-1bd1-4012-9fbf-18e02a9732a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8ed55c6c-e20d-49ad-a3fb-0f74afd29268" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_f6b5e54f-1bd1-4012-9fbf-18e02a9732a8" xlink:to="loc_srt_ProductsAndServicesDomain_8ed55c6c-e20d-49ad-a3fb-0f74afd29268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ProductAndServicesProductSalesNetOfDeductionsMember_7277771b-1411-46ac-9728-db89710c64db" xlink:href="jazz-20210930.xsd#jazz_ProductAndServicesProductSalesNetOfDeductionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8ed55c6c-e20d-49ad-a3fb-0f74afd29268" xlink:to="loc_jazz_ProductAndServicesProductSalesNetOfDeductionsMember_7277771b-1411-46ac-9728-db89710c64db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ProductAndServicesRoyaltiesAndContractRevenueMember_0152e900-ad6c-45bf-9622-6c87c534bb13" xlink:href="jazz-20210930.xsd#jazz_ProductAndServicesRoyaltiesAndContractRevenueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8ed55c6c-e20d-49ad-a3fb-0f74afd29268" xlink:to="loc_jazz_ProductAndServicesRoyaltiesAndContractRevenueMember_0152e900-ad6c-45bf-9622-6c87c534bb13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_78002dc5-ebe3-4318-b309-904cc24d506f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c5f3d0b5-529b-42db-a895-49a3a9460bf3" xlink:to="loc_us-gaap_StatementLineItems_78002dc5-ebe3-4318-b309-904cc24d506f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_bafd009e-698f-48b3-b8e6-fd599af2c537" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_78002dc5-ebe3-4318-b309-904cc24d506f" xlink:to="loc_us-gaap_RevenuesAbstract_bafd009e-698f-48b3-b8e6-fd599af2c537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_95710408-345c-4af9-9ec2-0b778368b260" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_bafd009e-698f-48b3-b8e6-fd599af2c537" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_95710408-345c-4af9-9ec2-0b778368b260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_070b40a7-de9a-4064-917d-65fce656263d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_78002dc5-ebe3-4318-b309-904cc24d506f" xlink:to="loc_us-gaap_OperatingExpensesAbstract_070b40a7-de9a-4064-917d-65fce656263d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment_a8db6713-2a52-40c2-8d77-6fc88809ad6d" xlink:href="jazz-20210930.xsd#jazz_CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_070b40a7-de9a-4064-917d-65fce656263d" xlink:to="loc_jazz_CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment_a8db6713-2a52-40c2-8d77-6fc88809ad6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_74bfde75-04ad-41cd-bd9e-4973cf99ed35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_070b40a7-de9a-4064-917d-65fce656263d" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_74bfde75-04ad-41cd-bd9e-4973cf99ed35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_2c08cd53-fabc-43aa-8613-9cdcbdc2015c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_070b40a7-de9a-4064-917d-65fce656263d" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_2c08cd53-fabc-43aa-8613-9cdcbdc2015c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_a0e88765-7f59-4e81-bb1e-f4e4fb70a957" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_070b40a7-de9a-4064-917d-65fce656263d" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_a0e88765-7f59-4e81-bb1e-f4e4fb70a957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_ea4829cc-d0b5-4b69-ac81-b43fa3e74509" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_070b40a7-de9a-4064-917d-65fce656263d" xlink:to="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_ea4829cc-d0b5-4b69-ac81-b43fa3e74509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_ac563aa3-fbc0-4d80-988d-342d070c893e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_070b40a7-de9a-4064-917d-65fce656263d" xlink:to="loc_us-gaap_AssetImpairmentCharges_ac563aa3-fbc0-4d80-988d-342d070c893e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_c41855bd-8947-4e29-9ff0-a6898bc6d5ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_070b40a7-de9a-4064-917d-65fce656263d" xlink:to="loc_us-gaap_CostsAndExpenses_c41855bd-8947-4e29-9ff0-a6898bc6d5ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ff855703-9e61-403c-abe3-a68cbc1fb39f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_78002dc5-ebe3-4318-b309-904cc24d506f" xlink:to="loc_us-gaap_OperatingIncomeLoss_ff855703-9e61-403c-abe3-a68cbc1fb39f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_00ffe849-5c21-4063-8078-7bf9b2859a74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_78002dc5-ebe3-4318-b309-904cc24d506f" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_00ffe849-5c21-4063-8078-7bf9b2859a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_6db3ed8f-05cb-4027-9c28-b7224cac7abb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_78002dc5-ebe3-4318-b309-904cc24d506f" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_6db3ed8f-05cb-4027-9c28-b7224cac7abb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_be65c35b-7d67-4992-a978-858ef68ab940" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_78002dc5-ebe3-4318-b309-904cc24d506f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_be65c35b-7d67-4992-a978-858ef68ab940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_23820499-1999-4f95-9ee5-59fae6ea058e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_78002dc5-ebe3-4318-b309-904cc24d506f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_23820499-1999-4f95-9ee5-59fae6ea058e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_9011febd-e2fd-4674-960d-4a16383e7e16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_78002dc5-ebe3-4318-b309-904cc24d506f" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_9011febd-e2fd-4674-960d-4a16383e7e16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_cc581c61-0748-4661-9f49-3017c3db1830" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_78002dc5-ebe3-4318-b309-904cc24d506f" xlink:to="loc_us-gaap_NetIncomeLoss_cc581c61-0748-4661-9f49-3017c3db1830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_fd6f2d79-eba1-4c7c-b61e-c51b41ae447c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_78002dc5-ebe3-4318-b309-904cc24d506f" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_fd6f2d79-eba1-4c7c-b61e-c51b41ae447c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_7e73becb-e687-4be3-a5d8-d73d79b0f5fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_fd6f2d79-eba1-4c7c-b61e-c51b41ae447c" xlink:to="loc_us-gaap_EarningsPerShareBasic_7e73becb-e687-4be3-a5d8-d73d79b0f5fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_f014296c-6e82-4a9a-925b-c6097344357b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_fd6f2d79-eba1-4c7c-b61e-c51b41ae447c" xlink:to="loc_us-gaap_EarningsPerShareDiluted_f014296c-6e82-4a9a-925b-c6097344357b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f5f7b050-3101-4808-a977-90fa487d3ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_78002dc5-ebe3-4318-b309-904cc24d506f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f5f7b050-3101-4808-a977-90fa487d3ccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f17fcb28-fe5d-4e60-9437-797633c620b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_78002dc5-ebe3-4318-b309-904cc24d506f" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f17fcb28-fe5d-4e60-9437-797633c620b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="jazz-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_214d7db8-b542-41f4-bd93-9423e592bb6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9ca9e4d4-c269-47ab-89cd-3e076899dec3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_214d7db8-b542-41f4-bd93-9423e592bb6c" xlink:to="loc_us-gaap_NetIncomeLoss_9ca9e4d4-c269-47ab-89cd-3e076899dec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9224a75c-e3e7-461d-8c5a-b684e039a533" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_214d7db8-b542-41f4-bd93-9423e592bb6c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9224a75c-e3e7-461d-8c5a-b684e039a533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_981fa823-2431-4529-888b-3b74290c57c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9224a75c-e3e7-461d-8c5a-b684e039a533" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_981fa823-2431-4529-888b-3b74290c57c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_3109a369-15a6-410d-babd-ecd02cd46690" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9224a75c-e3e7-461d-8c5a-b684e039a533" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_3109a369-15a6-410d-babd-ecd02cd46690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsTax_36a7fcc5-f993-43fb-b97f-d1701a4a5b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9224a75c-e3e7-461d-8c5a-b684e039a533" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsTax_36a7fcc5-f993-43fb-b97f-d1701a4a5b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_7be70dca-bd40-4a48-9bb9-ddb1ee1504c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9224a75c-e3e7-461d-8c5a-b684e039a533" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_7be70dca-bd40-4a48-9bb9-ddb1ee1504c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_715b0e9f-f28c-4a5f-bbf5-666512ccc221" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_214d7db8-b542-41f4-bd93-9423e592bb6c" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_715b0e9f-f28c-4a5f-bbf5-666512ccc221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSParenthetical" xlink:type="simple" xlink:href="jazz-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSParenthetical"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_fc039abf-d417-460e-a922-0d6163922be6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_998de823-0f0d-414b-addc-7d9a8fed72b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_fc039abf-d417-460e-a922-0d6163922be6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_998de823-0f0d-414b-addc-7d9a8fed72b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterReclassificationAdjustmentTax_7768192b-60a6-4f07-9818-828ee39e7e9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterReclassificationAdjustmentTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_fc039abf-d417-460e-a922-0d6163922be6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterReclassificationAdjustmentTax_7768192b-60a6-4f07-9818-828ee39e7e9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" xlink:type="simple" xlink:href="jazz-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSHAREHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_7481bb0b-2a79-4412-ab6b-3852db9d8a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_852c4fa4-a762-4e0e-b230-1c42bd3e2cbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_7481bb0b-2a79-4412-ab6b-3852db9d8a4b" xlink:to="loc_us-gaap_StatementTable_852c4fa4-a762-4e0e-b230-1c42bd3e2cbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2527a099-920b-4cbf-8f47-d02842bf86c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_852c4fa4-a762-4e0e-b230-1c42bd3e2cbf" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2527a099-920b-4cbf-8f47-d02842bf86c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a0a6683b-3415-4a99-b246-86bd73397498" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2527a099-920b-4cbf-8f47-d02842bf86c1" xlink:to="loc_us-gaap_EquityComponentDomain_a0a6683b-3415-4a99-b246-86bd73397498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_00a5cccf-5a44-426b-861b-2157e06f46ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a0a6683b-3415-4a99-b246-86bd73397498" xlink:to="loc_us-gaap_CommonStockMember_00a5cccf-5a44-426b-861b-2157e06f46ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_EuroDeferredSharesMember_baf01f0d-8407-4b70-bc04-b60e877e63bc" xlink:href="jazz-20210930.xsd#jazz_EuroDeferredSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a0a6683b-3415-4a99-b246-86bd73397498" xlink:to="loc_jazz_EuroDeferredSharesMember_baf01f0d-8407-4b70-bc04-b60e877e63bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_CapitalRedemptionReserveMember_002b2563-a72a-4a5c-9cd1-c1e9a55bcc52" xlink:href="jazz-20210930.xsd#jazz_CapitalRedemptionReserveMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a0a6683b-3415-4a99-b246-86bd73397498" xlink:to="loc_jazz_CapitalRedemptionReserveMember_002b2563-a72a-4a5c-9cd1-c1e9a55bcc52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_d6a62cde-0fa5-4563-acb2-cde4ac0db767" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a0a6683b-3415-4a99-b246-86bd73397498" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_d6a62cde-0fa5-4563-acb2-cde4ac0db767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_41e65b0f-cffc-4a78-8cad-8d0faa46d37e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a0a6683b-3415-4a99-b246-86bd73397498" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_41e65b0f-cffc-4a78-8cad-8d0faa46d37e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_84d65a49-6d24-4568-9c43-6e2c51718c46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a0a6683b-3415-4a99-b246-86bd73397498" xlink:to="loc_us-gaap_RetainedEarningsMember_84d65a49-6d24-4568-9c43-6e2c51718c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_bc1be24c-12ef-4821-93b3-c7eaa6e3e424" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_852c4fa4-a762-4e0e-b230-1c42bd3e2cbf" xlink:to="loc_us-gaap_AwardTypeAxis_bc1be24c-12ef-4821-93b3-c7eaa6e3e424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_27e2bf5f-b0c9-43d9-9498-e7ff71ea1ff9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_bc1be24c-12ef-4821-93b3-c7eaa6e3e424" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_27e2bf5f-b0c9-43d9-9498-e7ff71ea1ff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_6b738c39-c8d2-4f53-8af0-81ff6f67ac00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_27e2bf5f-b0c9-43d9-9498-e7ff71ea1ff9" xlink:to="loc_us-gaap_EmployeeStockOptionMember_6b738c39-c8d2-4f53-8af0-81ff6f67ac00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e12807b8-9ecf-4644-8157-8ce7da2cfa0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_852c4fa4-a762-4e0e-b230-1c42bd3e2cbf" xlink:to="loc_us-gaap_StatementLineItems_e12807b8-9ecf-4644-8157-8ce7da2cfa0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff35e501-cead-4017-bddb-5a6e8b98b9aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e12807b8-9ecf-4644-8157-8ce7da2cfa0c" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff35e501-cead-4017-bddb-5a6e8b98b9aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_67e2365b-efb3-4347-add4-c74960654b45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff35e501-cead-4017-bddb-5a6e8b98b9aa" xlink:to="loc_us-gaap_SharesOutstanding_67e2365b-efb3-4347-add4-c74960654b45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7eefb32e-bf3b-43b8-b408-5f31f3f46e60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff35e501-cead-4017-bddb-5a6e8b98b9aa" xlink:to="loc_us-gaap_StockholdersEquity_7eefb32e-bf3b-43b8-b408-5f31f3f46e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_11d4aea5-b36d-4554-b92a-19202af4e935" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff35e501-cead-4017-bddb-5a6e8b98b9aa" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_11d4aea5-b36d-4554-b92a-19202af4e935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeatureRepurchase_527cf4ea-6b32-4f0e-b057-fbb305d7b7e7" xlink:href="jazz-20210930.xsd#jazz_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeatureRepurchase"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff35e501-cead-4017-bddb-5a6e8b98b9aa" xlink:to="loc_jazz_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeatureRepurchase_527cf4ea-6b32-4f0e-b057-fbb305d7b7e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_12a4a200-843d-413c-a92f-9b53170f9d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff35e501-cead-4017-bddb-5a6e8b98b9aa" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_12a4a200-843d-413c-a92f-9b53170f9d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_54830496-0ab8-448d-a31a-c20e334cd3c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff35e501-cead-4017-bddb-5a6e8b98b9aa" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_54830496-0ab8-448d-a31a-c20e334cd3c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_bbdcdd63-9604-4eef-bcc8-ac228c9633ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff35e501-cead-4017-bddb-5a6e8b98b9aa" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_bbdcdd63-9604-4eef-bcc8-ac228c9633ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_438e4e64-77d7-4f6e-9344-545b4b91f08c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff35e501-cead-4017-bddb-5a6e8b98b9aa" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_438e4e64-77d7-4f6e-9344-545b4b91f08c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_110ebd3c-a690-4a95-bc25-88451a27eadd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff35e501-cead-4017-bddb-5a6e8b98b9aa" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_110ebd3c-a690-4a95-bc25-88451a27eadd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_20980bdc-be1b-4d48-9004-be0c95af0e45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff35e501-cead-4017-bddb-5a6e8b98b9aa" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_20980bdc-be1b-4d48-9004-be0c95af0e45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_b1700b08-8eab-4e0c-83fd-5f7817cb4115" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff35e501-cead-4017-bddb-5a6e8b98b9aa" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_b1700b08-8eab-4e0c-83fd-5f7817cb4115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_0b788920-54cd-4543-bd00-10a7175733b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff35e501-cead-4017-bddb-5a6e8b98b9aa" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_0b788920-54cd-4543-bd00-10a7175733b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_57c67d21-0b22-4b95-8c9b-12ad95ebbee3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff35e501-cead-4017-bddb-5a6e8b98b9aa" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_57c67d21-0b22-4b95-8c9b-12ad95ebbee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_cbd0023f-e268-4107-b9bf-484b22af202b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff35e501-cead-4017-bddb-5a6e8b98b9aa" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_cbd0023f-e268-4107-b9bf-484b22af202b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_7c1da70c-6902-4750-b8a3-3fd0aed148d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff35e501-cead-4017-bddb-5a6e8b98b9aa" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_7c1da70c-6902-4750-b8a3-3fd0aed148d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_595d57a9-e748-47d6-b528-eca9bd0fb497" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff35e501-cead-4017-bddb-5a6e8b98b9aa" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_595d57a9-e748-47d6-b528-eca9bd0fb497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_454e891d-af47-4da4-a97a-583aa956a273" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff35e501-cead-4017-bddb-5a6e8b98b9aa" xlink:to="loc_us-gaap_NetIncomeLoss_454e891d-af47-4da4-a97a-583aa956a273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_d9912bae-8466-4760-8c64-b25d3feaa437" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff35e501-cead-4017-bddb-5a6e8b98b9aa" xlink:to="loc_us-gaap_SharesOutstanding_d9912bae-8466-4760-8c64-b25d3feaa437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4539c05f-9340-4f8c-9b8e-a28cf8b9f1af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ff35e501-cead-4017-bddb-5a6e8b98b9aa" xlink:to="loc_us-gaap_StockholdersEquity_4539c05f-9340-4f8c-9b8e-a28cf8b9f1af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="jazz-20210930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_d0a8dbe0-2c2b-4a73-99e8-b62ad6d74bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c1ecb00e-fec0-4ac8-b197-ed4a1a432431" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d0a8dbe0-2c2b-4a73-99e8-b62ad6d74bd6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c1ecb00e-fec0-4ac8-b197-ed4a1a432431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f6ce8a29-4abf-49ba-8b94-7a025f54ed2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c1ecb00e-fec0-4ac8-b197-ed4a1a432431" xlink:to="loc_us-gaap_NetIncomeLoss_f6ce8a29-4abf-49ba-8b94-7a025f54ed2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_43c06120-94b6-41db-a0df-6ba3ea2c32c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c1ecb00e-fec0-4ac8-b197-ed4a1a432431" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_43c06120-94b6-41db-a0df-6ba3ea2c32c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_7d7e1dc1-c0c4-4429-a3a2-4e14079fe4c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_43c06120-94b6-41db-a0df-6ba3ea2c32c8" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_7d7e1dc1-c0c4-4429-a3a2-4e14079fe4c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_InventoryStepUpValueAdjustment_13a1e01b-82ad-46b5-a841-de8c4d5d0311" xlink:href="jazz-20210930.xsd#jazz_InventoryStepUpValueAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_43c06120-94b6-41db-a0df-6ba3ea2c32c8" xlink:to="loc_jazz_InventoryStepUpValueAdjustment_13a1e01b-82ad-46b5-a841-de8c4d5d0311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_1a26faf0-de5d-4b82-8204-74351affe78d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_43c06120-94b6-41db-a0df-6ba3ea2c32c8" xlink:to="loc_us-gaap_ShareBasedCompensation_1a26faf0-de5d-4b82-8204-74351affe78d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_575b7a8f-642f-4daf-8a42-6651eb29749d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_43c06120-94b6-41db-a0df-6ba3ea2c32c8" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_575b7a8f-642f-4daf-8a42-6651eb29749d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_NoncashInterestExpense_38cc67d4-60cb-4934-8829-07801296afdb" xlink:href="jazz-20210930.xsd#jazz_NoncashInterestExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_43c06120-94b6-41db-a0df-6ba3ea2c32c8" xlink:to="loc_jazz_NoncashInterestExpense_38cc67d4-60cb-4934-8829-07801296afdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_3af05341-07a8-42d8-a82a-c137280da76e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_43c06120-94b6-41db-a0df-6ba3ea2c32c8" xlink:to="loc_us-gaap_Depreciation_3af05341-07a8-42d8-a82a-c137280da76e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ProvisionForLossesOnAccountsReceivableAndInventory_f9365764-a10c-4465-99ee-28578b407758" xlink:href="jazz-20210930.xsd#jazz_ProvisionForLossesOnAccountsReceivableAndInventory"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_43c06120-94b6-41db-a0df-6ba3ea2c32c8" xlink:to="loc_jazz_ProvisionForLossesOnAccountsReceivableAndInventory_f9365764-a10c-4465-99ee-28578b407758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_9c3dbddd-60bc-4964-b40e-b8900bd299ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_43c06120-94b6-41db-a0df-6ba3ea2c32c8" xlink:to="loc_us-gaap_AssetImpairmentCharges_9c3dbddd-60bc-4964-b40e-b8900bd299ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_28a4f368-967d-46e0-aa60-21a4dce5b4c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_43c06120-94b6-41db-a0df-6ba3ea2c32c8" xlink:to="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_28a4f368-967d-46e0-aa60-21a4dce5b4c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_272cffe8-5943-4e43-a5a7-511f7af466d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_43c06120-94b6-41db-a0df-6ba3ea2c32c8" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_272cffe8-5943-4e43-a5a7-511f7af466d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c398f4d8-c87e-4672-8194-ad018a3a6c82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_43c06120-94b6-41db-a0df-6ba3ea2c32c8" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c398f4d8-c87e-4672-8194-ad018a3a6c82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_57e65a5d-5436-4cde-bd02-45904ba27ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c398f4d8-c87e-4672-8194-ad018a3a6c82" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_57e65a5d-5436-4cde-bd02-45904ba27ae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_23430510-ddf3-40e3-a544-cc0c5269398f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c398f4d8-c87e-4672-8194-ad018a3a6c82" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_23430510-ddf3-40e3-a544-cc0c5269398f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_6be06d18-72ae-46fa-b068-4c9290cdd9d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c398f4d8-c87e-4672-8194-ad018a3a6c82" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_6be06d18-72ae-46fa-b068-4c9290cdd9d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_IncreaseDecreaseInOperatingLeaseAssets_26945ab0-d6b6-403f-9aef-caf9141eb85e" xlink:href="jazz-20210930.xsd#jazz_IncreaseDecreaseInOperatingLeaseAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c398f4d8-c87e-4672-8194-ad018a3a6c82" xlink:to="loc_jazz_IncreaseDecreaseInOperatingLeaseAssets_26945ab0-d6b6-403f-9aef-caf9141eb85e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_e8239697-cc95-4b60-800c-5a2ea193912d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c398f4d8-c87e-4672-8194-ad018a3a6c82" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_e8239697-cc95-4b60-800c-5a2ea193912d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d51f4a7a-a20c-4737-abfc-b2f6b480642b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c398f4d8-c87e-4672-8194-ad018a3a6c82" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d51f4a7a-a20c-4737-abfc-b2f6b480642b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_81bd092f-4ae9-4aca-b348-cce43b464196" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c398f4d8-c87e-4672-8194-ad018a3a6c82" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_81bd092f-4ae9-4aca-b348-cce43b464196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_026c29ac-8ebf-482b-a396-691ef406ec2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c398f4d8-c87e-4672-8194-ad018a3a6c82" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_026c29ac-8ebf-482b-a396-691ef406ec2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_1c4049c0-0954-46a2-a512-92dfb1106ee9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c398f4d8-c87e-4672-8194-ad018a3a6c82" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_1c4049c0-0954-46a2-a512-92dfb1106ee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_IncreaseDecreaseInOperatingLeaseLiabilitiesNoncurrent_5096b88c-abca-4512-86e3-08b07b3d83da" xlink:href="jazz-20210930.xsd#jazz_IncreaseDecreaseInOperatingLeaseLiabilitiesNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c398f4d8-c87e-4672-8194-ad018a3a6c82" xlink:to="loc_jazz_IncreaseDecreaseInOperatingLeaseLiabilitiesNoncurrent_5096b88c-abca-4512-86e3-08b07b3d83da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_99ba93be-431a-4bd9-8492-f3f2fde2892c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c398f4d8-c87e-4672-8194-ad018a3a6c82" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_99ba93be-431a-4bd9-8492-f3f2fde2892c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_17722fab-a559-474f-b84b-f32c2a749eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c1ecb00e-fec0-4ac8-b197-ed4a1a432431" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_17722fab-a559-474f-b84b-f32c2a749eb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0f560def-59d2-4396-9263-19a0608161b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d0a8dbe0-2c2b-4a73-99e8-b62ad6d74bd6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0f560def-59d2-4396-9263-19a0608161b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_e680f87d-3435-4415-9796-54d74fec3a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0f560def-59d2-4396-9263-19a0608161b9" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_e680f87d-3435-4415-9796-54d74fec3a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c0dcc0cf-97bc-4117-84de-4066e86c0159" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0f560def-59d2-4396-9263-19a0608161b9" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c0dcc0cf-97bc-4117-84de-4066e86c0159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_62e78cd3-4ac3-4de2-8217-b004d0cb51a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0f560def-59d2-4396-9263-19a0608161b9" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_62e78cd3-4ac3-4de2-8217-b004d0cb51a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_5ac25297-c188-4e37-8dc4-944631f0c55e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0f560def-59d2-4396-9263-19a0608161b9" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_5ac25297-c188-4e37-8dc4-944631f0c55e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_PaymentToAcquireAssetsNetOfCashAcquired_d9049868-9c35-4719-9046-6f013d750276" xlink:href="jazz-20210930.xsd#jazz_PaymentToAcquireAssetsNetOfCashAcquired"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0f560def-59d2-4396-9263-19a0608161b9" xlink:to="loc_jazz_PaymentToAcquireAssetsNetOfCashAcquired_d9049868-9c35-4719-9046-6f013d750276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_PaymentstoAcquireInProcessResearchandDevelopmentOtherThanThroughBusinessCombination_14959566-c781-47d7-864d-43e1fcea3cbb" xlink:href="jazz-20210930.xsd#jazz_PaymentstoAcquireInProcessResearchandDevelopmentOtherThanThroughBusinessCombination"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0f560def-59d2-4396-9263-19a0608161b9" xlink:to="loc_jazz_PaymentstoAcquireInProcessResearchandDevelopmentOtherThanThroughBusinessCombination_14959566-c781-47d7-864d-43e1fcea3cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7cb29523-1a19-4875-a0e7-c39a5d3a67d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0f560def-59d2-4396-9263-19a0608161b9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7cb29523-1a19-4875-a0e7-c39a5d3a67d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_451c46e2-b2f4-417b-8634-2645c2b49eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d0a8dbe0-2c2b-4a73-99e8-b62ad6d74bd6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_451c46e2-b2f4-417b-8634-2645c2b49eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ProceedsFromIssuanceOfTermLoan_9f2ce8a3-e8dd-47e0-a116-78567b5c1bd7" xlink:href="jazz-20210930.xsd#jazz_ProceedsFromIssuanceOfTermLoan"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_451c46e2-b2f4-417b-8634-2645c2b49eb6" xlink:to="loc_jazz_ProceedsFromIssuanceOfTermLoan_9f2ce8a3-e8dd-47e0-a116-78567b5c1bd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_b15d8caf-2da3-4295-b16e-5ec1d309e2db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_451c46e2-b2f4-417b-8634-2645c2b49eb6" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_b15d8caf-2da3-4295-b16e-5ec1d309e2db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_54d67e60-70b2-4e3b-aee8-c7c74731a12f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_451c46e2-b2f4-417b-8634-2645c2b49eb6" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_54d67e60-70b2-4e3b-aee8-c7c74731a12f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_c799ae2b-c339-44c5-a1d3-beed446e858a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_451c46e2-b2f4-417b-8634-2645c2b49eb6" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_c799ae2b-c339-44c5-a1d3-beed446e858a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_3adf70b8-7045-4a92-8b0f-b06d1a11e1e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_451c46e2-b2f4-417b-8634-2645c2b49eb6" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_3adf70b8-7045-4a92-8b0f-b06d1a11e1e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSecuredDebt_88e77bc1-59cc-4e30-a8af-f1d482fc3d36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfSecuredDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_451c46e2-b2f4-417b-8634-2645c2b49eb6" xlink:to="loc_us-gaap_RepaymentsOfSecuredDebt_88e77bc1-59cc-4e30-a8af-f1d482fc3d36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_68e91cd8-6826-4352-a719-686556f7ab1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_451c46e2-b2f4-417b-8634-2645c2b49eb6" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_68e91cd8-6826-4352-a719-686556f7ab1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_c386e491-1e77-48f1-a4bf-c8b5fac8fc74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_451c46e2-b2f4-417b-8634-2645c2b49eb6" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_c386e491-1e77-48f1-a4bf-c8b5fac8fc74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_8a566f65-3790-42c8-b64d-39df7ef255ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_451c46e2-b2f4-417b-8634-2645c2b49eb6" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_8a566f65-3790-42c8-b64d-39df7ef255ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_8e1ffa5e-b050-4d3d-95bd-e627a17e995a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_451c46e2-b2f4-417b-8634-2645c2b49eb6" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_8e1ffa5e-b050-4d3d-95bd-e627a17e995a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_76b1904f-e375-4f92-8f3a-d366722402e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_451c46e2-b2f4-417b-8634-2645c2b49eb6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_76b1904f-e375-4f92-8f3a-d366722402e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_63b96a10-399a-4428-bcf5-1bf5fe49b837" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d0a8dbe0-2c2b-4a73-99e8-b62ad6d74bd6" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_63b96a10-399a-4428-bcf5-1bf5fe49b837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_500971f4-98ea-4ed1-917b-4a35be9aa62f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d0a8dbe0-2c2b-4a73-99e8-b62ad6d74bd6" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_500971f4-98ea-4ed1-917b-4a35be9aa62f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_334cc7d6-9937-43b9-b3d5-c55c8370445e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d0a8dbe0-2c2b-4a73-99e8-b62ad6d74bd6" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_334cc7d6-9937-43b9-b3d5-c55c8370445e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6eb439bb-2795-49b0-8d04-db6fd6a6c938" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d0a8dbe0-2c2b-4a73-99e8-b62ad6d74bd6" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6eb439bb-2795-49b0-8d04-db6fd6a6c938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/TheCompanyandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="jazz-20210930.xsd#TheCompanyandSummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/TheCompanyandSummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d0563c2e-00c5-483f-b63d-b592cddfebdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_53b86bee-a642-4a1d-89f7-b65b442bc24c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d0563c2e-00c5-483f-b63d-b592cddfebdc" xlink:to="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_53b86bee-a642-4a1d-89f7-b65b442bc24c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/TheCompanyandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="jazz-20210930.xsd#TheCompanyandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/TheCompanyandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_cfb7a0ba-b43e-495b-afe2-57a3f1a59984" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_abc94cdc-80cb-4cbc-938c-8917f4ceb41f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cfb7a0ba-b43e-495b-afe2-57a3f1a59984" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_abc94cdc-80cb-4cbc-938c-8917f4ceb41f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_fa672929-148a-4ebb-bde3-90cccdc00e19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cfb7a0ba-b43e-495b-afe2-57a3f1a59984" xlink:to="loc_us-gaap_UseOfEstimates_fa672929-148a-4ebb-bde3-90cccdc00e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_963beb50-4b13-4506-a3f5-ed83fc1f8ceb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cfb7a0ba-b43e-495b-afe2-57a3f1a59984" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_963beb50-4b13-4506-a3f5-ed83fc1f8ceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_52dc4be4-7140-4e7a-91b1-6158186ee90d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cfb7a0ba-b43e-495b-afe2-57a3f1a59984" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_52dc4be4-7140-4e7a-91b1-6158186ee90d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_5a1e1699-f361-45e9-b300-5708aadbf66c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cfb7a0ba-b43e-495b-afe2-57a3f1a59984" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_5a1e1699-f361-45e9-b300-5708aadbf66c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_a4e2e194-558b-4cbc-8445-045d575656d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cfb7a0ba-b43e-495b-afe2-57a3f1a59984" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_a4e2e194-558b-4cbc-8445-045d575656d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_61e20ef3-a350-4f57-b88b-edd3dde5f75f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cfb7a0ba-b43e-495b-afe2-57a3f1a59984" xlink:to="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_61e20ef3-a350-4f57-b88b-edd3dde5f75f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_SignificantRisksAndUncertaintiesPolicyTextBlock_ed5e5301-7c1b-4ea4-a761-67126c59052d" xlink:href="jazz-20210930.xsd#jazz_SignificantRisksAndUncertaintiesPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cfb7a0ba-b43e-495b-afe2-57a3f1a59984" xlink:to="loc_jazz_SignificantRisksAndUncertaintiesPolicyTextBlock_ed5e5301-7c1b-4ea4-a761-67126c59052d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_974043fc-a6fc-46c6-93b9-8491e43abe86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cfb7a0ba-b43e-495b-afe2-57a3f1a59984" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_974043fc-a6fc-46c6-93b9-8491e43abe86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/TheCompanyandSummaryofSignificantAccountingPoliciesBasisofPresentationNarrativeDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#TheCompanyandSummaryofSignificantAccountingPoliciesBasisofPresentationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/TheCompanyandSummaryofSignificantAccountingPoliciesBasisofPresentationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c7403a20-fd64-4b88-832a-6750148a6c22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0608f6a1-3c1a-4dc0-92be-6d5c865c7a12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c7403a20-fd64-4b88-832a-6750148a6c22" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0608f6a1-3c1a-4dc0-92be-6d5c865c7a12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_bfce5cda-6507-4392-848e-eac4008abcd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0608f6a1-3c1a-4dc0-92be-6d5c865c7a12" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_bfce5cda-6507-4392-848e-eac4008abcd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_42b001dc-92fc-4a08-a289-0473ca369136" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bfce5cda-6507-4392-848e-eac4008abcd2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_42b001dc-92fc-4a08-a289-0473ca369136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_GWPharmaceuticalsPlcMember_2b54b9db-2542-4e7c-a0c6-1bd0c3e7b785" xlink:href="jazz-20210930.xsd#jazz_GWPharmaceuticalsPlcMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_42b001dc-92fc-4a08-a289-0473ca369136" xlink:to="loc_jazz_GWPharmaceuticalsPlcMember_2b54b9db-2542-4e7c-a0c6-1bd0c3e7b785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_046db5ac-975e-4cb6-b91b-676c286afe29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0608f6a1-3c1a-4dc0-92be-6d5c865c7a12" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_046db5ac-975e-4cb6-b91b-676c286afe29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_047a429b-e2d5-4bdd-af32-3ee47d3ba1f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_046db5ac-975e-4cb6-b91b-676c286afe29" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_047a429b-e2d5-4bdd-af32-3ee47d3ba1f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_7c85d492-3646-41f1-99e1-545b06770f66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_046db5ac-975e-4cb6-b91b-676c286afe29" xlink:to="loc_us-gaap_NumberOfOperatingSegments_7c85d492-3646-41f1-99e1-545b06770f66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/TheCompanyandSummaryofSignificantAccountingPoliciesConcentrationsofRiskNarrativeDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#TheCompanyandSummaryofSignificantAccountingPoliciesConcentrationsofRiskNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/TheCompanyandSummaryofSignificantAccountingPoliciesConcentrationsofRiskNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b36f7d26-57ce-46f5-851d-02586fb805c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_92dc48bf-134a-4a8d-9c38-90c46381d080" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b36f7d26-57ce-46f5-851d-02586fb805c5" xlink:to="loc_us-gaap_ConcentrationRiskTable_92dc48bf-134a-4a8d-9c38-90c46381d080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_cc6fab91-07f7-48b7-b18d-52f0c996efcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_92dc48bf-134a-4a8d-9c38-90c46381d080" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_cc6fab91-07f7-48b7-b18d-52f0c996efcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_98f6372b-315e-4f1f-95ff-1d6cd590e5ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_cc6fab91-07f7-48b7-b18d-52f0c996efcd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_98f6372b-315e-4f1f-95ff-1d6cd590e5ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_e45cdacb-c0cb-427d-ad05-e4b08ebec8c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_98f6372b-315e-4f1f-95ff-1d6cd590e5ea" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_e45cdacb-c0cb-427d-ad05-e4b08ebec8c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_c89b5d98-a0c6-4ba2-a72b-252e75bb9500" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_98f6372b-315e-4f1f-95ff-1d6cd590e5ea" xlink:to="loc_us-gaap_InterestRateContractMember_c89b5d98-a0c6-4ba2-a72b-252e75bb9500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_d48641a2-f201-431d-a429-c0b6188e5ae8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_98f6372b-315e-4f1f-95ff-1d6cd590e5ea" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_d48641a2-f201-431d-a429-c0b6188e5ae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_77521e1f-f9dc-453d-a2c3-1b2cb744b090" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_92dc48bf-134a-4a8d-9c38-90c46381d080" xlink:to="loc_us-gaap_HedgingDesignationAxis_77521e1f-f9dc-453d-a2c3-1b2cb744b090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_8bab9aac-958c-4596-affb-2b0bb9d3dded" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_77521e1f-f9dc-453d-a2c3-1b2cb744b090" xlink:to="loc_us-gaap_HedgingDesignationDomain_8bab9aac-958c-4596-affb-2b0bb9d3dded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_e855568d-f265-496b-9a54-af3b0df74047" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_8bab9aac-958c-4596-affb-2b0bb9d3dded" xlink:to="loc_us-gaap_NondesignatedMember_e855568d-f265-496b-9a54-af3b0df74047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c6fc069f-d732-4f88-81f6-ba12a7d8f753" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_8bab9aac-958c-4596-affb-2b0bb9d3dded" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_c6fc069f-d732-4f88-81f6-ba12a7d8f753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_a288b2c7-1cdd-4e8e-aeeb-1803ec69c340" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_92dc48bf-134a-4a8d-9c38-90c46381d080" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_a288b2c7-1cdd-4e8e-aeeb-1803ec69c340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_fd3e0c53-6a9e-4e3f-b87b-99508ae86c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_a288b2c7-1cdd-4e8e-aeeb-1803ec69c340" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_fd3e0c53-6a9e-4e3f-b87b-99508ae86c5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_498cb95b-b239-46d2-9281-23e44fbd1551" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_fd3e0c53-6a9e-4e3f-b87b-99508ae86c5d" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_498cb95b-b239-46d2-9281-23e44fbd1551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c3946503-fa11-4179-b205-a29e6603167b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_92dc48bf-134a-4a8d-9c38-90c46381d080" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c3946503-fa11-4179-b205-a29e6603167b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6b28cc0a-9909-4342-8a63-c505ea56b80d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c3946503-fa11-4179-b205-a29e6603167b" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6b28cc0a-9909-4342-8a63-c505ea56b80d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_3eed60dd-35c4-4bbe-962f-0704022ba3b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6b28cc0a-9909-4342-8a63-c505ea56b80d" xlink:to="loc_us-gaap_AccountsReceivableMember_3eed60dd-35c4-4bbe-962f-0704022ba3b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_037ad5a6-67b3-4b0b-8f01-e65b4fcd8111" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_92dc48bf-134a-4a8d-9c38-90c46381d080" xlink:to="loc_srt_MajorCustomersAxis_037ad5a6-67b3-4b0b-8f01-e65b4fcd8111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_2f0e1260-ac52-4377-89f4-480000a9e41b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_037ad5a6-67b3-4b0b-8f01-e65b4fcd8111" xlink:to="loc_srt_NameOfMajorCustomerDomain_2f0e1260-ac52-4377-89f4-480000a9e41b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ThreeCustomersMember_a425a43b-6195-400a-bc36-47640e56fac9" xlink:href="jazz-20210930.xsd#jazz_ThreeCustomersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_2f0e1260-ac52-4377-89f4-480000a9e41b" xlink:to="loc_jazz_ThreeCustomersMember_a425a43b-6195-400a-bc36-47640e56fac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ExpressScriptsMember_8304770a-6aef-468c-8df0-d28e3441ebc5" xlink:href="jazz-20210930.xsd#jazz_ExpressScriptsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_ThreeCustomersMember_a425a43b-6195-400a-bc36-47640e56fac9" xlink:to="loc_jazz_ExpressScriptsMember_8304770a-6aef-468c-8df0-d28e3441ebc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_McKessonCorporationMember_2b1f9a70-fe1e-401a-a48c-3eb7b57abfbb" xlink:href="jazz-20210930.xsd#jazz_McKessonCorporationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_ThreeCustomersMember_a425a43b-6195-400a-bc36-47640e56fac9" xlink:to="loc_jazz_McKessonCorporationMember_2b1f9a70-fe1e-401a-a48c-3eb7b57abfbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_CardinalHealthIncMember_824e8792-a3f4-4292-a261-9b05a2637e57" xlink:href="jazz-20210930.xsd#jazz_CardinalHealthIncMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_ThreeCustomersMember_a425a43b-6195-400a-bc36-47640e56fac9" xlink:to="loc_jazz_CardinalHealthIncMember_824e8792-a3f4-4292-a261-9b05a2637e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_65ba4b22-4af0-432f-b907-532d0b96dd97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_92dc48bf-134a-4a8d-9c38-90c46381d080" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_65ba4b22-4af0-432f-b907-532d0b96dd97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_4d6a96a6-055c-457a-a35f-82bea193ddee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_65ba4b22-4af0-432f-b907-532d0b96dd97" xlink:to="loc_us-gaap_DerivativeNotionalAmount_4d6a96a6-055c-457a-a35f-82bea193ddee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_7d4c469f-139b-4e4e-8409-99c97959024e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_65ba4b22-4af0-432f-b907-532d0b96dd97" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_7d4c469f-139b-4e4e-8409-99c97959024e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_d3471db6-0c89-405b-a8dc-b278e17f3bd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_65ba4b22-4af0-432f-b907-532d0b96dd97" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_d3471db6-0c89-405b-a8dc-b278e17f3bd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/BusinessCombination" xlink:type="simple" xlink:href="jazz-20210930.xsd#BusinessCombination"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/BusinessCombination" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_d31dc659-613b-4d57-9d19-4147b8dec751" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_8323b64e-cfb5-4be6-8159-08722a9edfac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_d31dc659-613b-4d57-9d19-4147b8dec751" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_8323b64e-cfb5-4be6-8159-08722a9edfac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/BusinessCombinationsTables" xlink:type="simple" xlink:href="jazz-20210930.xsd#BusinessCombinationsTables"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/BusinessCombinationsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_288bce6c-dc07-44b5-997b-1ca3fe543541" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_621275a9-4565-4313-bc64-e289ee79d492" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_288bce6c-dc07-44b5-997b-1ca3fe543541" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_621275a9-4565-4313-bc64-e289ee79d492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_f96f2ff4-1a13-401c-a8ff-a5a4d67d98ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_288bce6c-dc07-44b5-997b-1ca3fe543541" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_f96f2ff4-1a13-401c-a8ff-a5a4d67d98ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_f229cd51-a8f3-4e77-9858-32846d7b1011" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_288bce6c-dc07-44b5-997b-1ca3fe543541" xlink:to="loc_us-gaap_BusinessAcquisitionProFormaInformationTextBlock_f229cd51-a8f3-4e77-9858-32846d7b1011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/BusinessCombinationNarrativeDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#BusinessCombinationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/BusinessCombinationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_5d0df579-ee83-42be-87f3-eda4f6bac0a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_43651aec-5c24-434d-8e40-9a9d56982790" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_5d0df579-ee83-42be-87f3-eda4f6bac0a7" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_43651aec-5c24-434d-8e40-9a9d56982790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_0563d5cc-4514-4dc3-a007-b14b80a5e808" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_43651aec-5c24-434d-8e40-9a9d56982790" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_0563d5cc-4514-4dc3-a007-b14b80a5e808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f69c487d-aacd-4034-8a89-5b87c51a61fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_0563d5cc-4514-4dc3-a007-b14b80a5e808" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f69c487d-aacd-4034-8a89-5b87c51a61fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_GWPharmaceuticalsPlcMember_950386e8-4762-4bd4-81cf-b82983126bca" xlink:href="jazz-20210930.xsd#jazz_GWPharmaceuticalsPlcMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f69c487d-aacd-4034-8a89-5b87c51a61fa" xlink:to="loc_jazz_GWPharmaceuticalsPlcMember_950386e8-4762-4bd4-81cf-b82983126bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_25c86cba-745d-4ef9-a700-9778a74a645c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_43651aec-5c24-434d-8e40-9a9d56982790" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_25c86cba-745d-4ef9-a700-9778a74a645c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_b79a8be8-be3b-413c-a0f7-7dba30d076df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_25c86cba-745d-4ef9-a700-9778a74a645c" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_b79a8be8-be3b-413c-a0f7-7dba30d076df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_e387a2ca-bfdf-4885-a0fa-abe6e4747efb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_b79a8be8-be3b-413c-a0f7-7dba30d076df" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_e387a2ca-bfdf-4885-a0fa-abe6e4747efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_03c73d17-a639-41e2-a7de-85082f1eb36f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_43651aec-5c24-434d-8e40-9a9d56982790" xlink:to="loc_us-gaap_ValuationTechniqueAxis_03c73d17-a639-41e2-a7de-85082f1eb36f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_db22eb19-4b35-4c9c-8bac-6a5a4a8432ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueAxis_03c73d17-a639-41e2-a7de-85082f1eb36f" xlink:to="loc_us-gaap_ValuationTechniqueDomain_db22eb19-4b35-4c9c-8bac-6a5a4a8432ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeApproachValuationTechniqueMember_156db3de-b45d-4cd6-b0ee-9b90063035e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeApproachValuationTechniqueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_db22eb19-4b35-4c9c-8bac-6a5a4a8432ee" xlink:to="loc_us-gaap_IncomeApproachValuationTechniqueMember_156db3de-b45d-4cd6-b0ee-9b90063035e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_737ab734-2547-462e-9d7c-2a62c3898d99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_43651aec-5c24-434d-8e40-9a9d56982790" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_737ab734-2547-462e-9d7c-2a62c3898d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cc379a6a-27e9-4a29-9d27-4b21d380fb30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_737ab734-2547-462e-9d7c-2a62c3898d99" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cc379a6a-27e9-4a29-9d27-4b21d380fb30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_b9164f0d-3f0d-4723-a981-3fce2047acef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cc379a6a-27e9-4a29-9d27-4b21d380fb30" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_b9164f0d-3f0d-4723-a981-3fce2047acef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_5d5e4183-2cba-4dfb-afd6-9c9cf25c596e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_43651aec-5c24-434d-8e40-9a9d56982790" xlink:to="loc_us-gaap_DebtInstrumentAxis_5d5e4183-2cba-4dfb-afd6-9c9cf25c596e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cebd9ea5-21e3-4f64-802f-c4f6d572e129" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_5d5e4183-2cba-4dfb-afd6-9c9cf25c596e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cebd9ea5-21e3-4f64-802f-c4f6d572e129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_SeniorNotesDue2029Member_1008b9ac-279c-4d3f-82f8-45867275af28" xlink:href="jazz-20210930.xsd#jazz_SeniorNotesDue2029Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cebd9ea5-21e3-4f64-802f-c4f6d572e129" xlink:to="loc_jazz_SeniorNotesDue2029Member_1008b9ac-279c-4d3f-82f8-45867275af28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_TwoThousandTwentyOneCreditAgreementDollarTermLoanMember_beeae0f0-e361-4d52-a732-8ed41dfd0855" xlink:href="jazz-20210930.xsd#jazz_TwoThousandTwentyOneCreditAgreementDollarTermLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cebd9ea5-21e3-4f64-802f-c4f6d572e129" xlink:to="loc_jazz_TwoThousandTwentyOneCreditAgreementDollarTermLoanMember_beeae0f0-e361-4d52-a732-8ed41dfd0855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_TwoThousandTwentyOneCreditAgreementEuroTermLoanMember_5a4dc453-c984-4c97-9b09-1b19c68b93a5" xlink:href="jazz-20210930.xsd#jazz_TwoThousandTwentyOneCreditAgreementEuroTermLoanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cebd9ea5-21e3-4f64-802f-c4f6d572e129" xlink:to="loc_jazz_TwoThousandTwentyOneCreditAgreementEuroTermLoanMember_5a4dc453-c984-4c97-9b09-1b19c68b93a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_TwoThousandTwentyOneCreditAgreementRevolvingCreditFacilityMember_b677c9b1-adc0-4694-a39d-05c8eb379515" xlink:href="jazz-20210930.xsd#jazz_TwoThousandTwentyOneCreditAgreementRevolvingCreditFacilityMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cebd9ea5-21e3-4f64-802f-c4f6d572e129" xlink:to="loc_jazz_TwoThousandTwentyOneCreditAgreementRevolvingCreditFacilityMember_b677c9b1-adc0-4694-a39d-05c8eb379515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_dea91f36-8b6e-4bce-80d0-1cede93a7b32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_43651aec-5c24-434d-8e40-9a9d56982790" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_dea91f36-8b6e-4bce-80d0-1cede93a7b32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_27f5393a-d024-4767-be50-e1c025094768" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_dea91f36-8b6e-4bce-80d0-1cede93a7b32" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_27f5393a-d024-4767-be50-e1c025094768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_TermLoanMember_04366965-9648-4dd8-9feb-b7050e2a9adc" xlink:href="jazz-20210930.xsd#jazz_TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_27f5393a-d024-4767-be50-e1c025094768" xlink:to="loc_jazz_TermLoanMember_04366965-9648-4dd8-9feb-b7050e2a9adc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_SeniorSecuredDebtMember_b9b7a29f-e9d9-4db4-8ab3-ec5c45d2854a" xlink:href="jazz-20210930.xsd#jazz_SeniorSecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_27f5393a-d024-4767-be50-e1c025094768" xlink:to="loc_jazz_SeniorSecuredDebtMember_b9b7a29f-e9d9-4db4-8ab3-ec5c45d2854a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_db205bdc-117c-468c-8acc-ab82795bfbae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_27f5393a-d024-4767-be50-e1c025094768" xlink:to="loc_us-gaap_LineOfCreditMember_db205bdc-117c-468c-8acc-ab82795bfbae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_8698cf48-9370-4a60-8000-354d04c42455" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_43651aec-5c24-434d-8e40-9a9d56982790" xlink:to="loc_dei_LegalEntityAxis_8698cf48-9370-4a60-8000-354d04c42455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_98109209-9d89-485e-8c05-daf98f37418d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_8698cf48-9370-4a60-8000-354d04c42455" xlink:to="loc_dei_EntityDomain_98109209-9d89-485e-8c05-daf98f37418d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_JazzSecuritiesDesignatedActivityCompanyMember_a9809786-ecc4-4a5b-b657-f40ce9ede09b" xlink:href="jazz-20210930.xsd#jazz_JazzSecuritiesDesignatedActivityCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_98109209-9d89-485e-8c05-daf98f37418d" xlink:to="loc_jazz_JazzSecuritiesDesignatedActivityCompanyMember_a9809786-ecc4-4a5b-b657-f40ce9ede09b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrecurringAdjustmentAxis_a63a108d-0b0f-419e-8395-440564bea411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonrecurringAdjustmentAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_43651aec-5c24-434d-8e40-9a9d56982790" xlink:to="loc_us-gaap_NonrecurringAdjustmentAxis_a63a108d-0b0f-419e-8395-440564bea411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonrecurringAdjustmentDomain_5f4beaef-39f8-4ba5-826f-24ca8adcca45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonrecurringAdjustmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonrecurringAdjustmentAxis_a63a108d-0b0f-419e-8395-440564bea411" xlink:to="loc_us-gaap_NonrecurringAdjustmentDomain_5f4beaef-39f8-4ba5-826f-24ca8adcca45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionRelatedCostsMember_62d4e845-0e26-4c95-a6d9-39dd521d5d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquisitionRelatedCostsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonrecurringAdjustmentDomain_5f4beaef-39f8-4ba5-826f-24ca8adcca45" xlink:to="loc_us-gaap_AcquisitionRelatedCostsMember_62d4e845-0e26-4c95-a6d9-39dd521d5d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_AmortizationExpenseAdjustmentMember_b1841427-0496-408a-a524-7bea6bbf9be0" xlink:href="jazz-20210930.xsd#jazz_AmortizationExpenseAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonrecurringAdjustmentDomain_5f4beaef-39f8-4ba5-826f-24ca8adcca45" xlink:to="loc_jazz_AmortizationExpenseAdjustmentMember_b1841427-0496-408a-a524-7bea6bbf9be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_CostOfProductSalesAdjustmentMember_d98be9dc-6e15-4206-a798-8bccc87e3781" xlink:href="jazz-20210930.xsd#jazz_CostOfProductSalesAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonrecurringAdjustmentDomain_5f4beaef-39f8-4ba5-826f-24ca8adcca45" xlink:to="loc_jazz_CostOfProductSalesAdjustmentMember_d98be9dc-6e15-4206-a798-8bccc87e3781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_InterestExpenseAdjustmentMember_bdd3d954-6284-4f98-91c5-dae7e06f384c" xlink:href="jazz-20210930.xsd#jazz_InterestExpenseAdjustmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonrecurringAdjustmentDomain_5f4beaef-39f8-4ba5-826f-24ca8adcca45" xlink:to="loc_jazz_InterestExpenseAdjustmentMember_bdd3d954-6284-4f98-91c5-dae7e06f384c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_aa35e514-9c20-4f19-99a9-e014083a03f8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_43651aec-5c24-434d-8e40-9a9d56982790" xlink:to="loc_srt_StatementScenarioAxis_aa35e514-9c20-4f19-99a9-e014083a03f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_69fd91df-32db-4b51-9e89-b1cafbbb0da8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_aa35e514-9c20-4f19-99a9-e014083a03f8" xlink:to="loc_srt_ScenarioUnspecifiedDomain_69fd91df-32db-4b51-9e89-b1cafbbb0da8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProFormaMember_819abaaa-a18c-45d5-9225-eb321727542b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProFormaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_69fd91df-32db-4b51-9e89-b1cafbbb0da8" xlink:to="loc_srt_ProFormaMember_819abaaa-a18c-45d5-9225-eb321727542b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_52c88a9f-cb96-4494-a737-2a9394319217" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_43651aec-5c24-434d-8e40-9a9d56982790" xlink:to="loc_us-gaap_CreditFacilityAxis_52c88a9f-cb96-4494-a737-2a9394319217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_2d1c4daf-bafd-4fe6-a51c-115eca377f64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_52c88a9f-cb96-4494-a737-2a9394319217" xlink:to="loc_us-gaap_CreditFacilityDomain_2d1c4daf-bafd-4fe6-a51c-115eca377f64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_168073a3-808e-47b6-8ed4-35276dfe87e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_2d1c4daf-bafd-4fe6-a51c-115eca377f64" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_168073a3-808e-47b6-8ed4-35276dfe87e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_54e777ec-0359-4a07-8df3-a2dc359bdb46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_43651aec-5c24-434d-8e40-9a9d56982790" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_54e777ec-0359-4a07-8df3-a2dc359bdb46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_3434fa1b-6415-4328-85cc-0dc4726912d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_54e777ec-0359-4a07-8df3-a2dc359bdb46" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_3434fa1b-6415-4328-85cc-0dc4726912d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_d5b5d1e2-3dd1-412f-a14b-6bdc56af5869" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_54e777ec-0359-4a07-8df3-a2dc359bdb46" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_d5b5d1e2-3dd1-412f-a14b-6bdc56af5869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_06bd0122-3936-4591-8a51-ee9024e072d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_54e777ec-0359-4a07-8df3-a2dc359bdb46" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_06bd0122-3936-4591-8a51-ee9024e072d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_87b42b7b-9e52-4cb8-838d-ecfdefdb254a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_54e777ec-0359-4a07-8df3-a2dc359bdb46" xlink:to="loc_us-gaap_DebtInstrumentTerm_87b42b7b-9e52-4cb8-838d-ecfdefdb254a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_61a15f93-a6e0-4b1c-8900-f0ac47350ced" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_54e777ec-0359-4a07-8df3-a2dc359bdb46" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_61a15f93-a6e0-4b1c-8900-f0ac47350ced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_BusinessAcquisitionTransactionsCostsIncurredDuringPeriod_11948f55-5a05-49a2-b530-a4380a9746e5" xlink:href="jazz-20210930.xsd#jazz_BusinessAcquisitionTransactionsCostsIncurredDuringPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_54e777ec-0359-4a07-8df3-a2dc359bdb46" xlink:to="loc_jazz_BusinessAcquisitionTransactionsCostsIncurredDuringPeriod_11948f55-5a05-49a2-b530-a4380a9746e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_5c3f335f-c274-455e-a42a-710a97bb6ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_54e777ec-0359-4a07-8df3-a2dc359bdb46" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual_5c3f335f-c274-455e-a42a-710a97bb6ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_263adb47-7338-4412-96d4-9343c7738d97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_54e777ec-0359-4a07-8df3-a2dc359bdb46" xlink:to="loc_us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual_263adb47-7338-4412-96d4-9343c7738d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_ee301304-4846-4470-883b-5c888c108fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_54e777ec-0359-4a07-8df3-a2dc359bdb46" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory_ee301304-4846-4470-883b-5c888c108fc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_45cf6598-85c4-43a5-950f-d6394886b1a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_54e777ec-0359-4a07-8df3-a2dc359bdb46" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_45cf6598-85c4-43a5-950f-d6394886b1a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_FiniteLivedIntangibleAssetMeasurementInput_2345f917-06d5-452c-8def-2566f5e450ea" xlink:href="jazz-20210930.xsd#jazz_FiniteLivedIntangibleAssetMeasurementInput"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_54e777ec-0359-4a07-8df3-a2dc359bdb46" xlink:to="loc_jazz_FiniteLivedIntangibleAssetMeasurementInput_2345f917-06d5-452c-8def-2566f5e450ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_df635d51-e6f5-4299-b043-7b51ed89af32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_54e777ec-0359-4a07-8df3-a2dc359bdb46" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_df635d51-e6f5-4299-b043-7b51ed89af32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostsNotExpensedDuringPeriod_f1cec9ea-d2a7-4849-96fe-f9cb547d89f4" xlink:href="jazz-20210930.xsd#jazz_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostsNotExpensedDuringPeriod"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_54e777ec-0359-4a07-8df3-a2dc359bdb46" xlink:to="loc_jazz_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostsNotExpensedDuringPeriod_f1cec9ea-d2a7-4849-96fe-f9cb547d89f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_3c2f433b-ad9b-40dc-83f8-869010bbddcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_54e777ec-0359-4a07-8df3-a2dc359bdb46" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_3c2f433b-ad9b-40dc-83f8-869010bbddcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensedDuringPeriod_b4389fb4-ab1e-4518-8d3d-9ccee7909974" xlink:href="jazz-20210930.xsd#jazz_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensedDuringPeriod"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_54e777ec-0359-4a07-8df3-a2dc359bdb46" xlink:to="loc_jazz_BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensedDuringPeriod_b4389fb4-ab1e-4518-8d3d-9ccee7909974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_0f48f3c7-c40e-4f25-8fd8-0cd56f787219" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_54e777ec-0359-4a07-8df3-a2dc359bdb46" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_0f48f3c7-c40e-4f25-8fd8-0cd56f787219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment_c23f0002-0737-4c0e-bd55-5111f495c421" xlink:href="jazz-20210930.xsd#jazz_CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_54e777ec-0359-4a07-8df3-a2dc359bdb46" xlink:to="loc_jazz_CostOfProductSalesExcludingAmortizationOfAcquiredDevelopedTechnologyAndIntangibleAssetImpairment_c23f0002-0737-4c0e-bd55-5111f495c421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_ecdf198e-a817-424a-9a33-dbfec804516e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_54e777ec-0359-4a07-8df3-a2dc359bdb46" xlink:to="loc_us-gaap_InterestExpense_ecdf198e-a817-424a-9a33-dbfec804516e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/BusinessCombinationScheduleofAggregateConsiderationDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#BusinessCombinationScheduleofAggregateConsiderationDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/BusinessCombinationScheduleofAggregateConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_736d42dd-0a48-48d7-9902-5e1c7ef7ebed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_59e11c57-1428-47f5-8115-ca4e4efedb55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_736d42dd-0a48-48d7-9902-5e1c7ef7ebed" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_59e11c57-1428-47f5-8115-ca4e4efedb55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_15569248-8d70-4635-8255-ad4f6ad7fc3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_59e11c57-1428-47f5-8115-ca4e4efedb55" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_15569248-8d70-4635-8255-ad4f6ad7fc3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_acf0b4ef-4416-454e-ba79-6cff3bf1354a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_15569248-8d70-4635-8255-ad4f6ad7fc3a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_acf0b4ef-4416-454e-ba79-6cff3bf1354a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_GWPharmaceuticalsPlcMember_37115337-1467-4d2b-a520-417c892eba94" xlink:href="jazz-20210930.xsd#jazz_GWPharmaceuticalsPlcMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_acf0b4ef-4416-454e-ba79-6cff3bf1354a" xlink:to="loc_jazz_GWPharmaceuticalsPlcMember_37115337-1467-4d2b-a520-417c892eba94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_9e06cd67-7acd-41ee-b05b-2638363a2e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_59e11c57-1428-47f5-8115-ca4e4efedb55" xlink:to="loc_us-gaap_StatementClassOfStockAxis_9e06cd67-7acd-41ee-b05b-2638363a2e4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_6afa2a02-d253-4b52-a74a-2dc2a1cfa631" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_9e06cd67-7acd-41ee-b05b-2638363a2e4f" xlink:to="loc_us-gaap_ClassOfStockDomain_6afa2a02-d253-4b52-a74a-2dc2a1cfa631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AdrMember_f1226c58-e3e5-409f-82ab-9026100d91b9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AdrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_6afa2a02-d253-4b52-a74a-2dc2a1cfa631" xlink:to="loc_dei_AdrMember_f1226c58-e3e5-409f-82ab-9026100d91b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_OrdinarySharesMember_02dd265d-9e15-4b83-87c5-86a35bdaa620" xlink:href="jazz-20210930.xsd#jazz_OrdinarySharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_6afa2a02-d253-4b52-a74a-2dc2a1cfa631" xlink:to="loc_jazz_OrdinarySharesMember_02dd265d-9e15-4b83-87c5-86a35bdaa620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1c561df9-218c-4354-aaf6-463c7ffcf898" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_59e11c57-1428-47f5-8115-ca4e4efedb55" xlink:to="loc_us-gaap_AwardTypeAxis_1c561df9-218c-4354-aaf6-463c7ffcf898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e059ea10-396a-4b50-8d1f-efb4f6a7bb79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1c561df9-218c-4354-aaf6-463c7ffcf898" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e059ea10-396a-4b50-8d1f-efb4f6a7bb79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_db421fc5-0567-4b73-9a5e-2ac060e43ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e059ea10-396a-4b50-8d1f-efb4f6a7bb79" xlink:to="loc_us-gaap_EmployeeStockOptionMember_db421fc5-0567-4b73-9a5e-2ac060e43ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_301ed995-eaba-4b8a-a4be-335c85d8e00f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_59e11c57-1428-47f5-8115-ca4e4efedb55" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_301ed995-eaba-4b8a-a4be-335c85d8e00f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_BusinessCombinationNumberOfAmericanDepositorySharesAcquired_9c81d870-30a7-429f-aa1a-a5397fe195e0" xlink:href="jazz-20210930.xsd#jazz_BusinessCombinationNumberOfAmericanDepositorySharesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_301ed995-eaba-4b8a-a4be-335c85d8e00f" xlink:to="loc_jazz_BusinessCombinationNumberOfAmericanDepositorySharesAcquired_9c81d870-30a7-429f-aa1a-a5397fe195e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionSharePrice_4878d4fb-2112-4a48-9c0b-df4c8db7c321" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionSharePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_301ed995-eaba-4b8a-a4be-335c85d8e00f" xlink:to="loc_us-gaap_BusinessAcquisitionSharePrice_4878d4fb-2112-4a48-9c0b-df4c8db7c321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_275d5344-022f-4da0-be1a-b139b242beeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_301ed995-eaba-4b8a-a4be-335c85d8e00f" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_275d5344-022f-4da0-be1a-b139b242beeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_ac984130-1329-458c-a7c9-1f676f40e57e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_301ed995-eaba-4b8a-a4be-335c85d8e00f" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_ac984130-1329-458c-a7c9-1f676f40e57e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_bf1ffcf9-7a1d-4cfe-909a-1fa262c7702d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_301ed995-eaba-4b8a-a4be-335c85d8e00f" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_bf1ffcf9-7a1d-4cfe-909a-1fa262c7702d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_b21b4699-9a32-4051-8184-31adb71aa182" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_301ed995-eaba-4b8a-a4be-335c85d8e00f" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_b21b4699-9a32-4051-8184-31adb71aa182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_BusinessAcquisitionEquityInterestIssuedOrIssuableSharePrice_f0289d92-58bc-453e-8131-242401f89cc0" xlink:href="jazz-20210930.xsd#jazz_BusinessAcquisitionEquityInterestIssuedOrIssuableSharePrice"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_301ed995-eaba-4b8a-a4be-335c85d8e00f" xlink:to="loc_jazz_BusinessAcquisitionEquityInterestIssuedOrIssuableSharePrice_f0289d92-58bc-453e-8131-242401f89cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/BusinessCombinationScheduleofAssetsandLiabilitiesAcquiredDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#BusinessCombinationScheduleofAssetsandLiabilitiesAcquiredDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/BusinessCombinationScheduleofAssetsandLiabilitiesAcquiredDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_a311aaf8-3c3d-4f43-a605-3d3efe66a576" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_34fa2683-4b5c-422b-b4a5-b47b0012793f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_a311aaf8-3c3d-4f43-a605-3d3efe66a576" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_34fa2683-4b5c-422b-b4a5-b47b0012793f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b708b69a-2db2-403e-b66c-0241e38dab8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_34fa2683-4b5c-422b-b4a5-b47b0012793f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b708b69a-2db2-403e-b66c-0241e38dab8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0de04db2-0c9d-4aef-a87c-ce9bbc5d9b8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b708b69a-2db2-403e-b66c-0241e38dab8a" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0de04db2-0c9d-4aef-a87c-ce9bbc5d9b8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_GWPharmaceuticalsPlcMember_588c4c10-6c67-4053-8d1f-bdbb45603813" xlink:href="jazz-20210930.xsd#jazz_GWPharmaceuticalsPlcMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0de04db2-0c9d-4aef-a87c-ce9bbc5d9b8f" xlink:to="loc_jazz_GWPharmaceuticalsPlcMember_588c4c10-6c67-4053-8d1f-bdbb45603813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_eb375ad8-4486-4aba-a2a0-0d6bf710a815" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_34fa2683-4b5c-422b-b4a5-b47b0012793f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_eb375ad8-4486-4aba-a2a0-0d6bf710a815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1ef64ec3-ab6e-4a4a-8332-1761ac6dee1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_eb375ad8-4486-4aba-a2a0-0d6bf710a815" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1ef64ec3-ab6e-4a4a-8332-1761ac6dee1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_d919371f-1fbf-4ec7-bde2-342424d0437f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1ef64ec3-ab6e-4a4a-8332-1761ac6dee1e" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_d919371f-1fbf-4ec7-bde2-342424d0437f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_43b67507-535d-4f65-9c8f-958ab7c10724" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1ef64ec3-ab6e-4a4a-8332-1761ac6dee1e" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_43b67507-535d-4f65-9c8f-958ab7c10724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_7b2d473c-fedd-46e8-ab0d-83e0687cbf47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_34fa2683-4b5c-422b-b4a5-b47b0012793f" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_7b2d473c-fedd-46e8-ab0d-83e0687cbf47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_2eaffba3-57c1-4229-9350-fff29667bfba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b2d473c-fedd-46e8-ab0d-83e0687cbf47" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_2eaffba3-57c1-4229-9350-fff29667bfba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a7480057-57d6-4ced-bff7-457cf96105d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b2d473c-fedd-46e8-ab0d-83e0687cbf47" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a7480057-57d6-4ced-bff7-457cf96105d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_e5c5649c-a827-48b5-9ff2-50bdc3aa4b88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b2d473c-fedd-46e8-ab0d-83e0687cbf47" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_e5c5649c-a827-48b5-9ff2-50bdc3aa4b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_8baad38b-02b7-416a-8d72-ce31ee30b3e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b2d473c-fedd-46e8-ab0d-83e0687cbf47" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_8baad38b-02b7-416a-8d72-ce31ee30b3e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_b94b4d66-6a5d-448c-8420-046156e41692" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b2d473c-fedd-46e8-ab0d-83e0687cbf47" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_b94b4d66-6a5d-448c-8420-046156e41692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_4357c17b-744a-4265-8a11-9c5522ed7b21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b2d473c-fedd-46e8-ab0d-83e0687cbf47" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_4357c17b-744a-4265-8a11-9c5522ed7b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_cea5bd5d-4fb6-46ac-9acd-35a1be002a06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b2d473c-fedd-46e8-ab0d-83e0687cbf47" xlink:to="loc_us-gaap_Goodwill_cea5bd5d-4fb6-46ac-9acd-35a1be002a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_50e76c75-b4bf-4c5c-9357-be4bf9018a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b2d473c-fedd-46e8-ab0d-83e0687cbf47" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_50e76c75-b4bf-4c5c-9357-be4bf9018a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities_b3c92a56-e396-447d-90ac-d48b3f1b8f31" xlink:href="jazz-20210930.xsd#jazz_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b2d473c-fedd-46e8-ab0d-83e0687cbf47" xlink:to="loc_jazz_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities_b3c92a56-e396-447d-90ac-d48b3f1b8f31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsLiabilities_d2586f41-106c-4684-8e2e-b708810ced9a" xlink:href="jazz-20210930.xsd#jazz_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b2d473c-fedd-46e8-ab0d-83e0687cbf47" xlink:to="loc_jazz_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsLiabilities_d2586f41-106c-4684-8e2e-b708810ced9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_3e914386-d89a-43c4-b862-1e5dd50a8269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7b2d473c-fedd-46e8-ab0d-83e0687cbf47" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_3e914386-d89a-43c4-b862-1e5dd50a8269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/BusinessCombinationProFormaInformationDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#BusinessCombinationProFormaInformationDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/BusinessCombinationProFormaInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_d5f252a2-c847-44a1-8515-c44f4eceeb7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_865e56bb-f8ba-43ce-866c-696dc88287e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_d5f252a2-c847-44a1-8515-c44f4eceeb7f" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_865e56bb-f8ba-43ce-866c-696dc88287e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_29b1c0ef-c9b6-4e37-a469-014e39b356e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_865e56bb-f8ba-43ce-866c-696dc88287e7" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_29b1c0ef-c9b6-4e37-a469-014e39b356e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_16224383-deb8-4249-bc05-102e3f2b6523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_29b1c0ef-c9b6-4e37-a469-014e39b356e3" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_16224383-deb8-4249-bc05-102e3f2b6523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_GWPharmaceuticalsPlcMember_bb40d3a8-b134-424b-8c9d-4e8d0aba444b" xlink:href="jazz-20210930.xsd#jazz_GWPharmaceuticalsPlcMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_16224383-deb8-4249-bc05-102e3f2b6523" xlink:to="loc_jazz_GWPharmaceuticalsPlcMember_bb40d3a8-b134-424b-8c9d-4e8d0aba444b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_a2e5d842-5cc9-4204-a1df-9d24e5e07201" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_865e56bb-f8ba-43ce-866c-696dc88287e7" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_a2e5d842-5cc9-4204-a1df-9d24e5e07201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_08f7975a-b0ca-4392-bd4d-5ea76e7bd2a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a2e5d842-5cc9-4204-a1df-9d24e5e07201" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaRevenue_08f7975a-b0ca-4392-bd4d-5ea76e7bd2a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_f0e3e36a-5bfc-4641-902b-4d16eff717ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a2e5d842-5cc9-4204-a1df-9d24e5e07201" xlink:to="loc_us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_f0e3e36a-5bfc-4641-902b-4d16eff717ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CashandAvailableforSaleSecurities" xlink:type="simple" xlink:href="jazz-20210930.xsd#CashandAvailableforSaleSecurities"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/CashandAvailableforSaleSecurities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_bf58d293-587e-45f4-8f16-ed0faece6cde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_d1e7689c-d9a1-4eb5-89d1-4fa40e6e0cca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_bf58d293-587e-45f4-8f16-ed0faece6cde" xlink:to="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_d1e7689c-d9a1-4eb5-89d1-4fa40e6e0cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CashandAvailableforSaleSecuritiesTables" xlink:type="simple" xlink:href="jazz-20210930.xsd#CashandAvailableforSaleSecuritiesTables"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/CashandAvailableforSaleSecuritiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_681862da-0fdc-46ff-aa42-4aa944d381d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_c326d96f-a6c0-40bc-95a2-2f45f7511ead" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_681862da-0fdc-46ff-aa42-4aa944d381d4" xlink:to="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_c326d96f-a6c0-40bc-95a2-2f45f7511ead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CashandAvailableforSaleSecuritiesSummaryofCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#CashandAvailableforSaleSecuritiesSummaryofCashandCashEquivalentsDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/CashandAvailableforSaleSecuritiesSummaryofCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_96f303fd-7c07-4848-8cda-0e5290c1aee5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_492bfff5-79da-4438-b490-8ae0e0d13d64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_96f303fd-7c07-4848-8cda-0e5290c1aee5" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_492bfff5-79da-4438-b490-8ae0e0d13d64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_5c38826d-d465-4784-9bf4-f1e6f80d9a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_492bfff5-79da-4438-b490-8ae0e0d13d64" xlink:to="loc_us-gaap_FinancialInstrumentAxis_5c38826d-d465-4784-9bf4-f1e6f80d9a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d0398cb4-a2f4-44bf-b544-39a68e9e8edd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_5c38826d-d465-4784-9bf4-f1e6f80d9a8c" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d0398cb4-a2f4-44bf-b544-39a68e9e8edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_db0392c4-19f0-4d40-9a1f-32675e9cba48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d0398cb4-a2f4-44bf-b544-39a68e9e8edd" xlink:to="loc_us-gaap_CashMember_db0392c4-19f0-4d40-9a1f-32675e9cba48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankTimeDepositsMember_1818b3b2-0af4-4fb6-8bc1-7ffcd08e809e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BankTimeDepositsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d0398cb4-a2f4-44bf-b544-39a68e9e8edd" xlink:to="loc_us-gaap_BankTimeDepositsMember_1818b3b2-0af4-4fb6-8bc1-7ffcd08e809e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_1fcd7a6c-56d7-4d20-8a84-937f2d490f22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d0398cb4-a2f4-44bf-b544-39a68e9e8edd" xlink:to="loc_us-gaap_MoneyMarketFundsMember_1fcd7a6c-56d7-4d20-8a84-937f2d490f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_09500808-993b-4d30-a4c6-7d0680e0b26b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_492bfff5-79da-4438-b490-8ae0e0d13d64" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_09500808-993b-4d30-a4c6-7d0680e0b26b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_33fe6d76-b207-4354-af97-e90e6771da5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_09500808-993b-4d30-a4c6-7d0680e0b26b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_33fe6d76-b207-4354-af97-e90e6771da5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d67c6491-34d4-48b5-81d5-c543d0b24af8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_09500808-993b-4d30-a4c6-7d0680e0b26b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d67c6491-34d4-48b5-81d5-c543d0b24af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_b06b26ac-65c1-475e-aa02-40655a9d68de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_09500808-993b-4d30-a4c6-7d0680e0b26b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_b06b26ac-65c1-475e-aa02-40655a9d68de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1fa49938-cc2f-46b1-842f-3cd1778872d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_09500808-993b-4d30-a4c6-7d0680e0b26b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1fa49938-cc2f-46b1-842f-3cd1778872d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0bdccf88-e3fc-4a8f-a724-8b4816f9d8d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_09500808-993b-4d30-a4c6-7d0680e0b26b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0bdccf88-e3fc-4a8f-a724-8b4816f9d8d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_cae5c0d5-0ba7-4b96-81ac-ed2efb6a6431" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_09500808-993b-4d30-a4c6-7d0680e0b26b" xlink:to="loc_us-gaap_Investments_cae5c0d5-0ba7-4b96-81ac-ed2efb6a6431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CashandAvailableforSaleSecuritiesNarrativeDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#CashandAvailableforSaleSecuritiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/CashandAvailableforSaleSecuritiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_5a547a71-9285-4c1c-98c8-3cd6eed18d03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_6bd3f7ec-9fc3-430c-8583-47be8c8d6f25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_5a547a71-9285-4c1c-98c8-3cd6eed18d03" xlink:to="loc_us-gaap_InvestmentIncomeInterest_6bd3f7ec-9fc3-430c-8583-47be8c8d6f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/FairValueMeasurement" xlink:type="simple" xlink:href="jazz-20210930.xsd#FairValueMeasurement"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/FairValueMeasurement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_668f1998-fda7-44b0-90c7-812a232d6a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_fb8f0cac-72d4-4488-9514-5d29ca911584" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_668f1998-fda7-44b0-90c7-812a232d6a3d" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_fb8f0cac-72d4-4488-9514-5d29ca911584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/FairValueMeasurementTables" xlink:type="simple" xlink:href="jazz-20210930.xsd#FairValueMeasurementTables"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/FairValueMeasurementTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_2a0f2941-de42-4f96-9121-c8f963cd15e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_c7ac483b-7d71-4b48-ac93-ad188f6903f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2a0f2941-de42-4f96-9121-c8f963cd15e0" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_c7ac483b-7d71-4b48-ac93-ad188f6903f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/FairValueMeasurementAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6d1afe10-6126-42f7-b522-8c60cad7b701" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5aac5359-324e-4693-b066-bce9937257a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6d1afe10-6126-42f7-b522-8c60cad7b701" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5aac5359-324e-4693-b066-bce9937257a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_19c05b51-f599-41a9-a087-67f163e32d60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5aac5359-324e-4693-b066-bce9937257a0" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_19c05b51-f599-41a9-a087-67f163e32d60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_3c690550-52ac-48cc-8ac9-5ac7fb64ec49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_19c05b51-f599-41a9-a087-67f163e32d60" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_3c690550-52ac-48cc-8ac9-5ac7fb64ec49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_9187949d-b2bf-472e-b4b8-617c51be592f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_3c690550-52ac-48cc-8ac9-5ac7fb64ec49" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_9187949d-b2bf-472e-b4b8-617c51be592f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b20a4504-f77e-48ed-b1ac-3516ffe92ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5aac5359-324e-4693-b066-bce9937257a0" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b20a4504-f77e-48ed-b1ac-3516ffe92ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bf96ac4a-97a7-4a37-be7b-8ccb86cfa1fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b20a4504-f77e-48ed-b1ac-3516ffe92ee7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bf96ac4a-97a7-4a37-be7b-8ccb86cfa1fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_1e1814c4-9232-4e19-a1a8-ffba21740766" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bf96ac4a-97a7-4a37-be7b-8ccb86cfa1fc" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_1e1814c4-9232-4e19-a1a8-ffba21740766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_125bb040-e164-416f-a430-ebc9ab8bed9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bf96ac4a-97a7-4a37-be7b-8ccb86cfa1fc" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_125bb040-e164-416f-a430-ebc9ab8bed9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1e53f70f-bca5-4a79-8faf-7f3339b997a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5aac5359-324e-4693-b066-bce9937257a0" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1e53f70f-bca5-4a79-8faf-7f3339b997a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2ba86878-96e7-4fd0-850f-6f4d28fc6df1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1e53f70f-bca5-4a79-8faf-7f3339b997a7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2ba86878-96e7-4fd0-850f-6f4d28fc6df1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_231fd1d0-e38b-4b0a-9658-044a66d81509" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2ba86878-96e7-4fd0-850f-6f4d28fc6df1" xlink:to="loc_us-gaap_MoneyMarketFundsMember_231fd1d0-e38b-4b0a-9658-044a66d81509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankTimeDepositsMember_1412dd6e-3eb9-412b-aee3-dfb9c1044737" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BankTimeDepositsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2ba86878-96e7-4fd0-850f-6f4d28fc6df1" xlink:to="loc_us-gaap_BankTimeDepositsMember_1412dd6e-3eb9-412b-aee3-dfb9c1044737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_2aed3dcd-abea-48e5-ad22-1ceb5e8dd1ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2ba86878-96e7-4fd0-850f-6f4d28fc6df1" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_2aed3dcd-abea-48e5-ad22-1ceb5e8dd1ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_affc26e6-a894-4cc0-8af9-84f3d59ddc56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2ba86878-96e7-4fd0-850f-6f4d28fc6df1" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_affc26e6-a894-4cc0-8af9-84f3d59ddc56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_5a84a043-23a5-46c6-aac3-3c3abf2a4ab5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2ba86878-96e7-4fd0-850f-6f4d28fc6df1" xlink:to="loc_us-gaap_InterestRateContractMember_5a84a043-23a5-46c6-aac3-3c3abf2a4ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9a39980b-a8b3-401d-b35b-e98fb3258b91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5aac5359-324e-4693-b066-bce9937257a0" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9a39980b-a8b3-401d-b35b-e98fb3258b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_87c0bef5-7e58-4c4e-99e3-c6508930d1c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9a39980b-a8b3-401d-b35b-e98fb3258b91" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_87c0bef5-7e58-4c4e-99e3-c6508930d1c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_c96591dd-5029-4cdc-98c9-3676ac3f8266" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_87c0bef5-7e58-4c4e-99e3-c6508930d1c6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAbstract_c96591dd-5029-4cdc-98c9-3676ac3f8266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f38ef547-a792-4243-9422-95dbe56e84a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_c96591dd-5029-4cdc-98c9-3676ac3f8266" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f38ef547-a792-4243-9422-95dbe56e84a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_075b0348-0fee-461b-bf8e-daa4bbb37c73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_87c0bef5-7e58-4c4e-99e3-c6508930d1c6" xlink:to="loc_us-gaap_DerivativeAssets_075b0348-0fee-461b-bf8e-daa4bbb37c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_7c95be60-bf21-4559-8080-a1fac8015769" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_87c0bef5-7e58-4c4e-99e3-c6508930d1c6" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_7c95be60-bf21-4559-8080-a1fac8015769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_d6af4771-aa6d-4f84-864d-8e6d2008f87d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_9a39980b-a8b3-401d-b35b-e98fb3258b91" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_d6af4771-aa6d-4f84-864d-8e6d2008f87d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_146028b5-db2a-4931-99be-4c04d8210322" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_d6af4771-aa6d-4f84-864d-8e6d2008f87d" xlink:to="loc_us-gaap_DerivativeLiabilities_146028b5-db2a-4931-99be-4c04d8210322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_82534224-0068-4459-9e25-011c6dd42305" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_d6af4771-aa6d-4f84-864d-8e6d2008f87d" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_82534224-0068-4459-9e25-011c6dd42305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/FairValueMeasurementNarrativeDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#FairValueMeasurementNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/FairValueMeasurementNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_2ecbdc49-2850-48b9-9d88-f251887df230" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_c43d77fb-0a64-4e2d-90e8-2dcf5610b50b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2ecbdc49-2850-48b9-9d88-f251887df230" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_c43d77fb-0a64-4e2d-90e8-2dcf5610b50b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a299f659-b770-4b92-a37c-b5c96f083518" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_c43d77fb-0a64-4e2d-90e8-2dcf5610b50b" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a299f659-b770-4b92-a37c-b5c96f083518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b0c12c0b-751b-44ba-8de7-eb427cd52582" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a299f659-b770-4b92-a37c-b5c96f083518" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b0c12c0b-751b-44ba-8de7-eb427cd52582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_d5a28ff5-e3f8-4d30-8fbe-d6ea7c2ab764" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b0c12c0b-751b-44ba-8de7-eb427cd52582" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_d5a28ff5-e3f8-4d30-8fbe-d6ea7c2ab764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_eefd37c2-f859-4518-9e00-bcb02bc8551f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_c43d77fb-0a64-4e2d-90e8-2dcf5610b50b" xlink:to="loc_us-gaap_DebtInstrumentAxis_eefd37c2-f859-4518-9e00-bcb02bc8551f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c00bf13d-8cf1-4412-9f98-be086ee0f43d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_eefd37c2-f859-4518-9e00-bcb02bc8551f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c00bf13d-8cf1-4412-9f98-be086ee0f43d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ExchangeableSeniorNotesDue2021Member_bac0451a-eb00-4cf1-9269-1298392363e0" xlink:href="jazz-20210930.xsd#jazz_ExchangeableSeniorNotesDue2021Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c00bf13d-8cf1-4412-9f98-be086ee0f43d" xlink:to="loc_jazz_ExchangeableSeniorNotesDue2021Member_bac0451a-eb00-4cf1-9269-1298392363e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ExchangeableSeniorNotesDue2024Member_76c30158-2ad2-4c36-a8ec-4005a2286caf" xlink:href="jazz-20210930.xsd#jazz_ExchangeableSeniorNotesDue2024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c00bf13d-8cf1-4412-9f98-be086ee0f43d" xlink:to="loc_jazz_ExchangeableSeniorNotesDue2024Member_76c30158-2ad2-4c36-a8ec-4005a2286caf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ExchangeableSeniorNotesDue2026Member_2a7a0e87-64f7-42aa-bcc2-32e382e2a6a3" xlink:href="jazz-20210930.xsd#jazz_ExchangeableSeniorNotesDue2026Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c00bf13d-8cf1-4412-9f98-be086ee0f43d" xlink:to="loc_jazz_ExchangeableSeniorNotesDue2026Member_2a7a0e87-64f7-42aa-bcc2-32e382e2a6a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_SeniorNotesDue2029Member_220532a5-b3f2-4c7f-83a1-5051579ad600" xlink:href="jazz-20210930.xsd#jazz_SeniorNotesDue2029Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c00bf13d-8cf1-4412-9f98-be086ee0f43d" xlink:to="loc_jazz_SeniorNotesDue2029Member_220532a5-b3f2-4c7f-83a1-5051579ad600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_TwoThousandTwentyOneCreditAgreementDollarTermLoanMember_99f8949c-758b-48c8-8930-5fa48800f8f9" xlink:href="jazz-20210930.xsd#jazz_TwoThousandTwentyOneCreditAgreementDollarTermLoanMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c00bf13d-8cf1-4412-9f98-be086ee0f43d" xlink:to="loc_jazz_TwoThousandTwentyOneCreditAgreementDollarTermLoanMember_99f8949c-758b-48c8-8930-5fa48800f8f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_TwoThousandTwentyOneCreditAgreementEuroTermLoanMember_39265575-0e8e-4ce5-a561-78230d4faac6" xlink:href="jazz-20210930.xsd#jazz_TwoThousandTwentyOneCreditAgreementEuroTermLoanMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c00bf13d-8cf1-4412-9f98-be086ee0f43d" xlink:to="loc_jazz_TwoThousandTwentyOneCreditAgreementEuroTermLoanMember_39265575-0e8e-4ce5-a561-78230d4faac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_c0334f10-a891-4372-b012-6c6851c2828f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_c43d77fb-0a64-4e2d-90e8-2dcf5610b50b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_c0334f10-a891-4372-b012-6c6851c2828f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1f2b4195-42a9-4199-b224-d4abad5c4960" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_c0334f10-a891-4372-b012-6c6851c2828f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1f2b4195-42a9-4199-b224-d4abad5c4960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_f3611447-8d1e-43fe-8613-97f7dfabd897" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1f2b4195-42a9-4199-b224-d4abad5c4960" xlink:to="loc_us-gaap_ConvertibleDebtMember_f3611447-8d1e-43fe-8613-97f7dfabd897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_SeniorSecuredDebtMember_19a46e09-1ef5-41b7-b943-8690bb2a3f42" xlink:href="jazz-20210930.xsd#jazz_SeniorSecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1f2b4195-42a9-4199-b224-d4abad5c4960" xlink:to="loc_jazz_SeniorSecuredDebtMember_19a46e09-1ef5-41b7-b943-8690bb2a3f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_7a915bc5-ff81-4aee-a6b9-d0525030a285" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1f2b4195-42a9-4199-b224-d4abad5c4960" xlink:to="loc_us-gaap_LineOfCreditMember_7a915bc5-ff81-4aee-a6b9-d0525030a285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_1b1b3b56-1855-45b5-9675-39d0e99db926" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_c43d77fb-0a64-4e2d-90e8-2dcf5610b50b" xlink:to="loc_dei_LegalEntityAxis_1b1b3b56-1855-45b5-9675-39d0e99db926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_b6168c0d-433e-4cb0-b74c-d7b80af740fd" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_1b1b3b56-1855-45b5-9675-39d0e99db926" xlink:to="loc_dei_EntityDomain_b6168c0d-433e-4cb0-b74c-d7b80af740fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_JazzSecuritiesDesignatedActivityCompanyMember_3086b420-561f-4374-95db-ea8ae764f6e4" xlink:href="jazz-20210930.xsd#jazz_JazzSecuritiesDesignatedActivityCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_b6168c0d-433e-4cb0-b74c-d7b80af740fd" xlink:to="loc_jazz_JazzSecuritiesDesignatedActivityCompanyMember_3086b420-561f-4374-95db-ea8ae764f6e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_734fa7e8-2620-46a4-b996-267b6e873fef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_c43d77fb-0a64-4e2d-90e8-2dcf5610b50b" xlink:to="loc_us-gaap_CreditFacilityAxis_734fa7e8-2620-46a4-b996-267b6e873fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_5efd1bf1-d162-4c9d-813b-e49152d07bbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_734fa7e8-2620-46a4-b996-267b6e873fef" xlink:to="loc_us-gaap_CreditFacilityDomain_5efd1bf1-d162-4c9d-813b-e49152d07bbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_26944b6d-c883-4f81-a71c-b1c9f149a82f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_5efd1bf1-d162-4c9d-813b-e49152d07bbd" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_26944b6d-c883-4f81-a71c-b1c9f149a82f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_31fbf774-a630-440f-b0c3-6fa5e55d95b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_c43d77fb-0a64-4e2d-90e8-2dcf5610b50b" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_31fbf774-a630-440f-b0c3-6fa5e55d95b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_aedb5901-573f-44aa-9aab-fde992c9be3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_31fbf774-a630-440f-b0c3-6fa5e55d95b8" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_aedb5901-573f-44aa-9aab-fde992c9be3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_30b1bb68-dcac-4b15-a238-e0c1d2317b07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_31fbf774-a630-440f-b0c3-6fa5e55d95b8" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_30b1bb68-dcac-4b15-a238-e0c1d2317b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_2f769f56-2e01-4948-8f07-02408cfd827e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_31fbf774-a630-440f-b0c3-6fa5e55d95b8" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_2f769f56-2e01-4948-8f07-02408cfd827e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableFairValueDisclosure_a8205b85-f50a-4e5d-b19f-35a840d2cfc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_31fbf774-a630-440f-b0c3-6fa5e55d95b8" xlink:to="loc_us-gaap_NotesPayableFairValueDisclosure_a8205b85-f50a-4e5d-b19f-35a840d2cfc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditFairValueDisclosure_d773e25a-ad74-46f4-bd15-6d64c4ed2636" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LinesOfCreditFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_31fbf774-a630-440f-b0c3-6fa5e55d95b8" xlink:to="loc_us-gaap_LinesOfCreditFairValueDisclosure_d773e25a-ad74-46f4-bd15-6d64c4ed2636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivities" xlink:type="simple" xlink:href="jazz-20210930.xsd#DerivativeInstrumentsandHedgingActivities"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_155802a8-e9be-4491-8508-30e52b855c03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_f654ff22-e816-4b77-b8fa-96a2be59f322" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_155802a8-e9be-4491-8508-30e52b855c03" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_f654ff22-e816-4b77-b8fa-96a2be59f322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesTables" xlink:type="simple" xlink:href="jazz-20210930.xsd#DerivativeInstrumentsandHedgingActivitiesTables"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_654a3cf6-d34b-4c66-8455-02a5adbd480f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ScheduleOfFairValueHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_72f7023c-d6f5-4ac6-92fa-9e26245a0e0f" xlink:href="jazz-20210930.xsd#jazz_ScheduleOfFairValueHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_654a3cf6-d34b-4c66-8455-02a5adbd480f" xlink:to="loc_jazz_ScheduleOfFairValueHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_72f7023c-d6f5-4ac6-92fa-9e26245a0e0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_e5cd0bb3-a391-45f8-8d5c-8d41f5ed8f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_654a3cf6-d34b-4c66-8455-02a5adbd480f" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_e5cd0bb3-a391-45f8-8d5c-8d41f5ed8f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_c2496d9e-ec14-43e9-90b1-77becbe7d7d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_654a3cf6-d34b-4c66-8455-02a5adbd480f" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_c2496d9e-ec14-43e9-90b1-77becbe7d7d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_5c39085d-1917-4063-8b21-c8c7e63f31cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_654a3cf6-d34b-4c66-8455-02a5adbd480f" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_5c39085d-1917-4063-8b21-c8c7e63f31cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTableTextBlock_c0133b93-e979-45dd-8615-863e5142cdb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OffsettingAssetsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_654a3cf6-d34b-4c66-8455-02a5adbd480f" xlink:to="loc_us-gaap_OffsettingAssetsTableTextBlock_c0133b93-e979-45dd-8615-863e5142cdb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingLiabilitiesTableTextBlock_2d43b1cf-1faa-42a8-ba06-40f2dc990ebd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OffsettingLiabilitiesTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_654a3cf6-d34b-4c66-8455-02a5adbd480f" xlink:to="loc_us-gaap_OffsettingLiabilitiesTableTextBlock_2d43b1cf-1faa-42a8-ba06-40f2dc990ebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#DerivativeInstrumentsandHedgingActivitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ddd2b0d4-4bec-49f7-9711-ed63e7caca21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_8097efa2-9c8f-458b-9895-098b00390936" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ddd2b0d4-4bec-49f7-9711-ed63e7caca21" xlink:to="loc_us-gaap_DerivativeTable_8097efa2-9c8f-458b-9895-098b00390936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_0a408a88-5a4a-4cf6-8284-68be5ff6d96a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_8097efa2-9c8f-458b-9895-098b00390936" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_0a408a88-5a4a-4cf6-8284-68be5ff6d96a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_393c3858-4ca7-40f6-ac1f-8a3409f10df3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0a408a88-5a4a-4cf6-8284-68be5ff6d96a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_393c3858-4ca7-40f6-ac1f-8a3409f10df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_a6cf9f83-e72d-4337-8f60-fa32742dcb5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_393c3858-4ca7-40f6-ac1f-8a3409f10df3" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_a6cf9f83-e72d-4337-8f60-fa32742dcb5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_be37475a-4fc1-454e-a351-836667793d12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_393c3858-4ca7-40f6-ac1f-8a3409f10df3" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_be37475a-4fc1-454e-a351-836667793d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_ca0fc135-9e46-4a2e-b3c7-536966ab2e92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_8097efa2-9c8f-458b-9895-098b00390936" xlink:to="loc_us-gaap_HedgingDesignationAxis_ca0fc135-9e46-4a2e-b3c7-536966ab2e92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5cf51e50-9345-4c36-ab69-0a250771cb3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_ca0fc135-9e46-4a2e-b3c7-536966ab2e92" xlink:to="loc_us-gaap_HedgingDesignationDomain_5cf51e50-9345-4c36-ab69-0a250771cb3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_8658e3e0-2674-46e0-a3ee-1083c8559593" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_5cf51e50-9345-4c36-ab69-0a250771cb3c" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_8658e3e0-2674-46e0-a3ee-1083c8559593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_58a68e97-c94f-4684-b0e7-e140d4aebf56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_5cf51e50-9345-4c36-ab69-0a250771cb3c" xlink:to="loc_us-gaap_NondesignatedMember_58a68e97-c94f-4684-b0e7-e140d4aebf56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_2234f799-6dbd-4557-bec8-ad70d06e4e02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_8097efa2-9c8f-458b-9895-098b00390936" xlink:to="loc_us-gaap_DerivativeLineItems_2234f799-6dbd-4557-bec8-ad70d06e4e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_93ac5d20-d2fa-4686-a0a0-8f5160155ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_2234f799-6dbd-4557-bec8-ad70d06e4e02" xlink:to="loc_us-gaap_DerivativeNotionalAmount_93ac5d20-d2fa-4686-a0a0-8f5160155ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_77730429-da0b-415c-9f45-92b64dbe71b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_2234f799-6dbd-4557-bec8-ad70d06e4e02" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_77730429-da0b-415c-9f45-92b64dbe71b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesCrossCurrencyLossDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#DerivativeInstrumentsandHedgingActivitiesCrossCurrencyLossDerivativeInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesCrossCurrencyLossDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4fb66f1f-9ba9-4c39-9cc1-549550fdf33d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_538e9778-b163-4ace-9d0a-1b70cc23e30c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4fb66f1f-9ba9-4c39-9cc1-549550fdf33d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_538e9778-b163-4ace-9d0a-1b70cc23e30c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c51916b9-e3e9-4e92-8d60-08d6e3a4f763" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_538e9778-b163-4ace-9d0a-1b70cc23e30c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c51916b9-e3e9-4e92-8d60-08d6e3a4f763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d2db4aa3-fb5b-431c-949d-94457276cff4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c51916b9-e3e9-4e92-8d60-08d6e3a4f763" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d2db4aa3-fb5b-431c-949d-94457276cff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_7f9485cb-4eca-44c4-ac50-04f7e59cc2ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d2db4aa3-fb5b-431c-949d-94457276cff4" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_7f9485cb-4eca-44c4-ac50-04f7e59cc2ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_bb0836be-8bfe-4e7d-8976-e3f6e5549a31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_538e9778-b163-4ace-9d0a-1b70cc23e30c" xlink:to="loc_us-gaap_HedgingDesignationAxis_bb0836be-8bfe-4e7d-8976-e3f6e5549a31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_ae033d56-0363-4bd5-98ca-a53111a27b28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_bb0836be-8bfe-4e7d-8976-e3f6e5549a31" xlink:to="loc_us-gaap_HedgingDesignationDomain_ae033d56-0363-4bd5-98ca-a53111a27b28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fe521032-f541-4ff2-b161-77ee12e06761" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_ae033d56-0363-4bd5-98ca-a53111a27b28" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_fe521032-f541-4ff2-b161-77ee12e06761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_04d9f6d6-a1a0-40e3-bafb-f9386c44c558" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_538e9778-b163-4ace-9d0a-1b70cc23e30c" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_04d9f6d6-a1a0-40e3-bafb-f9386c44c558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustment_a106d5ef-30cb-4278-af24-4bfb4121e157" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_04d9f6d6-a1a0-40e3-bafb-f9386c44c558" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustment_a106d5ef-30cb-4278-af24-4bfb4121e157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_a9f6d34f-d2c6-4e9d-b517-ad0dc92bc3ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_04d9f6d6-a1a0-40e3-bafb-f9386c44c558" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_a9f6d34f-d2c6-4e9d-b517-ad0dc92bc3ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_4b5efa2c-130f-41e0-b852-0861bc3be846" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_04d9f6d6-a1a0-40e3-bafb-f9386c44c558" xlink:to="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_4b5efa2c-130f-41e0-b852-0861bc3be846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesForeignExchangeGainLossDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#DerivativeInstrumentsandHedgingActivitiesForeignExchangeGainLossDerivativeInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesForeignExchangeGainLossDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_039c66fb-4efc-40d3-b208-51e0b401c06f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_ee319fff-ffb1-4fd6-ac7b-dc32e15a1341" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_039c66fb-4efc-40d3-b208-51e0b401c06f" xlink:to="loc_us-gaap_DerivativeTable_ee319fff-ffb1-4fd6-ac7b-dc32e15a1341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_028957e0-218f-44a8-bbd9-db3ca2cd3a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ee319fff-ffb1-4fd6-ac7b-dc32e15a1341" xlink:to="loc_us-gaap_HedgingDesignationAxis_028957e0-218f-44a8-bbd9-db3ca2cd3a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_2a88a5d7-f9a9-40e6-8250-9dce4f8c18fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_028957e0-218f-44a8-bbd9-db3ca2cd3a5b" xlink:to="loc_us-gaap_HedgingDesignationDomain_2a88a5d7-f9a9-40e6-8250-9dce4f8c18fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_4347a78b-7d39-4f34-ae8b-9e42c0dfb536" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_2a88a5d7-f9a9-40e6-8250-9dce4f8c18fc" xlink:to="loc_us-gaap_NondesignatedMember_4347a78b-7d39-4f34-ae8b-9e42c0dfb536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c389c200-408c-4a2a-a5bb-4c7171601da4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ee319fff-ffb1-4fd6-ac7b-dc32e15a1341" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c389c200-408c-4a2a-a5bb-4c7171601da4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_1c0517cd-9f7d-412c-91e0-10bb12cf0a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c389c200-408c-4a2a-a5bb-4c7171601da4" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_1c0517cd-9f7d-412c-91e0-10bb12cf0a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_a6cd98e5-d784-40d5-af77-754e70560dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_1c0517cd-9f7d-412c-91e0-10bb12cf0a7a" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_a6cd98e5-d784-40d5-af77-754e70560dc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_ff574c7c-0ba7-4aab-a8a3-7e52a8e45616" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ee319fff-ffb1-4fd6-ac7b-dc32e15a1341" xlink:to="loc_us-gaap_DerivativeLineItems_ff574c7c-0ba7-4aab-a8a3-7e52a8e45616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_5cd57e19-e99b-49b2-8450-577a5868b6b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_ff574c7c-0ba7-4aab-a8a3-7e52a8e45616" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_5cd57e19-e99b-49b2-8450-577a5868b6b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesGainLossonDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#DerivativeInstrumentsandHedgingActivitiesGainLossonDerivativeInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesGainLossonDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_34c0342c-4cb6-4101-96ae-3e5e73f5ec73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_b0c1e829-8624-4008-9a98-18bdd609a9b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_34c0342c-4cb6-4101-96ae-3e5e73f5ec73" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_b0c1e829-8624-4008-9a98-18bdd609a9b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_39ab5290-8000-4f53-8f21-bbb2c17f58fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_b0c1e829-8624-4008-9a98-18bdd609a9b5" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_39ab5290-8000-4f53-8f21-bbb2c17f58fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_627eebbe-4b8c-43d2-9ceb-53585239bb65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_39ab5290-8000-4f53-8f21-bbb2c17f58fe" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_627eebbe-4b8c-43d2-9ceb-53585239bb65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_2951eebf-35c3-42ba-b8bb-5aafc105dcb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_627eebbe-4b8c-43d2-9ceb-53585239bb65" xlink:to="loc_us-gaap_InterestRateContractMember_2951eebf-35c3-42ba-b8bb-5aafc105dcb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_581a984b-4011-469c-8d5e-f02e3c625ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_b0c1e829-8624-4008-9a98-18bdd609a9b5" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_581a984b-4011-469c-8d5e-f02e3c625ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_c951a65c-1d53-4770-b232-fff7e03889c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_581a984b-4011-469c-8d5e-f02e3c625ee6" xlink:to="loc_us-gaap_HedgingRelationshipDomain_c951a65c-1d53-4770-b232-fff7e03889c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_d066d81e-5843-4df2-adec-4c5c987123a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_c951a65c-1d53-4770-b232-fff7e03889c8" xlink:to="loc_us-gaap_CashFlowHedgingMember_d066d81e-5843-4df2-adec-4c5c987123a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_f150faf1-12c2-4dda-bf56-d037b168c631" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_b0c1e829-8624-4008-9a98-18bdd609a9b5" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_f150faf1-12c2-4dda-bf56-d037b168c631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_d19ab3d8-73c5-4553-a2c1-2ba2c19e5395" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_f150faf1-12c2-4dda-bf56-d037b168c631" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_d19ab3d8-73c5-4553-a2c1-2ba2c19e5395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_7b00e6e2-9285-4dd3-ad13-8dafa5b8df4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_f150faf1-12c2-4dda-bf56-d037b168c631" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_7b00e6e2-9285-4dd3-ad13-8dafa5b8df4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesFairValueofOutstandingDerivativesDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#DerivativeInstrumentsandHedgingActivitiesFairValueofOutstandingDerivativesDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesFairValueofOutstandingDerivativesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d4a3f12e-51d6-41e8-9fca-6594ed54ab15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_eaf10904-7dd3-42a0-9ef8-06277b189dad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d4a3f12e-51d6-41e8-9fca-6594ed54ab15" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_eaf10904-7dd3-42a0-9ef8-06277b189dad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_596fabe7-7f05-4615-a5a5-a447a14edc12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_eaf10904-7dd3-42a0-9ef8-06277b189dad" xlink:to="loc_us-gaap_HedgingDesignationAxis_596fabe7-7f05-4615-a5a5-a447a14edc12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_d1c397e6-d86f-409b-934c-409c6ceafadf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_596fabe7-7f05-4615-a5a5-a447a14edc12" xlink:to="loc_us-gaap_HedgingDesignationDomain_d1c397e6-d86f-409b-934c-409c6ceafadf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_f17b2fe4-b5c0-473c-9a86-e401d4b8fb51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_d1c397e6-d86f-409b-934c-409c6ceafadf" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_f17b2fe4-b5c0-473c-9a86-e401d4b8fb51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_55d5378f-dbfc-4adb-bda3-c59c56b71c16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_d1c397e6-d86f-409b-934c-409c6ceafadf" xlink:to="loc_us-gaap_NondesignatedMember_55d5378f-dbfc-4adb-bda3-c59c56b71c16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_28ded9ea-54d3-4596-86b2-d27207165570" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_eaf10904-7dd3-42a0-9ef8-06277b189dad" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_28ded9ea-54d3-4596-86b2-d27207165570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ca9d43f9-1e91-497a-9df0-17d726cb4a86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_28ded9ea-54d3-4596-86b2-d27207165570" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ca9d43f9-1e91-497a-9df0-17d726cb4a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_20f4745a-90c0-4cc4-8cb3-14c2df09b718" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ca9d43f9-1e91-497a-9df0-17d726cb4a86" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_20f4745a-90c0-4cc4-8cb3-14c2df09b718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_1c447dd9-eec0-40dc-98fa-df5ad10e0906" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ca9d43f9-1e91-497a-9df0-17d726cb4a86" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_1c447dd9-eec0-40dc-98fa-df5ad10e0906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_242e4859-be29-48f3-909c-29b9ec6d9188" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ca9d43f9-1e91-497a-9df0-17d726cb4a86" xlink:to="loc_us-gaap_InterestRateContractMember_242e4859-be29-48f3-909c-29b9ec6d9188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_e1aa7b85-a713-4522-ab03-2f257a8f4350" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_eaf10904-7dd3-42a0-9ef8-06277b189dad" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_e1aa7b85-a713-4522-ab03-2f257a8f4350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_4bafff2d-4d38-458b-8612-6ca12b93bb9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e1aa7b85-a713-4522-ab03-2f257a8f4350" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_4bafff2d-4d38-458b-8612-6ca12b93bb9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_cfc93f2c-9dac-4b19-91c6-fa5bebd41a8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_4bafff2d-4d38-458b-8612-6ca12b93bb9c" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_cfc93f2c-9dac-4b19-91c6-fa5bebd41a8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_e5656828-1e0f-4af5-991c-0b5a3ac0e9bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_4bafff2d-4d38-458b-8612-6ca12b93bb9c" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_e5656828-1e0f-4af5-991c-0b5a3ac0e9bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_7b214f0d-57c0-4694-acba-dba15e22d204" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_eaf10904-7dd3-42a0-9ef8-06277b189dad" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_7b214f0d-57c0-4694-acba-dba15e22d204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement_b1922ee8-12e7-4727-b1c8-14939c89bd67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_7b214f0d-57c0-4694-acba-dba15e22d204" xlink:to="loc_us-gaap_DerivativeAssetFairValueGrossAssetIncludingNotSubjectToMasterNettingArrangement_b1922ee8-12e7-4727-b1c8-14939c89bd67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement_e1c56c19-4765-4f36-b254-52e1a03266a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_7b214f0d-57c0-4694-acba-dba15e22d204" xlink:to="loc_us-gaap_DerivativeLiabilityFairValueGrossLiabilityIncludingNotSubjectToMasterNettingArrangement_e1c56c19-4765-4f36-b254-52e1a03266a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesOffsettingAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#DerivativeInstrumentsandHedgingActivitiesOffsettingAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/DerivativeInstrumentsandHedgingActivitiesOffsettingAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8a5fc676-88c5-4499-86f9-bde630b64f24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTable_6c2bf8e7-808c-4a42-8783-162847532a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OffsettingAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8a5fc676-88c5-4499-86f9-bde630b64f24" xlink:to="loc_us-gaap_OffsettingAssetsTable_6c2bf8e7-808c-4a42-8783-162847532a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_3d3a0bc5-46e5-4746-a627-c95ffad6e15e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_6c2bf8e7-808c-4a42-8783-162847532a9d" xlink:to="loc_srt_StatementScenarioAxis_3d3a0bc5-46e5-4746-a627-c95ffad6e15e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_c1534e5d-9dec-46df-9573-e0bf708d1fd1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_3d3a0bc5-46e5-4746-a627-c95ffad6e15e" xlink:to="loc_srt_ScenarioUnspecifiedDomain_c1534e5d-9dec-46df-9573-e0bf708d1fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProFormaMember_bc3d10a0-0412-4e6a-a5bd-8a4b582cb37e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProFormaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_c1534e5d-9dec-46df-9573-e0bf708d1fd1" xlink:to="loc_srt_ProFormaMember_bc3d10a0-0412-4e6a-a5bd-8a4b582cb37e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsLineItems_66ebff2f-54d4-407c-9805-6a5cee6fb07f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OffsettingAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_6c2bf8e7-808c-4a42-8783-162847532a9d" xlink:to="loc_us-gaap_OffsettingAssetsLineItems_66ebff2f-54d4-407c-9805-6a5cee6fb07f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsAbstract_8e52e0f2-2fa7-47b1-b5a5-dc7f327cef73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_66ebff2f-54d4-407c-9805-6a5cee6fb07f" xlink:to="loc_us-gaap_DerivativeAssetsAbstract_8e52e0f2-2fa7-47b1-b5a5-dc7f327cef73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_f761cec0-7fa8-4c8f-aad2-ba802a12da1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_8e52e0f2-2fa7-47b1-b5a5-dc7f327cef73" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_f761cec0-7fa8-4c8f-aad2-ba802a12da1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueGrossLiability_c9bdca57-d839-49c5-b937-91d2fe6d7640" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetFairValueGrossLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_8e52e0f2-2fa7-47b1-b5a5-dc7f327cef73" xlink:to="loc_us-gaap_DerivativeAssetFairValueGrossLiability_c9bdca57-d839-49c5-b937-91d2fe6d7640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_fd178ed2-960e-4228-bd8f-8d82ea186689" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetsAbstract_8e52e0f2-2fa7-47b1-b5a5-dc7f327cef73" xlink:to="loc_us-gaap_DerivativeAssets_fd178ed2-960e-4228-bd8f-8d82ea186689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueAmountOffsetAgainstCollateralAbstract_cc40311e-db87-469b-a703-f4e2f54fb4f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssetFairValueAmountOffsetAgainstCollateralAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_66ebff2f-54d4-407c-9805-6a5cee6fb07f" xlink:to="loc_us-gaap_DerivativeAssetFairValueAmountOffsetAgainstCollateralAbstract_cc40311e-db87-469b-a703-f4e2f54fb4f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralObligationToReturnSecurities_ed3fb29e-2024-451d-9432-71f8a66f6da6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeCollateralObligationToReturnSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetFairValueAmountOffsetAgainstCollateralAbstract_cc40311e-db87-469b-a703-f4e2f54fb4f3" xlink:to="loc_us-gaap_DerivativeCollateralObligationToReturnSecurities_ed3fb29e-2024-451d-9432-71f8a66f6da6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralObligationToReturnCash_d2648191-41e8-45a8-9bf7-01e1f737e041" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeCollateralObligationToReturnCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetFairValueAmountOffsetAgainstCollateralAbstract_cc40311e-db87-469b-a703-f4e2f54fb4f3" xlink:to="loc_us-gaap_DerivativeCollateralObligationToReturnCash_d2648191-41e8-45a8-9bf7-01e1f737e041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_424ce4f3-fd79-4a9e-9415-22d42964c5e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeAssetFairValueAmountOffsetAgainstCollateralAbstract_cc40311e-db87-469b-a703-f4e2f54fb4f3" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_424ce4f3-fd79-4a9e-9415-22d42964c5e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingLiabilitiesTable_5f6c1839-5c2c-4f88-9bcd-d6d2eb990b64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OffsettingLiabilitiesTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8a5fc676-88c5-4499-86f9-bde630b64f24" xlink:to="loc_us-gaap_OffsettingLiabilitiesTable_5f6c1839-5c2c-4f88-9bcd-d6d2eb990b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_103d1b4e-99c1-4b97-9117-e1bb23570a23" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingLiabilitiesTable_5f6c1839-5c2c-4f88-9bcd-d6d2eb990b64" xlink:to="loc_srt_StatementScenarioAxis_103d1b4e-99c1-4b97-9117-e1bb23570a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_d3c665b8-cce0-4891-8c36-ed21c0255587" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProFormaMember_e922096b-9012-4db4-886d-6d4e96481083" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProFormaMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingLiabilitiesLineItems_0f441e30-c6e2-4905-8308-75c4cb1df6ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OffsettingLiabilitiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingLiabilitiesTable_5f6c1839-5c2c-4f88-9bcd-d6d2eb990b64" xlink:to="loc_us-gaap_OffsettingLiabilitiesLineItems_0f441e30-c6e2-4905-8308-75c4cb1df6ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesAbstract_99694108-6b22-4ec1-aa52-178bdec5bb08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingLiabilitiesLineItems_0f441e30-c6e2-4905-8308-75c4cb1df6ae" xlink:to="loc_us-gaap_DerivativeLiabilitiesAbstract_99694108-6b22-4ec1-aa52-178bdec5bb08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_92e44f00-f8ac-4e6c-aec3-24e97d6c1733" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_99694108-6b22-4ec1-aa52-178bdec5bb08" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_92e44f00-f8ac-4e6c-aec3-24e97d6c1733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_76607c12-4772-48e9-8b77-0a309125932e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityFairValueGrossAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_99694108-6b22-4ec1-aa52-178bdec5bb08" xlink:to="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_76607c12-4772-48e9-8b77-0a309125932e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_7859a4c9-1183-4277-90b8-b7847f55ed71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLiabilitiesAbstract_99694108-6b22-4ec1-aa52-178bdec5bb08" xlink:to="loc_us-gaap_DerivativeLiabilities_7859a4c9-1183-4277-90b8-b7847f55ed71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueAmountOffsetAgainstCollateralAbstract_efcffbf3-e0a1-4c7a-accd-d0d53c84100e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityFairValueAmountOffsetAgainstCollateralAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingLiabilitiesLineItems_0f441e30-c6e2-4905-8308-75c4cb1df6ae" xlink:to="loc_us-gaap_DerivativeLiabilityFairValueAmountOffsetAgainstCollateralAbstract_efcffbf3-e0a1-4c7a-accd-d0d53c84100e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralRightToReclaimSecurities_dc7138cd-b390-4214-93f4-ddbb7eac821c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeCollateralRightToReclaimSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLiabilityFairValueAmountOffsetAgainstCollateralAbstract_efcffbf3-e0a1-4c7a-accd-d0d53c84100e" xlink:to="loc_us-gaap_DerivativeCollateralRightToReclaimSecurities_dc7138cd-b390-4214-93f4-ddbb7eac821c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeCollateralRightToReclaimCash_6b2311fc-ee38-4d17-a0b6-bcefc86dd003" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeCollateralRightToReclaimCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLiabilityFairValueAmountOffsetAgainstCollateralAbstract_efcffbf3-e0a1-4c7a-accd-d0d53c84100e" xlink:to="loc_us-gaap_DerivativeCollateralRightToReclaimCash_6b2311fc-ee38-4d17-a0b6-bcefc86dd003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_03c11fe6-7fb1-4dce-a27b-f2e320e54d06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLiabilityFairValueAmountOffsetAgainstCollateralAbstract_efcffbf3-e0a1-4c7a-accd-d0d53c84100e" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_03c11fe6-7fb1-4dce-a27b-f2e320e54d06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/Inventories" xlink:type="simple" xlink:href="jazz-20210930.xsd#Inventories"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/Inventories" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_3af4528f-b3ed-4773-b063-5acea68f17a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_261c6bd6-5d44-453f-8c58-08740af53262" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_3af4528f-b3ed-4773-b063-5acea68f17a8" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_261c6bd6-5d44-453f-8c58-08740af53262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/InventoriesTables" xlink:type="simple" xlink:href="jazz-20210930.xsd#InventoriesTables"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/InventoriesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_6d072f6c-8ca5-4496-b33f-882b60c90936" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_dd8a80e8-e74a-41da-912f-4838b9d0455b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_6d072f6c-8ca5-4496-b33f-882b60c90936" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_dd8a80e8-e74a-41da-912f-4838b9d0455b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/InventoriesComponentsofInventoriesDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#InventoriesComponentsofInventoriesDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/InventoriesComponentsofInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_5aa91e7e-49f5-4394-95e3-6ac8d2151c96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable_aa991110-bdb5-4aac-911b-35af09f24e8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryCurrentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_5aa91e7e-49f5-4394-95e3-6ac8d2151c96" xlink:to="loc_us-gaap_InventoryCurrentTable_aa991110-bdb5-4aac-911b-35af09f24e8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4d66b68e-c12c-42c1-8173-50a7862fe595" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryCurrentTable_aa991110-bdb5-4aac-911b-35af09f24e8e" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4d66b68e-c12c-42c1-8173-50a7862fe595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_437bdb23-1bf3-43c8-bbc1-ec239f412655" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4d66b68e-c12c-42c1-8173-50a7862fe595" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_437bdb23-1bf3-43c8-bbc1-ec239f412655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_GWPharmaceuticalsPlcMember_60362dc1-320c-4fd8-a6c5-ae3197bc4ff9" xlink:href="jazz-20210930.xsd#jazz_GWPharmaceuticalsPlcMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_437bdb23-1bf3-43c8-bbc1-ec239f412655" xlink:to="loc_jazz_GWPharmaceuticalsPlcMember_60362dc1-320c-4fd8-a6c5-ae3197bc4ff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems_5f172e26-84f4-43a0-8c83-396a9ab318af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryCurrentTable_aa991110-bdb5-4aac-911b-35af09f24e8e" xlink:to="loc_us-gaap_InventoryLineItems_5f172e26-84f4-43a0-8c83-396a9ab318af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_0339677d-ee01-43a4-9c52-ea758b118346" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_5f172e26-84f4-43a0-8c83-396a9ab318af" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_0339677d-ee01-43a4-9c52-ea758b118346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_693c6980-47ef-49fa-9e8a-e8d5f4e4196c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_5f172e26-84f4-43a0-8c83-396a9ab318af" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_693c6980-47ef-49fa-9e8a-e8d5f4e4196c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_2dc87c92-d521-47d5-8e64-2a20af3b7372" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_5f172e26-84f4-43a0-8c83-396a9ab318af" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_2dc87c92-d521-47d5-8e64-2a20af3b7372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_2b58bb32-8671-4625-a6cf-1cb441e5b72a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_5f172e26-84f4-43a0-8c83-396a9ab318af" xlink:to="loc_us-gaap_InventoryNet_2b58bb32-8671-4625-a6cf-1cb441e5b72a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_InventoryStepUpValue_81effdaa-a852-44dd-b353-4bac88963ce0" xlink:href="jazz-20210930.xsd#jazz_InventoryStepUpValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_5f172e26-84f4-43a0-8c83-396a9ab318af" xlink:to="loc_jazz_InventoryStepUpValue_81effdaa-a852-44dd-b353-4bac88963ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/GoodwillandIntangibleAssets" xlink:type="simple" xlink:href="jazz-20210930.xsd#GoodwillandIntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/GoodwillandIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2834575f-97cd-440b-b84d-d429f0b9fa3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_ac97edbf-0b06-4f42-9011-681b2da68912" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2834575f-97cd-440b-b84d-d429f0b9fa3d" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_ac97edbf-0b06-4f42-9011-681b2da68912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsTables" xlink:type="simple" xlink:href="jazz-20210930.xsd#GoodwillandIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bd9fc0bb-c689-4823-a3a7-9b7d3cffd813" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_0bf30170-5e06-4a23-b725-cd8761a17a3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bd9fc0bb-c689-4823-a3a7-9b7d3cffd813" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_0bf30170-5e06-4a23-b725-cd8761a17a3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsTableTextBlock_26ca0384-887f-448a-9593-96970c4a6cb3" xlink:href="jazz-20210930.xsd#jazz_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bd9fc0bb-c689-4823-a3a7-9b7d3cffd813" xlink:to="loc_jazz_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsTableTextBlock_26ca0384-887f-448a-9593-96970c4a6cb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_cc23eac8-345b-476a-b9fd-7016f0ebda80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bd9fc0bb-c689-4823-a3a7-9b7d3cffd813" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_cc23eac8-345b-476a-b9fd-7016f0ebda80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsGoodwillActivityDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#GoodwillandIntangibleAssetsGoodwillActivityDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsGoodwillActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_26c2399c-35b6-4145-ac9d-394baecd23ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_a0a24023-0984-43ae-b21b-8f93bc3acd28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_26c2399c-35b6-4145-ac9d-394baecd23ee" xlink:to="loc_us-gaap_GoodwillRollForward_a0a24023-0984-43ae-b21b-8f93bc3acd28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d43cbf66-874b-46a7-b042-e349a8f72c68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_a0a24023-0984-43ae-b21b-8f93bc3acd28" xlink:to="loc_us-gaap_Goodwill_d43cbf66-874b-46a7-b042-e349a8f72c68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_f0c3074d-6540-402f-9a0a-080c38dd1429" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_a0a24023-0984-43ae-b21b-8f93bc3acd28" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_f0c3074d-6540-402f-9a0a-080c38dd1429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_98fb102f-4d1d-4721-9500-80bc942659af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_a0a24023-0984-43ae-b21b-8f93bc3acd28" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_98fb102f-4d1d-4721-9500-80bc942659af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6024c59d-b811-474d-b54f-675a35e82d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_a0a24023-0984-43ae-b21b-8f93bc3acd28" xlink:to="loc_us-gaap_Goodwill_6024c59d-b811-474d-b54f-675a35e82d7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsGrossCarryingAmountsandNetBookValuesofIntangibleAssetsDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#GoodwillandIntangibleAssetsGrossCarryingAmountsandNetBookValuesofIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsGrossCarryingAmountsandNetBookValuesofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6fcf9ae5-35ce-4ea7-b4eb-468ab09fbd6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9f8872b4-4887-41c3-a508-310b54697011" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6fcf9ae5-35ce-4ea7-b4eb-468ab09fbd6d" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9f8872b4-4887-41c3-a508-310b54697011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_48b6e83f-2599-4675-89b9-1fad83c681e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9f8872b4-4887-41c3-a508-310b54697011" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_48b6e83f-2599-4675-89b9-1fad83c681e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_54173f72-9ad7-4096-9b82-7848cdac81ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_48b6e83f-2599-4675-89b9-1fad83c681e5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_54173f72-9ad7-4096-9b82-7848cdac81ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_9426db6b-17b0-45fc-8af4-17b877cf9a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_54173f72-9ad7-4096-9b82-7848cdac81ae" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_9426db6b-17b0-45fc-8af4-17b877cf9a6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ManufacturingContractsMember_eee04c1e-f2ac-4e00-8dd9-0d143e14f398" xlink:href="jazz-20210930.xsd#jazz_ManufacturingContractsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_54173f72-9ad7-4096-9b82-7848cdac81ae" xlink:to="loc_jazz_ManufacturingContractsMember_eee04c1e-f2ac-4e00-8dd9-0d143e14f398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_984e08cf-2d7f-4fc9-af4a-4d24078efb97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_54173f72-9ad7-4096-9b82-7848cdac81ae" xlink:to="loc_us-gaap_TrademarksMember_984e08cf-2d7f-4fc9-af4a-4d24078efb97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b5ff4d33-671e-481a-afad-45348fb08be0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9f8872b4-4887-41c3-a508-310b54697011" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b5ff4d33-671e-481a-afad-45348fb08be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_067d86f5-8a1b-4385-8f9d-f34425324e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_b5ff4d33-671e-481a-afad-45348fb08be0" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_067d86f5-8a1b-4385-8f9d-f34425324e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_ec68713a-2d58-415e-87c0-8ce005cd637f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_067d86f5-8a1b-4385-8f9d-f34425324e2a" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_ec68713a-2d58-415e-87c0-8ce005cd637f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d66f5f62-c6ce-4ee7-b4d8-dad89ee19ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9f8872b4-4887-41c3-a508-310b54697011" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d66f5f62-c6ce-4ee7-b4d8-dad89ee19ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_84755322-647d-454b-83ef-027d3efed91e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d66f5f62-c6ce-4ee7-b4d8-dad89ee19ce9" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_84755322-647d-454b-83ef-027d3efed91e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_55ffc5d7-d47f-4c75-875e-64c6eebdd4c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d66f5f62-c6ce-4ee7-b4d8-dad89ee19ce9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_55ffc5d7-d47f-4c75-875e-64c6eebdd4c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_80de0daa-f34d-4e49-906f-9a18546dd3ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d66f5f62-c6ce-4ee7-b4d8-dad89ee19ce9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_80de0daa-f34d-4e49-906f-9a18546dd3ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_cbf93b7a-9d58-47ee-a970-17a21b9a4a31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d66f5f62-c6ce-4ee7-b4d8-dad89ee19ce9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_cbf93b7a-9d58-47ee-a970-17a21b9a4a31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_0b50bcd5-e9b4-4160-b471-4bef5571ccd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d66f5f62-c6ce-4ee7-b4d8-dad89ee19ce9" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_0b50bcd5-e9b4-4160-b471-4bef5571ccd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_2b5e2301-aa66-4f37-a395-896fb93fc8f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d66f5f62-c6ce-4ee7-b4d8-dad89ee19ce9" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_2b5e2301-aa66-4f37-a395-896fb93fc8f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a64a1051-d992-455c-b6ae-d0884568888d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_d66f5f62-c6ce-4ee7-b4d8-dad89ee19ce9" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a64a1051-d992-455c-b6ae-d0884568888d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsEstimatedFutureAmortizationCostsDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#GoodwillandIntangibleAssetsEstimatedFutureAmortizationCostsDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/GoodwillandIntangibleAssetsEstimatedFutureAmortizationCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bdaf281f-10db-40ab-aa02-716285cfb38f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_d80c4513-7f11-4577-a2c4-ba743893037b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bdaf281f-10db-40ab-aa02-716285cfb38f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_d80c4513-7f11-4577-a2c4-ba743893037b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_063aad02-66a4-4533-ad3d-db0f48bb1479" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bdaf281f-10db-40ab-aa02-716285cfb38f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_063aad02-66a4-4533-ad3d-db0f48bb1479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_de7442be-61bd-4554-bd28-0e280ed71ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bdaf281f-10db-40ab-aa02-716285cfb38f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_de7442be-61bd-4554-bd28-0e280ed71ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_ed6fa875-6899-410f-8981-cfbad704b812" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bdaf281f-10db-40ab-aa02-716285cfb38f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_ed6fa875-6899-410f-8981-cfbad704b812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_4ed37a96-e142-4c3e-929f-282f121b5657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bdaf281f-10db-40ab-aa02-716285cfb38f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_4ed37a96-e142-4c3e-929f-282f121b5657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_3a3d1b2c-c6a2-44c5-9052-046c7e0e409a" xlink:href="jazz-20210930.xsd#jazz_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bdaf281f-10db-40ab-aa02-716285cfb38f" xlink:to="loc_jazz_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour_3a3d1b2c-c6a2-44c5-9052-046c7e0e409a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_eb746a7a-9c36-4392-b206-e834697e150e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bdaf281f-10db-40ab-aa02-716285cfb38f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_eb746a7a-9c36-4392-b206-e834697e150e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CertainBalanceSheetItems" xlink:type="simple" xlink:href="jazz-20210930.xsd#CertainBalanceSheetItems"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/CertainBalanceSheetItems" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_jazz_CertainBalanceSheetItemsAbstract_e6b2add9-c446-43b3-9f47-6e373ec650d9" xlink:href="jazz-20210930.xsd#jazz_CertainBalanceSheetItemsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_0d3b7408-ace8-4616-836e-cde560220223" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_e6b2add9-c446-43b3-9f47-6e373ec650d9" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_0d3b7408-ace8-4616-836e-cde560220223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CertainBalanceSheetItemsTables" xlink:type="simple" xlink:href="jazz-20210930.xsd#CertainBalanceSheetItemsTables"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/CertainBalanceSheetItemsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_jazz_CertainBalanceSheetItemsAbstract_4397208f-18c4-4fe3-a377-11117486002e" xlink:href="jazz-20210930.xsd#jazz_CertainBalanceSheetItemsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_6d2173ec-d0e5-4388-8e09-056d87b537e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_4397208f-18c4-4fe3-a377-11117486002e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_6d2173ec-d0e5-4388-8e09-056d87b537e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_762eb772-5bf8-4869-bbf4-bf52b023025b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_4397208f-18c4-4fe3-a377-11117486002e" xlink:to="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_762eb772-5bf8-4869-bbf4-bf52b023025b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_813291db-3082-4200-bb42-b2c200a88d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_4397208f-18c4-4fe3-a377-11117486002e" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_813291db-3082-4200-bb42-b2c200a88d2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CertainBalanceSheetItemsPropertyandEquipmentDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#CertainBalanceSheetItemsPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/CertainBalanceSheetItemsPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_jazz_CertainBalanceSheetItemsAbstract_253f7961-ae0b-4992-9211-f54658bdd3b2" xlink:href="jazz-20210930.xsd#jazz_CertainBalanceSheetItemsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_424953f9-f93f-447f-b39b-2702b1ad09fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_253f7961-ae0b-4992-9211-f54658bdd3b2" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_424953f9-f93f-447f-b39b-2702b1ad09fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ba8eae44-ae4a-43c7-a6b3-cca8dc0079e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_424953f9-f93f-447f-b39b-2702b1ad09fe" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ba8eae44-ae4a-43c7-a6b3-cca8dc0079e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b4fd8087-14b4-41a9-b73c-eb378665de7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ba8eae44-ae4a-43c7-a6b3-cca8dc0079e7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b4fd8087-14b4-41a9-b73c-eb378665de7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_82e41328-2f40-4eca-8282-69e100eee198" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b4fd8087-14b4-41a9-b73c-eb378665de7c" xlink:to="loc_us-gaap_ConstructionInProgressMember_82e41328-2f40-4eca-8282-69e100eee198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndBuildingMember_c8f55a95-4a2a-4a7b-a874-659ff9166e06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LandAndBuildingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b4fd8087-14b4-41a9-b73c-eb378665de7c" xlink:to="loc_us-gaap_LandAndBuildingMember_c8f55a95-4a2a-4a7b-a874-659ff9166e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_f1423018-cc9a-4da3-b158-0b00d1def73d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b4fd8087-14b4-41a9-b73c-eb378665de7c" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_f1423018-cc9a-4da3-b158-0b00d1def73d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_d324966c-da9b-45ee-8628-476fec9c0408" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b4fd8087-14b4-41a9-b73c-eb378665de7c" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_d324966c-da9b-45ee-8628-476fec9c0408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_9a628a3e-2283-48fa-aea1-cd41fc452e21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b4fd8087-14b4-41a9-b73c-eb378665de7c" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_9a628a3e-2283-48fa-aea1-cd41fc452e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_aec314dd-788f-4fe4-881d-49688bb8d184" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b4fd8087-14b4-41a9-b73c-eb378665de7c" xlink:to="loc_us-gaap_ComputerEquipmentMember_aec314dd-788f-4fe4-881d-49688bb8d184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_ed58cff0-f1fa-48ee-952b-9a700e02a35e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b4fd8087-14b4-41a9-b73c-eb378665de7c" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_ed58cff0-f1fa-48ee-952b-9a700e02a35e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2bfca790-0c53-44d2-a78d-f750a1f19d23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_424953f9-f93f-447f-b39b-2702b1ad09fe" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2bfca790-0c53-44d2-a78d-f750a1f19d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_9bdc52af-7b35-473f-8810-ddd1b27a2756" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2bfca790-0c53-44d2-a78d-f750a1f19d23" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_9bdc52af-7b35-473f-8810-ddd1b27a2756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_8b23a981-320c-40e1-85c5-b7280af575c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2bfca790-0c53-44d2-a78d-f750a1f19d23" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_8b23a981-320c-40e1-85c5-b7280af575c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_25170bae-c311-4b31-ab4b-558ffc242893" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_2bfca790-0c53-44d2-a78d-f750a1f19d23" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_25170bae-c311-4b31-ab4b-558ffc242893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CertainBalanceSheetItemsOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#CertainBalanceSheetItemsOtherCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/CertainBalanceSheetItemsOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_jazz_CertainBalanceSheetItemsAbstract_0959f035-3602-4958-8b83-7a75bf14fd96" xlink:href="jazz-20210930.xsd#jazz_CertainBalanceSheetItemsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_DeferredTaxIntercompanyProfitCurrent_7cfa41f8-2479-4d90-b252-7c4957596224" xlink:href="jazz-20210930.xsd#jazz_DeferredTaxIntercompanyProfitCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_0959f035-3602-4958-8b83-7a75bf14fd96" xlink:to="loc_jazz_DeferredTaxIntercompanyProfitCurrent_7cfa41f8-2479-4d90-b252-7c4957596224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousCurrent_7981293d-5b48-41f2-bfb2-20bc295fa9eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMiscellaneousCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_0959f035-3602-4958-8b83-7a75bf14fd96" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousCurrent_7981293d-5b48-41f2-bfb2-20bc295fa9eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_01adb2c6-3bc9-4cbf-8a52-759846321e57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_0959f035-3602-4958-8b83-7a75bf14fd96" xlink:to="loc_us-gaap_OtherAssetsCurrent_01adb2c6-3bc9-4cbf-8a52-759846321e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CertainBalanceSheetItemsAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#CertainBalanceSheetItemsAccruedLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/CertainBalanceSheetItemsAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_jazz_CertainBalanceSheetItemsAbstract_c77a790e-f9fc-4b51-8ddc-5e7169961cb7" xlink:href="jazz-20210930.xsd#jazz_CertainBalanceSheetItemsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_AccruedRebatesAndOtherSalesDeductions_562adf32-b1d0-433e-88d9-1979ed74e5ab" xlink:href="jazz-20210930.xsd#jazz_AccruedRebatesAndOtherSalesDeductions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_c77a790e-f9fc-4b51-8ddc-5e7169961cb7" xlink:to="loc_jazz_AccruedRebatesAndOtherSalesDeductions_562adf32-b1d0-433e-88d9-1979ed74e5ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent_d787b059-c064-4886-8d9f-9c3f79f5e7b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_c77a790e-f9fc-4b51-8ddc-5e7169961cb7" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrent_d787b059-c064-4886-8d9f-9c3f79f5e7b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_AccruedInterest_c01773be-cbd5-432d-86a5-0a62dfc7e68a" xlink:href="jazz-20210930.xsd#jazz_AccruedInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_c77a790e-f9fc-4b51-8ddc-5e7169961cb7" xlink:to="loc_jazz_AccruedInterest_c01773be-cbd5-432d-86a5-0a62dfc7e68a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_9edcf2ee-9d13-47c3-8faf-27c8a7029b52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_c77a790e-f9fc-4b51-8ddc-5e7169961cb7" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_9edcf2ee-9d13-47c3-8faf-27c8a7029b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_AccruedClinicalTrialLiability_5b9b9468-b230-4e74-9f43-1306e22b0500" xlink:href="jazz-20210930.xsd#jazz_AccruedClinicalTrialLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_c77a790e-f9fc-4b51-8ddc-5e7169961cb7" xlink:to="loc_jazz_AccruedClinicalTrialLiability_5b9b9468-b230-4e74-9f43-1306e22b0500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_2e30cb74-fa03-42b2-ad4a-f1fff14fbb8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_c77a790e-f9fc-4b51-8ddc-5e7169961cb7" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_2e30cb74-fa03-42b2-ad4a-f1fff14fbb8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_6c8adace-fb67-4b58-836c-f023f1a488f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_c77a790e-f9fc-4b51-8ddc-5e7169961cb7" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_6c8adace-fb67-4b58-836c-f023f1a488f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_LeaseLiabilityCurrent_e41c9ad2-305f-4c97-96a5-5c50bafb2c01" xlink:href="jazz-20210930.xsd#jazz_LeaseLiabilityCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_c77a790e-f9fc-4b51-8ddc-5e7169961cb7" xlink:to="loc_jazz_LeaseLiabilityCurrent_e41c9ad2-305f-4c97-96a5-5c50bafb2c01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_db96edfd-f4d1-4bb9-9846-36a5bfd3731d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_c77a790e-f9fc-4b51-8ddc-5e7169961cb7" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_db96edfd-f4d1-4bb9-9846-36a5bfd3731d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_SalesReturnReserve_63ac1edb-6ab7-4a72-b7ed-cb09f660b35c" xlink:href="jazz-20210930.xsd#jazz_SalesReturnReserve"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_c77a790e-f9fc-4b51-8ddc-5e7169961cb7" xlink:to="loc_jazz_SalesReturnReserve_63ac1edb-6ab7-4a72-b7ed-cb09f660b35c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_AccruedInventoryRelatedLiabilities_8b64dda0-3680-48d8-ab7a-3601692398eb" xlink:href="jazz-20210930.xsd#jazz_AccruedInventoryRelatedLiabilities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_c77a790e-f9fc-4b51-8ddc-5e7169961cb7" xlink:to="loc_jazz_AccruedInventoryRelatedLiabilities_8b64dda0-3680-48d8-ab7a-3601692398eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_AccruedConstructionInProgress_e2ed8cde-70cd-4d2b-a950-b237101c3f4e" xlink:href="jazz-20210930.xsd#jazz_AccruedConstructionInProgress"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_c77a790e-f9fc-4b51-8ddc-5e7169961cb7" xlink:to="loc_jazz_AccruedConstructionInProgress_e2ed8cde-70cd-4d2b-a950-b237101c3f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_13dd86d1-3a47-4186-a6b6-cdbebf29bfd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_c77a790e-f9fc-4b51-8ddc-5e7169961cb7" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_13dd86d1-3a47-4186-a6b6-cdbebf29bfd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_64135284-d025-4565-8b37-ffcb4e3d03e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CertainBalanceSheetItemsAbstract_c77a790e-f9fc-4b51-8ddc-5e7169961cb7" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_64135284-d025-4565-8b37-ffcb4e3d03e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/Debt" xlink:type="simple" xlink:href="jazz-20210930.xsd#Debt"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2df5510b-c53d-4000-ab33-1a76f73c3730" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_b638c6f6-35e9-424c-86fa-8d0b9e6e7cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2df5510b-c53d-4000-ab33-1a76f73c3730" xlink:to="loc_us-gaap_LongTermDebtTextBlock_b638c6f6-35e9-424c-86fa-8d0b9e6e7cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DebtTables" xlink:type="simple" xlink:href="jazz-20210930.xsd#DebtTables"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_15377808-30ef-479f-9ff0-5c574ee3abf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_ad86d422-6fcd-457c-86b8-9467678ffd4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_15377808-30ef-479f-9ff0-5c574ee3abf0" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_ad86d422-6fcd-457c-86b8-9467678ffd4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_c9ae35cb-478e-4253-88f6-92b91013ee77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_15377808-30ef-479f-9ff0-5c574ee3abf0" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_c9ae35cb-478e-4253-88f6-92b91013ee77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DebtScheduleofLongtermDebtDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#DebtScheduleofLongtermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/DebtScheduleofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e3087444-c771-4551-bbe4-f7441884b9fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_34e15a97-bf13-49c3-b371-1ed0846967f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e3087444-c771-4551-bbe4-f7441884b9fa" xlink:to="loc_us-gaap_DebtInstrumentTable_34e15a97-bf13-49c3-b371-1ed0846967f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_0c189bcf-da31-4aa0-a236-e5e8dfd543ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_34e15a97-bf13-49c3-b371-1ed0846967f1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_0c189bcf-da31-4aa0-a236-e5e8dfd543ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e56a92f9-5232-4955-9259-8dcc37c6532a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0c189bcf-da31-4aa0-a236-e5e8dfd543ab" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e56a92f9-5232-4955-9259-8dcc37c6532a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_c1756039-e863-4f5d-aa06-c54f29a0fa38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e56a92f9-5232-4955-9259-8dcc37c6532a" xlink:to="loc_us-gaap_ConvertibleDebtMember_c1756039-e863-4f5d-aa06-c54f29a0fa38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_TermLoanMember_aeadf9df-b825-475f-9038-cc867d285a2e" xlink:href="jazz-20210930.xsd#jazz_TermLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e56a92f9-5232-4955-9259-8dcc37c6532a" xlink:to="loc_jazz_TermLoanMember_aeadf9df-b825-475f-9038-cc867d285a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_2af6fb3d-9eff-45f3-9a15-b70bf93e8667" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_34e15a97-bf13-49c3-b371-1ed0846967f1" xlink:to="loc_us-gaap_DebtInstrumentAxis_2af6fb3d-9eff-45f3-9a15-b70bf93e8667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8e7941ab-491d-457d-a564-4e6681e90f8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_2af6fb3d-9eff-45f3-9a15-b70bf93e8667" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8e7941ab-491d-457d-a564-4e6681e90f8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ExchangeableSeniorNotesDue2021Member_7a907e8a-0a0c-475f-ad1a-d522d1644bad" xlink:href="jazz-20210930.xsd#jazz_ExchangeableSeniorNotesDue2021Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8e7941ab-491d-457d-a564-4e6681e90f8d" xlink:to="loc_jazz_ExchangeableSeniorNotesDue2021Member_7a907e8a-0a0c-475f-ad1a-d522d1644bad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ExchangeableSeniorNotesDue2024Member_031f4d80-ae51-4692-a954-47bb9a752e99" xlink:href="jazz-20210930.xsd#jazz_ExchangeableSeniorNotesDue2024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8e7941ab-491d-457d-a564-4e6681e90f8d" xlink:to="loc_jazz_ExchangeableSeniorNotesDue2024Member_031f4d80-ae51-4692-a954-47bb9a752e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ExchangeableSeniorNotesDue2026Member_e6755045-affc-4b74-9f02-2a627c4e6fa9" xlink:href="jazz-20210930.xsd#jazz_ExchangeableSeniorNotesDue2026Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8e7941ab-491d-457d-a564-4e6681e90f8d" xlink:to="loc_jazz_ExchangeableSeniorNotesDue2026Member_e6755045-affc-4b74-9f02-2a627c4e6fa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_SeniorNotesDue2029Member_fe0c273b-db25-48ce-96d3-a1a130732a69" xlink:href="jazz-20210930.xsd#jazz_SeniorNotesDue2029Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8e7941ab-491d-457d-a564-4e6681e90f8d" xlink:to="loc_jazz_SeniorNotesDue2029Member_fe0c273b-db25-48ce-96d3-a1a130732a69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_cc7146ac-021c-454f-a2c1-371f15aa3f88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_34e15a97-bf13-49c3-b371-1ed0846967f1" xlink:to="loc_us-gaap_DebtInstrumentLineItems_cc7146ac-021c-454f-a2c1-371f15aa3f88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_50797461-2c83-468e-b8d6-50c70631be34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc7146ac-021c-454f-a2c1-371f15aa3f88" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_50797461-2c83-468e-b8d6-50c70631be34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_95892171-fa6e-4a3e-bc4c-31b8703a3d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc7146ac-021c-454f-a2c1-371f15aa3f88" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_95892171-fa6e-4a3e-bc4c-31b8703a3d8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_4a4dbfc4-5c32-4c16-9690-a0be2eae3f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc7146ac-021c-454f-a2c1-371f15aa3f88" xlink:to="loc_us-gaap_LongTermDebt_4a4dbfc4-5c32-4c16-9690-a0be2eae3f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_a726f203-c59d-45d1-a3a1-060e5804b613" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc7146ac-021c-454f-a2c1-371f15aa3f88" xlink:to="loc_us-gaap_LongTermDebtCurrent_a726f203-c59d-45d1-a3a1-060e5804b613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_5bc2eb65-f5a1-4580-86e7-f233c247e6ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_cc7146ac-021c-454f-a2c1-371f15aa3f88" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_5bc2eb65-f5a1-4580-86e7-f233c247e6ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DebtScheduleofLongtermDebtDetails_1" xlink:type="simple" xlink:href="jazz-20210930.xsd#DebtScheduleofLongtermDebtDetails_1"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/DebtScheduleofLongtermDebtDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#DebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/DebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_eb79aa70-5d89-4d4f-9deb-8df24e3c2ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_e282e75a-2849-4a9d-8a96-f05726c47b93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_eb79aa70-5d89-4d4f-9deb-8df24e3c2ef6" xlink:to="loc_us-gaap_DebtInstrumentTable_e282e75a-2849-4a9d-8a96-f05726c47b93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_ca8bf32f-09a4-492a-a49f-80e4a67c8d88" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e282e75a-2849-4a9d-8a96-f05726c47b93" xlink:to="loc_srt_OwnershipAxis_ca8bf32f-09a4-492a-a49f-80e4a67c8d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_197fe6ba-3ba0-4a99-889e-2106fb0ade8a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_ca8bf32f-09a4-492a-a49f-80e4a67c8d88" xlink:to="loc_srt_OwnershipDomain_197fe6ba-3ba0-4a99-889e-2106fb0ade8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_JazzInvestmentsILimitedMember_db343134-2e2d-4c35-8e25-66558409a856" xlink:href="jazz-20210930.xsd#jazz_JazzInvestmentsILimitedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_197fe6ba-3ba0-4a99-889e-2106fb0ade8a" xlink:to="loc_jazz_JazzInvestmentsILimitedMember_db343134-2e2d-4c35-8e25-66558409a856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ed5427ab-64e5-4abe-a56a-510edd47365f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e282e75a-2849-4a9d-8a96-f05726c47b93" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ed5427ab-64e5-4abe-a56a-510edd47365f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5d173dfd-2997-47d9-b15a-712de5fd9acf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ed5427ab-64e5-4abe-a56a-510edd47365f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5d173dfd-2997-47d9-b15a-712de5fd9acf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_d255b3eb-a63d-4032-8925-17db371465d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5d173dfd-2997-47d9-b15a-712de5fd9acf" xlink:to="loc_us-gaap_LineOfCreditMember_d255b3eb-a63d-4032-8925-17db371465d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_TermLoanMember_764e84a4-2332-43a0-b4da-68dd5a9edfdd" xlink:href="jazz-20210930.xsd#jazz_TermLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5d173dfd-2997-47d9-b15a-712de5fd9acf" xlink:to="loc_jazz_TermLoanMember_764e84a4-2332-43a0-b4da-68dd5a9edfdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_SeniorSecuredDebtMember_1f40742e-2274-4296-8c76-706edae668f1" xlink:href="jazz-20210930.xsd#jazz_SeniorSecuredDebtMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5d173dfd-2997-47d9-b15a-712de5fd9acf" xlink:to="loc_jazz_SeniorSecuredDebtMember_1f40742e-2274-4296-8c76-706edae668f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_9b874739-5107-48c0-9258-cbc4a27c6d4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5d173dfd-2997-47d9-b15a-712de5fd9acf" xlink:to="loc_us-gaap_ConvertibleDebtMember_9b874739-5107-48c0-9258-cbc4a27c6d4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d998ab1d-7f00-426e-af95-b29a5c6245d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e282e75a-2849-4a9d-8a96-f05726c47b93" xlink:to="loc_us-gaap_DebtInstrumentAxis_d998ab1d-7f00-426e-af95-b29a5c6245d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d5a0952c-7987-4adb-9cc3-2aa4b4716c44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_d998ab1d-7f00-426e-af95-b29a5c6245d3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d5a0952c-7987-4adb-9cc3-2aa4b4716c44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_TwoThousandFifteenCreditAgreementMember_8e709adf-765b-4658-9040-65d52b2b1005" xlink:href="jazz-20210930.xsd#jazz_TwoThousandFifteenCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d5a0952c-7987-4adb-9cc3-2aa4b4716c44" xlink:to="loc_jazz_TwoThousandFifteenCreditAgreementMember_8e709adf-765b-4658-9040-65d52b2b1005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_TermLoanFacilityMember_605075b9-36dd-40e1-ae42-40fdd8909527" xlink:href="jazz-20210930.xsd#jazz_TermLoanFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d5a0952c-7987-4adb-9cc3-2aa4b4716c44" xlink:to="loc_jazz_TermLoanFacilityMember_605075b9-36dd-40e1-ae42-40fdd8909527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_TwoThousandTwentyOneCreditAgreementDollarTermLoanMember_f37df88c-910f-4b29-929f-efea2e0a50bf" xlink:href="jazz-20210930.xsd#jazz_TwoThousandTwentyOneCreditAgreementDollarTermLoanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d5a0952c-7987-4adb-9cc3-2aa4b4716c44" xlink:to="loc_jazz_TwoThousandTwentyOneCreditAgreementDollarTermLoanMember_f37df88c-910f-4b29-929f-efea2e0a50bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_TwoThousandTwentyOneCreditAgreementEuroTermLoanMember_6891d985-13c5-454f-8722-87edf999c01a" xlink:href="jazz-20210930.xsd#jazz_TwoThousandTwentyOneCreditAgreementEuroTermLoanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d5a0952c-7987-4adb-9cc3-2aa4b4716c44" xlink:to="loc_jazz_TwoThousandTwentyOneCreditAgreementEuroTermLoanMember_6891d985-13c5-454f-8722-87edf999c01a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_TwoThousandTwentyOneCreditAgreementRevolvingCreditFacilityMember_9a4f9deb-0a30-4c67-bdea-003b7746a9db" xlink:href="jazz-20210930.xsd#jazz_TwoThousandTwentyOneCreditAgreementRevolvingCreditFacilityMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d5a0952c-7987-4adb-9cc3-2aa4b4716c44" xlink:to="loc_jazz_TwoThousandTwentyOneCreditAgreementRevolvingCreditFacilityMember_9a4f9deb-0a30-4c67-bdea-003b7746a9db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_SeniorNotesDue2029Member_6e5e9fcb-b805-48d3-90b0-53171430fd94" xlink:href="jazz-20210930.xsd#jazz_SeniorNotesDue2029Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d5a0952c-7987-4adb-9cc3-2aa4b4716c44" xlink:to="loc_jazz_SeniorNotesDue2029Member_6e5e9fcb-b805-48d3-90b0-53171430fd94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ExchangeableSeniorNotesDue2021Member_fa3d7076-52c1-49e7-bf14-aed32b204119" xlink:href="jazz-20210930.xsd#jazz_ExchangeableSeniorNotesDue2021Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d5a0952c-7987-4adb-9cc3-2aa4b4716c44" xlink:to="loc_jazz_ExchangeableSeniorNotesDue2021Member_fa3d7076-52c1-49e7-bf14-aed32b204119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ExchangeableSeniorNotesDue2024Member_4aca4e85-6fdb-45db-80a0-c9a5f6a1cea1" xlink:href="jazz-20210930.xsd#jazz_ExchangeableSeniorNotesDue2024Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d5a0952c-7987-4adb-9cc3-2aa4b4716c44" xlink:to="loc_jazz_ExchangeableSeniorNotesDue2024Member_4aca4e85-6fdb-45db-80a0-c9a5f6a1cea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ExchangeableSeniorNotesDue2026Member_804c28cf-db51-49e6-af88-8dea01f0e719" xlink:href="jazz-20210930.xsd#jazz_ExchangeableSeniorNotesDue2026Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d5a0952c-7987-4adb-9cc3-2aa4b4716c44" xlink:to="loc_jazz_ExchangeableSeniorNotesDue2026Member_804c28cf-db51-49e6-af88-8dea01f0e719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_a19b514d-30ea-4dbe-8fe1-0865901430fe" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e282e75a-2849-4a9d-8a96-f05726c47b93" xlink:to="loc_dei_LegalEntityAxis_a19b514d-30ea-4dbe-8fe1-0865901430fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_1405594f-6f15-4cd0-b3ad-3821499b7c83" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_a19b514d-30ea-4dbe-8fe1-0865901430fe" xlink:to="loc_dei_EntityDomain_1405594f-6f15-4cd0-b3ad-3821499b7c83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_JazzSecuritiesDesignatedActivityCompanyMember_2c71c8e4-960e-4e8e-a250-bf5da1589f24" xlink:href="jazz-20210930.xsd#jazz_JazzSecuritiesDesignatedActivityCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_1405594f-6f15-4cd0-b3ad-3821499b7c83" xlink:to="loc_jazz_JazzSecuritiesDesignatedActivityCompanyMember_2c71c8e4-960e-4e8e-a250-bf5da1589f24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_8597d50b-4690-45b2-a717-11724986e3ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e282e75a-2849-4a9d-8a96-f05726c47b93" xlink:to="loc_us-gaap_CreditFacilityAxis_8597d50b-4690-45b2-a717-11724986e3ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a34fc688-2eee-41c8-970c-e73822b2f6a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_8597d50b-4690-45b2-a717-11724986e3ff" xlink:to="loc_us-gaap_CreditFacilityDomain_a34fc688-2eee-41c8-970c-e73822b2f6a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_8bfc4639-56ae-462b-84dc-610634110345" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_a34fc688-2eee-41c8-970c-e73822b2f6a9" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_8bfc4639-56ae-462b-84dc-610634110345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7ccd3eb3-c07b-4aa9-a621-0bedca3bc103" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e282e75a-2849-4a9d-8a96-f05726c47b93" xlink:to="loc_srt_RangeAxis_7ccd3eb3-c07b-4aa9-a621-0bedca3bc103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b0c9da6d-ec2c-405a-a0aa-b302693ade42" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_7ccd3eb3-c07b-4aa9-a621-0bedca3bc103" xlink:to="loc_srt_RangeMember_b0c9da6d-ec2c-405a-a0aa-b302693ade42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2ae3733c-4bf7-465a-8b5d-57524ba97be9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b0c9da6d-ec2c-405a-a0aa-b302693ade42" xlink:to="loc_srt_MaximumMember_2ae3733c-4bf7-465a-8b5d-57524ba97be9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7ecba638-00d2-42f0-a60f-c54311f42d3e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b0c9da6d-ec2c-405a-a0aa-b302693ade42" xlink:to="loc_srt_MinimumMember_7ecba638-00d2-42f0-a60f-c54311f42d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_ada26dac-61bd-4518-b755-40e9afaf57e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e282e75a-2849-4a9d-8a96-f05726c47b93" xlink:to="loc_us-gaap_VariableRateAxis_ada26dac-61bd-4518-b755-40e9afaf57e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_8e296fd1-45a8-493b-a50f-eef95eac6999" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_ada26dac-61bd-4518-b755-40e9afaf57e6" xlink:to="loc_us-gaap_VariableRateDomain_8e296fd1-45a8-493b-a50f-eef95eac6999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_LIBOROrEURIBORMember_213df3f5-51ac-4155-b558-4fe6674977d6" xlink:href="jazz-20210930.xsd#jazz_LIBOROrEURIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_8e296fd1-45a8-493b-a50f-eef95eac6999" xlink:to="loc_jazz_LIBOROrEURIBORMember_213df3f5-51ac-4155-b558-4fe6674977d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrimeRateMember_2ffd8deb-351f-4cdc-8c5c-c54646c7d4a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrimeRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_8e296fd1-45a8-493b-a50f-eef95eac6999" xlink:to="loc_us-gaap_PrimeRateMember_2ffd8deb-351f-4cdc-8c5c-c54646c7d4a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_1ad1f24a-a870-4684-bf3b-327de9fcf835" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_8e296fd1-45a8-493b-a50f-eef95eac6999" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_1ad1f24a-a870-4684-bf3b-327de9fcf835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_da5af470-3349-45cf-92d3-cec5ad6ec17f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e282e75a-2849-4a9d-8a96-f05726c47b93" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_da5af470-3349-45cf-92d3-cec5ad6ec17f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_57aef7ff-aaa9-4317-9335-4de675dbe421" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_da5af470-3349-45cf-92d3-cec5ad6ec17f" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_57aef7ff-aaa9-4317-9335-4de675dbe421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_bacb1d30-ec99-4ec1-8e73-12a7e64071c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_57aef7ff-aaa9-4317-9335-4de675dbe421" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_bacb1d30-ec99-4ec1-8e73-12a7e64071c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_edfc610d-6cf2-4a86-98a8-7540befc6ca5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_57aef7ff-aaa9-4317-9335-4de675dbe421" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_edfc610d-6cf2-4a86-98a8-7540befc6ca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_4670d6d0-6c07-4147-aa8e-d74ea345bfcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_57aef7ff-aaa9-4317-9335-4de675dbe421" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_4670d6d0-6c07-4147-aa8e-d74ea345bfcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember_34a13cd6-4ae3-4438-a715-07e86f5a5e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_57aef7ff-aaa9-4317-9335-4de675dbe421" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember_34a13cd6-4ae3-4438-a715-07e86f5a5e0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_c448cd85-10d3-4499-aa07-02e644583f30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e282e75a-2849-4a9d-8a96-f05726c47b93" xlink:to="loc_us-gaap_DebtInstrumentLineItems_c448cd85-10d3-4499-aa07-02e644583f30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_c418c7a5-9b05-462a-949c-ffd5d8077b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c448cd85-10d3-4499-aa07-02e644583f30" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_c418c7a5-9b05-462a-949c-ffd5d8077b9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_9d1de861-4551-43c4-800c-4d36139dbf73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c448cd85-10d3-4499-aa07-02e644583f30" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_9d1de861-4551-43c4-800c-4d36139dbf73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_658781f3-1464-4e79-8da0-b3528bd53899" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c448cd85-10d3-4499-aa07-02e644583f30" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_658781f3-1464-4e79-8da0-b3528bd53899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0f476f9e-935a-4cd4-be68-5d550ff8f42d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c448cd85-10d3-4499-aa07-02e644583f30" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_0f476f9e-935a-4cd4-be68-5d550ff8f42d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_efc8fba1-1ba8-4f42-89bc-6b2ae7a4d69c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c448cd85-10d3-4499-aa07-02e644583f30" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_efc8fba1-1ba8-4f42-89bc-6b2ae7a4d69c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_2c34f07f-25ad-4acf-81a4-62bc2e1d4aff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c448cd85-10d3-4499-aa07-02e644583f30" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_2c34f07f-25ad-4acf-81a4-62bc2e1d4aff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_7a7a9732-1033-444d-b5ac-1e6dbbae7dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c448cd85-10d3-4499-aa07-02e644583f30" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_7a7a9732-1033-444d-b5ac-1e6dbbae7dd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_3a9221b4-7a66-4a71-8be4-61bb4cf586e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c448cd85-10d3-4499-aa07-02e644583f30" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_3a9221b4-7a66-4a71-8be4-61bb4cf586e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_DebtCovenantOutstandingAmountThreshold_771f1257-d94c-4c66-b26f-99d4a480b1f6" xlink:href="jazz-20210930.xsd#jazz_DebtCovenantOutstandingAmountThreshold"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c448cd85-10d3-4499-aa07-02e644583f30" xlink:to="loc_jazz_DebtCovenantOutstandingAmountThreshold_771f1257-d94c-4c66-b26f-99d4a480b1f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_531a1b1f-654f-4839-b8a5-7e5065a12e27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c448cd85-10d3-4499-aa07-02e644583f30" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_531a1b1f-654f-4839-b8a5-7e5065a12e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_DebtInstrumentPercentageOfPrincipalSubjectToRedemption_3d2dbf27-f145-4355-af9b-67d6ddbdb442" xlink:href="jazz-20210930.xsd#jazz_DebtInstrumentPercentageOfPrincipalSubjectToRedemption"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c448cd85-10d3-4499-aa07-02e644583f30" xlink:to="loc_jazz_DebtInstrumentPercentageOfPrincipalSubjectToRedemption_3d2dbf27-f145-4355-af9b-67d6ddbdb442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_eca8af84-e8b8-4b68-8c52-c1bb2d5b7035" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c448cd85-10d3-4499-aa07-02e644583f30" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_eca8af84-e8b8-4b68-8c52-c1bb2d5b7035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_0ebd3536-16f7-4fae-b761-9441c3314733" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c448cd85-10d3-4499-aa07-02e644583f30" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_0ebd3536-16f7-4fae-b761-9441c3314733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_985dd3ba-4b79-4a0d-b578-b37ac4f30012" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c448cd85-10d3-4499-aa07-02e644583f30" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_985dd3ba-4b79-4a0d-b578-b37ac4f30012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_2eec069f-fad2-4afd-abe5-00334242dfdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_c448cd85-10d3-4499-aa07-02e644583f30" xlink:to="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_2eec069f-fad2-4afd-abe5-00334242dfdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/DebtScheduleofMaturitiesofLongtermDebtDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#DebtScheduleofMaturitiesofLongtermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/DebtScheduleofMaturitiesofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e19e3427-ccf6-4f82-88d5-e86c67b9878f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_5709287b-0e3d-4274-bfb9-fc1a2423dfa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e19e3427-ccf6-4f82-88d5-e86c67b9878f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_5709287b-0e3d-4274-bfb9-fc1a2423dfa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_07330667-7def-45b3-8cdc-938e8edfe6f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e19e3427-ccf6-4f82-88d5-e86c67b9878f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_07330667-7def-45b3-8cdc-938e8edfe6f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_c38297d7-190f-4d3e-a66e-f0f9c88124c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e19e3427-ccf6-4f82-88d5-e86c67b9878f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_c38297d7-190f-4d3e-a66e-f0f9c88124c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_e44beb28-be84-4293-8035-50eafeef7200" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e19e3427-ccf6-4f82-88d5-e86c67b9878f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_e44beb28-be84-4293-8035-50eafeef7200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_4beeac39-8f96-4b8b-8069-7284e6723dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e19e3427-ccf6-4f82-88d5-e86c67b9878f" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_4beeac39-8f96-4b8b-8069-7284e6723dcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_LongTermDebtMaturityAfterYearFour_a765736d-7cfd-4b7b-afa7-46376f643cfa" xlink:href="jazz-20210930.xsd#jazz_LongTermDebtMaturityAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e19e3427-ccf6-4f82-88d5-e86c67b9878f" xlink:to="loc_jazz_LongTermDebtMaturityAfterYearFour_a765736d-7cfd-4b7b-afa7-46376f643cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_0de876c8-f028-48d7-a94f-bc1ad08085b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e19e3427-ccf6-4f82-88d5-e86c67b9878f" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_0de876c8-f028-48d7-a94f-bc1ad08085b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/Leases" xlink:type="simple" xlink:href="jazz-20210930.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_55c905b8-ddce-4ac6-9807-4dae9ac6f85e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_92ae318e-8dad-4a4b-be7f-c395b7dc5ac7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_55c905b8-ddce-4ac6-9807-4dae9ac6f85e" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_92ae318e-8dad-4a4b-be7f-c395b7dc5ac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/LeasesTables" xlink:type="simple" xlink:href="jazz-20210930.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_82ec23a3-f033-4a88-a2f7-94f7b93b0ca8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_a1909690-4ca1-4f6f-814f-34501d719934" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_82ec23a3-f033-4a88-a2f7-94f7b93b0ca8" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_a1909690-4ca1-4f6f-814f-34501d719934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_AssetsAndLiabilitiesLesseeTableTextBlock_11106fa4-d112-4fa8-a6d8-dfd2a9be77c4" xlink:href="jazz-20210930.xsd#jazz_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_82ec23a3-f033-4a88-a2f7-94f7b93b0ca8" xlink:to="loc_jazz_AssetsAndLiabilitiesLesseeTableTextBlock_11106fa4-d112-4fa8-a6d8-dfd2a9be77c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_b2afc83a-41a3-4ea2-a1e6-680e2b758357" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_82ec23a3-f033-4a88-a2f7-94f7b93b0ca8" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_b2afc83a-41a3-4ea2-a1e6-680e2b758357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_7755bd94-63b7-4dfa-ad72-3b2b04e4511d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_82ec23a3-f033-4a88-a2f7-94f7b93b0ca8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_7755bd94-63b7-4dfa-ad72-3b2b04e4511d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/LeasesLeaseCostDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#LeasesLeaseCostDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/LeasesLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_fa1c84d1-003f-4fa4-8dc2-9ae6e132315a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_08908fa7-2fac-4682-bc16-8ccfe6bec93d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fa1c84d1-003f-4fa4-8dc2-9ae6e132315a" xlink:to="loc_us-gaap_OperatingLeaseCost_08908fa7-2fac-4682-bc16-8ccfe6bec93d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_d1e8e0a6-502b-4821-adc7-1adb82130e32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fa1c84d1-003f-4fa4-8dc2-9ae6e132315a" xlink:to="loc_us-gaap_ShortTermLeaseCost_d1e8e0a6-502b-4821-adc7-1adb82130e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_1ccd16b7-7338-4bb1-bae1-a97252539ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fa1c84d1-003f-4fa4-8dc2-9ae6e132315a" xlink:to="loc_us-gaap_SubleaseIncome_1ccd16b7-7338-4bb1-bae1-a97252539ee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_6f476a56-7dbd-48f7-8bef-e3d2afb92583" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fa1c84d1-003f-4fa4-8dc2-9ae6e132315a" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_6f476a56-7dbd-48f7-8bef-e3d2afb92583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_ed23e9ac-5f8d-4c24-9113-e0f2545c7264" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fa1c84d1-003f-4fa4-8dc2-9ae6e132315a" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_ed23e9ac-5f8d-4c24-9113-e0f2545c7264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_56925cf6-7432-426a-9ea0-12dd04e78c09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fa1c84d1-003f-4fa4-8dc2-9ae6e132315a" xlink:to="loc_us-gaap_LeaseCost_56925cf6-7432-426a-9ea0-12dd04e78c09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_9930507f-7d86-49a4-84e4-49edc1a174eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_93ec100a-d348-4d02-af7d-9b3ac728d2cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9930507f-7d86-49a4-84e4-49edc1a174eb" xlink:to="loc_us-gaap_AssetsAbstract_93ec100a-d348-4d02-af7d-9b3ac728d2cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_6a924720-78da-4f3e-bcfe-bdcd5c68fb90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_93ec100a-d348-4d02-af7d-9b3ac728d2cd" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_6a924720-78da-4f3e-bcfe-bdcd5c68fb90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_983e4667-3ec4-4bde-854b-e58911aa5e09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_93ec100a-d348-4d02-af7d-9b3ac728d2cd" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_983e4667-3ec4-4bde-854b-e58911aa5e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_6ff19261-68ea-4b73-aae3-306fc964c59f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_93ec100a-d348-4d02-af7d-9b3ac728d2cd" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_6ff19261-68ea-4b73-aae3-306fc964c59f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_OperatingLeaseAndFinanceLeaseRightOfUseAsset_7378f45b-350b-4a9d-b71c-e2d3058afe3b" xlink:href="jazz-20210930.xsd#jazz_OperatingLeaseAndFinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_93ec100a-d348-4d02-af7d-9b3ac728d2cd" xlink:to="loc_jazz_OperatingLeaseAndFinanceLeaseRightOfUseAsset_7378f45b-350b-4a9d-b71c-e2d3058afe3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_16b361f9-5434-4c5a-9ca4-89fbadf4cf6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9930507f-7d86-49a4-84e4-49edc1a174eb" xlink:to="loc_us-gaap_LiabilitiesAbstract_16b361f9-5434-4c5a-9ca4-89fbadf4cf6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_09dd37af-5756-48b0-b879-ed32e94c8902" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_16b361f9-5434-4c5a-9ca4-89fbadf4cf6e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_09dd37af-5756-48b0-b879-ed32e94c8902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_1f9f704e-86fd-45c7-98c7-09c13a252ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_16b361f9-5434-4c5a-9ca4-89fbadf4cf6e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_1f9f704e-86fd-45c7-98c7-09c13a252ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_97f9c441-b838-4cad-ba1d-9fd20c99dcb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_16b361f9-5434-4c5a-9ca4-89fbadf4cf6e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_97f9c441-b838-4cad-ba1d-9fd20c99dcb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_331b3a86-f742-4b5b-804f-028feeaf4590" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_16b361f9-5434-4c5a-9ca4-89fbadf4cf6e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_331b3a86-f742-4b5b-804f-028feeaf4590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_71ef0fb4-2fe6-48b0-bbba-5fb2e85fcc8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_16b361f9-5434-4c5a-9ca4-89fbadf4cf6e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_71ef0fb4-2fe6-48b0-bbba-5fb2e85fcc8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_facdf2cf-fd49-4182-9f0f-ca83231132c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_16b361f9-5434-4c5a-9ca4-89fbadf4cf6e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_facdf2cf-fd49-4182-9f0f-ca83231132c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_3f04eb87-922e-4da4-b1bc-79aeaf20ab61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_16b361f9-5434-4c5a-9ca4-89fbadf4cf6e" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_3f04eb87-922e-4da4-b1bc-79aeaf20ab61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_OperatingAndFinanceLeaseLiability_03e4b867-6b6b-464e-9146-b478caeff5f2" xlink:href="jazz-20210930.xsd#jazz_OperatingAndFinanceLeaseLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_16b361f9-5434-4c5a-9ca4-89fbadf4cf6e" xlink:to="loc_jazz_OperatingAndFinanceLeaseLiability_03e4b867-6b6b-464e-9146-b478caeff5f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/LeasesWeightedAverageTermsandDiscountRatesDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#LeasesWeightedAverageTermsandDiscountRatesDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/LeasesWeightedAverageTermsandDiscountRatesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_4d83b4d4-3f0d-4600-b76e-fb366ba68575" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_WeightedAverageRemainingLeaseTermAbstract_91359e0e-b322-40c5-8d2b-40dbe65871ed" xlink:href="jazz-20210930.xsd#jazz_WeightedAverageRemainingLeaseTermAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4d83b4d4-3f0d-4600-b76e-fb366ba68575" xlink:to="loc_jazz_WeightedAverageRemainingLeaseTermAbstract_91359e0e-b322-40c5-8d2b-40dbe65871ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_ede1f3e9-1e97-4208-afbd-a7653d7abbd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_WeightedAverageRemainingLeaseTermAbstract_91359e0e-b322-40c5-8d2b-40dbe65871ed" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_ede1f3e9-1e97-4208-afbd-a7653d7abbd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_b8eef14a-d375-4cba-acbb-f93cab7ed21f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_WeightedAverageRemainingLeaseTermAbstract_91359e0e-b322-40c5-8d2b-40dbe65871ed" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_b8eef14a-d375-4cba-acbb-f93cab7ed21f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_WeightedAverageDiscountRateAbstract_d26655c7-f538-43ce-b47d-1479394aaa54" xlink:href="jazz-20210930.xsd#jazz_WeightedAverageDiscountRateAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4d83b4d4-3f0d-4600-b76e-fb366ba68575" xlink:to="loc_jazz_WeightedAverageDiscountRateAbstract_d26655c7-f538-43ce-b47d-1479394aaa54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_a7b8a687-e4e2-422c-b96f-7ae336ec9e7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_WeightedAverageDiscountRateAbstract_d26655c7-f538-43ce-b47d-1479394aaa54" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_a7b8a687-e4e2-422c-b96f-7ae336ec9e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_bdf180b2-795f-4b6b-81a3-b115209bd6a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_WeightedAverageDiscountRateAbstract_d26655c7-f538-43ce-b47d-1479394aaa54" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_bdf180b2-795f-4b6b-81a3-b115209bd6a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#LeasesSupplementalCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_b39efd2c-41db-4852-b438-af75a079ac98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract_5a2b59a3-f87b-4f4a-b37c-a6d216bfef14" xlink:href="jazz-20210930.xsd#jazz_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b39efd2c-41db-4852-b438-af75a079ac98" xlink:to="loc_jazz_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract_5a2b59a3-f87b-4f4a-b37c-a6d216bfef14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_b4af3f51-e43c-4fa6-866f-6eb4da43e941" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract_5a2b59a3-f87b-4f4a-b37c-a6d216bfef14" xlink:to="loc_us-gaap_OperatingLeasePayments_b4af3f51-e43c-4fa6-866f-6eb4da43e941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_9d719a58-1421-4f04-8849-e4b0bf04d940" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract_5a2b59a3-f87b-4f4a-b37c-a6d216bfef14" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_9d719a58-1421-4f04-8849-e4b0bf04d940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_cb86fc94-6288-41c2-98f1-d67768999aea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract_5a2b59a3-f87b-4f4a-b37c-a6d216bfef14" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_cb86fc94-6288-41c2-98f1-d67768999aea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_NoncashoperatingactivitiesAbstract_0a38368a-6067-428c-a336-9126412add7a" xlink:href="jazz-20210930.xsd#jazz_NoncashoperatingactivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b39efd2c-41db-4852-b438-af75a079ac98" xlink:to="loc_jazz_NoncashoperatingactivitiesAbstract_0a38368a-6067-428c-a336-9126412add7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_6f65cfab-8c45-4105-875c-ecc4517d60b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_NoncashoperatingactivitiesAbstract_0a38368a-6067-428c-a336-9126412add7a" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_6f65cfab-8c45-4105-875c-ecc4517d60b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_5cafc201-c937-498b-937e-0311034dd552" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_NoncashoperatingactivitiesAbstract_0a38368a-6067-428c-a336-9126412add7a" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_5cafc201-c937-498b-937e-0311034dd552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_DeRecognitionOfOperatingLeaseAssetOnLeaseAssignment_3b9887a0-acdc-4dce-a35c-d5cfd316e9c8" xlink:href="jazz-20210930.xsd#jazz_DeRecognitionOfOperatingLeaseAssetOnLeaseAssignment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_NoncashoperatingactivitiesAbstract_0a38368a-6067-428c-a336-9126412add7a" xlink:to="loc_jazz_DeRecognitionOfOperatingLeaseAssetOnLeaseAssignment_3b9887a0-acdc-4dce-a35c-d5cfd316e9c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_DeRecognitionOfOperatingLeaseLiabilityOnLeaseAssignment_5bf288b9-550f-4a23-b56f-dc865e68da7c" xlink:href="jazz-20210930.xsd#jazz_DeRecognitionOfOperatingLeaseLiabilityOnLeaseAssignment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_NoncashoperatingactivitiesAbstract_0a38368a-6067-428c-a336-9126412add7a" xlink:to="loc_jazz_DeRecognitionOfOperatingLeaseLiabilityOnLeaseAssignment_5bf288b9-550f-4a23-b56f-dc865e68da7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_4fd34f04-a334-4adc-888f-e226f9be167c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOperatingAbstract_91546c8f-30fd-4f8b-bf4b-af84cabe290b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesOperatingAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4fd34f04-a334-4adc-888f-e226f9be167c" xlink:to="loc_us-gaap_LeasesOperatingAbstract_91546c8f-30fd-4f8b-bf4b-af84cabe290b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_dfee2bae-39ef-4961-86be-cd2b503ccc44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_91546c8f-30fd-4f8b-bf4b-af84cabe290b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_dfee2bae-39ef-4961-86be-cd2b503ccc44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f264136e-7c2c-4117-8d8c-6aa331a32c61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_91546c8f-30fd-4f8b-bf4b-af84cabe290b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f264136e-7c2c-4117-8d8c-6aa331a32c61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c8bcf282-4a95-46ca-9783-25fd194af86b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_91546c8f-30fd-4f8b-bf4b-af84cabe290b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c8bcf282-4a95-46ca-9783-25fd194af86b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2306318b-50f5-4f1b-8f9e-c576df36c1da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_91546c8f-30fd-4f8b-bf4b-af84cabe290b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2306318b-50f5-4f1b-8f9e-c576df36c1da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_7cdc68f2-28ff-40d1-b720-8ff902d12772" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_91546c8f-30fd-4f8b-bf4b-af84cabe290b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_7cdc68f2-28ff-40d1-b720-8ff902d12772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_759d4252-098f-4a7c-8554-825fea94777b" xlink:href="jazz-20210930.xsd#jazz_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_91546c8f-30fd-4f8b-bf4b-af84cabe290b" xlink:to="loc_jazz_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_759d4252-098f-4a7c-8554-825fea94777b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d3854d7e-491a-4912-a510-aacb21cbd111" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_91546c8f-30fd-4f8b-bf4b-af84cabe290b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d3854d7e-491a-4912-a510-aacb21cbd111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_13bc67b2-890e-4eb4-b033-b8e5bb5c13dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_91546c8f-30fd-4f8b-bf4b-af84cabe290b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_13bc67b2-890e-4eb4-b033-b8e5bb5c13dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_1676a15c-8f13-4219-b515-8acca70b7970" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_91546c8f-30fd-4f8b-bf4b-af84cabe290b" xlink:to="loc_us-gaap_OperatingLeaseLiability_1676a15c-8f13-4219-b515-8acca70b7970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityAbstract_d5aa515e-a06e-4452-8d22-04f7d8199ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4fd34f04-a334-4adc-888f-e226f9be167c" xlink:to="loc_us-gaap_FinanceLeaseLiabilityAbstract_d5aa515e-a06e-4452-8d22-04f7d8199ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_d8091a7a-7ec4-49e4-812a-627d64926817" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_d5aa515e-a06e-4452-8d22-04f7d8199ab8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_d8091a7a-7ec4-49e4-812a-627d64926817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c6737689-02e6-4e83-917b-260db3e84574" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_d5aa515e-a06e-4452-8d22-04f7d8199ab8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c6737689-02e6-4e83-917b-260db3e84574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_5352f39d-7022-4acd-b769-dedd9df5cd22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_d5aa515e-a06e-4452-8d22-04f7d8199ab8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_5352f39d-7022-4acd-b769-dedd9df5cd22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_6864984d-d987-4a7c-8e9d-3ff65c7d09c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_d5aa515e-a06e-4452-8d22-04f7d8199ab8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_6864984d-d987-4a7c-8e9d-3ff65c7d09c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_6824b2a4-dcc6-4635-b85e-f2a499ee0d19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_d5aa515e-a06e-4452-8d22-04f7d8199ab8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_6824b2a4-dcc6-4635-b85e-f2a499ee0d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_FinanceLeaseLiabilityToBePaidAfterYearFour_e046b814-6944-4887-9a5c-cca14a24c951" xlink:href="jazz-20210930.xsd#jazz_FinanceLeaseLiabilityToBePaidAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_d5aa515e-a06e-4452-8d22-04f7d8199ab8" xlink:to="loc_jazz_FinanceLeaseLiabilityToBePaidAfterYearFour_e046b814-6944-4887-9a5c-cca14a24c951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a2d43228-f5b1-4ac1-919b-f81e9037be96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_d5aa515e-a06e-4452-8d22-04f7d8199ab8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a2d43228-f5b1-4ac1-919b-f81e9037be96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_70ff5626-a80a-4c3d-9896-b2bb38c5dfd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_d5aa515e-a06e-4452-8d22-04f7d8199ab8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_70ff5626-a80a-4c3d-9896-b2bb38c5dfd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_48bb6b49-28af-470a-a08c-9be0ad9398df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_d5aa515e-a06e-4452-8d22-04f7d8199ab8" xlink:to="loc_us-gaap_FinanceLeaseLiability_48bb6b49-28af-470a-a08c-9be0ad9398df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="jazz-20210930.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="jazz-20210930.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ca18d839-e191-41bb-8297-bcf48b42fe4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_a9088868-2afb-49b3-99a2-4b5c7a4a852d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ca18d839-e191-41bb-8297-bcf48b42fe4d" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_a9088868-2afb-49b3-99a2-4b5c7a4a852d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#CommitmentsandContingenciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/CommitmentsandContingenciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_87bc316d-3ffe-4e13-ba7c-e675126f0ab4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_d83a1f41-f015-492a-ab81-d840f13c8fcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_87bc316d-3ffe-4e13-ba7c-e675126f0ab4" xlink:to="loc_us-gaap_LossContingenciesTable_d83a1f41-f015-492a-ab81-d840f13c8fcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_5752813e-4129-4081-853d-c5a27ac2abd0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_d83a1f41-f015-492a-ab81-d840f13c8fcf" xlink:to="loc_srt_LitigationCaseAxis_5752813e-4129-4081-853d-c5a27ac2abd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_0a34f074-7001-499d-972c-5e5cf7adcc87" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_5752813e-4129-4081-853d-c5a27ac2abd0" xlink:to="loc_srt_LitigationCaseTypeDomain_0a34f074-7001-499d-972c-5e5cf7adcc87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_TeamstersAndGEHALawsuitsMember_c2ce5c62-a24d-4405-9e5c-6005363e6a86" xlink:href="jazz-20210930.xsd#jazz_TeamstersAndGEHALawsuitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_0a34f074-7001-499d-972c-5e5cf7adcc87" xlink:to="loc_jazz_TeamstersAndGEHALawsuitsMember_c2ce5c62-a24d-4405-9e5c-6005363e6a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_FarrellLawsuitAndLevyLawsuitMember_6ba2037a-97e5-43dd-849e-ddbaf55892e5" xlink:href="jazz-20210930.xsd#jazz_FarrellLawsuitAndLevyLawsuitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_0a34f074-7001-499d-972c-5e5cf7adcc87" xlink:to="loc_jazz_FarrellLawsuitAndLevyLawsuitMember_6ba2037a-97e5-43dd-849e-ddbaf55892e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_GWLitigationMember_723bb270-5b96-41e1-b913-8cf57ead558c" xlink:href="jazz-20210930.xsd#jazz_GWLitigationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_0a34f074-7001-499d-972c-5e5cf7adcc87" xlink:to="loc_jazz_GWLitigationMember_723bb270-5b96-41e1-b913-8cf57ead558c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_AvadelPharmaceuticalsPlcLawsuitMember_e89df31b-c00e-420c-b315-d26309ba8849" xlink:href="jazz-20210930.xsd#jazz_AvadelPharmaceuticalsPlcLawsuitMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_0a34f074-7001-499d-972c-5e5cf7adcc87" xlink:to="loc_jazz_AvadelPharmaceuticalsPlcLawsuitMember_e89df31b-c00e-420c-b315-d26309ba8849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_LupinLawsuitMember_82741983-9fae-4976-add7-937f5b0874a1" xlink:href="jazz-20210930.xsd#jazz_LupinLawsuitMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_0a34f074-7001-499d-972c-5e5cf7adcc87" xlink:to="loc_jazz_LupinLawsuitMember_82741983-9fae-4976-add7-937f5b0874a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_bf2066f0-8044-40a6-86d6-64219f0bd41b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_d83a1f41-f015-492a-ab81-d840f13c8fcf" xlink:to="loc_srt_ProductOrServiceAxis_bf2066f0-8044-40a6-86d6-64219f0bd41b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4b5cc9e7-f2b4-48d4-a052-39326ae78acb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_bf2066f0-8044-40a6-86d6-64219f0bd41b" xlink:to="loc_srt_ProductsAndServicesDomain_4b5cc9e7-f2b4-48d4-a052-39326ae78acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_XywavMember_6e76a37c-f6db-48cc-9418-1becbe0b8d87" xlink:href="jazz-20210930.xsd#jazz_XywavMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4b5cc9e7-f2b4-48d4-a052-39326ae78acb" xlink:to="loc_jazz_XywavMember_6e76a37c-f6db-48cc-9418-1becbe0b8d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_59196e01-ab6c-4e1b-aacb-ab888de27d28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_d83a1f41-f015-492a-ab81-d840f13c8fcf" xlink:to="loc_us-gaap_LossContingenciesLineItems_59196e01-ab6c-4e1b-aacb-ab888de27d28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted_f30c288e-d3ae-454b-ac5c-e2f23f0330dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_59196e01-ab6c-4e1b-aacb-ab888de27d28" xlink:to="loc_us-gaap_PurchaseCommitmentRemainingMinimumAmountCommitted_f30c288e-d3ae-454b-ac5c-e2f23f0330dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_810caa8f-85ad-4028-a973-aec0ffec131a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_59196e01-ab6c-4e1b-aacb-ab888de27d28" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_810caa8f-85ad-4028-a973-aec0ffec131a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_InfringedPatentsSuitNumberOfPatents_31dd3e30-45c9-436a-a0f5-7902a7871327" xlink:href="jazz-20210930.xsd#jazz_InfringedPatentsSuitNumberOfPatents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_59196e01-ab6c-4e1b-aacb-ab888de27d28" xlink:to="loc_jazz_InfringedPatentsSuitNumberOfPatents_31dd3e30-45c9-436a-a0f5-7902a7871327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_FDAStayOfApprovalPeriod_a1db7869-cc23-4530-ab31-a10994c3a841" xlink:href="jazz-20210930.xsd#jazz_FDAStayOfApprovalPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_59196e01-ab6c-4e1b-aacb-ab888de27d28" xlink:to="loc_jazz_FDAStayOfApprovalPeriod_a1db7869-cc23-4530-ab31-a10994c3a841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_FDARecognitionOfOrphanDrugExclusivityPeriod_dc57c6d0-9f32-4f5e-ae74-a6532dfa72fa" xlink:href="jazz-20210930.xsd#jazz_FDARecognitionOfOrphanDrugExclusivityPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_59196e01-ab6c-4e1b-aacb-ab888de27d28" xlink:to="loc_jazz_FDARecognitionOfOrphanDrugExclusivityPeriod_dc57c6d0-9f32-4f5e-ae74-a6532dfa72fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareholdersEquity" xlink:type="simple" xlink:href="jazz-20210930.xsd#ShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/ShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_d26171e5-9586-4364-866e-b644b2506961" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_6484e84b-6e33-4cb7-ba10-aab8c0888674" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_d26171e5-9586-4364-866e-b644b2506961" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_6484e84b-6e33-4cb7-ba10-aab8c0888674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareholdersEquityTables" xlink:type="simple" xlink:href="jazz-20210930.xsd#ShareholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/ShareholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_c4386f60-9d9c-4116-bf32-4535fd8fb95f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_871ea2a6-a17c-4834-a43e-184183b6ae25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_c4386f60-9d9c-4116-bf32-4535fd8fb95f" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_871ea2a6-a17c-4834-a43e-184183b6ae25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareholdersEquityShareRepurchaseProgramsDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#ShareholdersEquityShareRepurchaseProgramsDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/ShareholdersEquityShareRepurchaseProgramsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_47b07238-f34a-471d-8a33-e4296a43abb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_1fe77597-b1e2-4362-a9c9-e4688ff1f71a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_47b07238-f34a-471d-8a33-e4296a43abb9" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_1fe77597-b1e2-4362-a9c9-e4688ff1f71a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_69106e88-6ba9-4db9-9730-bcb0cfd27b28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1fe77597-b1e2-4362-a9c9-e4688ff1f71a" xlink:to="loc_us-gaap_AwardTypeAxis_69106e88-6ba9-4db9-9730-bcb0cfd27b28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7b770922-3439-4f74-8c4d-3cec9ca05e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_69106e88-6ba9-4db9-9730-bcb0cfd27b28" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7b770922-3439-4f74-8c4d-3cec9ca05e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_OrdinarySharesMember_a3d45275-07da-41fb-9af8-451394e66baf" xlink:href="jazz-20210930.xsd#jazz_OrdinarySharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7b770922-3439-4f74-8c4d-3cec9ca05e3a" xlink:to="loc_jazz_OrdinarySharesMember_a3d45275-07da-41fb-9af8-451394e66baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_4ac12be5-c4bb-4a22-81da-db8d12e94936" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1fe77597-b1e2-4362-a9c9-e4688ff1f71a" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_4ac12be5-c4bb-4a22-81da-db8d12e94936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_e5e4540d-c1eb-4f1f-bac2-636f60b30770" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_4ac12be5-c4bb-4a22-81da-db8d12e94936" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_e5e4540d-c1eb-4f1f-bac2-636f60b30770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_November2016ShareRepurchaseProgramMember_5df04ba8-f5f9-48e4-9ed3-2326429669b8" xlink:href="jazz-20210930.xsd#jazz_November2016ShareRepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_e5e4540d-c1eb-4f1f-bac2-636f60b30770" xlink:to="loc_jazz_November2016ShareRepurchaseProgramMember_5df04ba8-f5f9-48e4-9ed3-2326429669b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_ade4e52e-3606-41ca-8e7a-acbaef8588b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_1fe77597-b1e2-4362-a9c9-e4688ff1f71a" xlink:to="loc_us-gaap_ClassOfStockLineItems_ade4e52e-3606-41ca-8e7a-acbaef8588b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_b7825512-2ea1-4a63-87b6-f68ca48a953c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_ade4e52e-3606-41ca-8e7a-acbaef8588b4" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_b7825512-2ea1-4a63-87b6-f68ca48a953c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_f584460b-9a95-452c-9859-9f00d9edb879" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_ade4e52e-3606-41ca-8e7a-acbaef8588b4" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_f584460b-9a95-452c-9859-9f00d9edb879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_face5b60-8440-4838-bd5f-47fd2c78e03a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_ade4e52e-3606-41ca-8e7a-acbaef8588b4" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_face5b60-8440-4838-bd5f-47fd2c78e03a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareholdersEquityComponentofAccumulatedOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#ShareholdersEquityComponentofAccumulatedOtherComprehensiveLossDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/ShareholdersEquityComponentofAccumulatedOtherComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_2e8186df-9ee3-4141-bb7a-60d696e59f37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_68579be2-9062-4e6d-94fd-2ac2d470a8ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_2e8186df-9ee3-4141-bb7a-60d696e59f37" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_68579be2-9062-4e6d-94fd-2ac2d470a8ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f985bf1b-4627-42e7-9c4c-f75656c38f5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_68579be2-9062-4e6d-94fd-2ac2d470a8ef" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f985bf1b-4627-42e7-9c4c-f75656c38f5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e15e1639-dfbf-4d61-967c-3e1e63264461" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f985bf1b-4627-42e7-9c4c-f75656c38f5b" xlink:to="loc_us-gaap_EquityComponentDomain_e15e1639-dfbf-4d61-967c-3e1e63264461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_876330df-bffa-44f8-b3d8-3ef43382fb6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e15e1639-dfbf-4d61-967c-3e1e63264461" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_876330df-bffa-44f8-b3d8-3ef43382fb6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_fc653f39-87c1-41b3-85f1-dea2beca2c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e15e1639-dfbf-4d61-967c-3e1e63264461" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_fc653f39-87c1-41b3-85f1-dea2beca2c2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7ee16783-5187-413b-a9a0-711f2aee2e9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e15e1639-dfbf-4d61-967c-3e1e63264461" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7ee16783-5187-413b-a9a0-711f2aee2e9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0e4754dc-794b-4be0-ae11-d0d33259f2c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_68579be2-9062-4e6d-94fd-2ac2d470a8ef" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0e4754dc-794b-4be0-ae11-d0d33259f2c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_2343b7df-5bad-41a7-a348-76c825c62e66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0e4754dc-794b-4be0-ae11-d0d33259f2c7" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_2343b7df-5bad-41a7-a348-76c825c62e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0feddfff-1a69-493e-9ded-f442c0f13d1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_2343b7df-5bad-41a7-a348-76c825c62e66" xlink:to="loc_us-gaap_StockholdersEquity_0feddfff-1a69-493e-9ded-f442c0f13d1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_f2b65935-bd91-4b13-ab61-3cd8bbe8ab50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_2343b7df-5bad-41a7-a348-76c825c62e66" xlink:to="loc_us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent_f2b65935-bd91-4b13-ab61-3cd8bbe8ab50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_0e792a4e-c094-45d7-8140-04cafc9e7680" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_2343b7df-5bad-41a7-a348-76c825c62e66" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent_0e792a4e-c094-45d7-8140-04cafc9e7680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3b7fc3e5-118e-4929-869a-095b2b0251b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_2343b7df-5bad-41a7-a348-76c825c62e66" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3b7fc3e5-118e-4929-869a-095b2b0251b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0d5e992c-1cb8-49ae-a6b4-77028039f251" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_2343b7df-5bad-41a7-a348-76c825c62e66" xlink:to="loc_us-gaap_StockholdersEquity_0d5e992c-1cb8-49ae-a6b4-77028039f251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/NetIncomeLossperOrdinaryShare" xlink:type="simple" xlink:href="jazz-20210930.xsd#NetIncomeLossperOrdinaryShare"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/NetIncomeLossperOrdinaryShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_9b545e32-1ceb-4de2-a140-5afb8ebfa5a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_a6772851-038b-4789-94f2-9d3083b92aae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9b545e32-1ceb-4de2-a140-5afb8ebfa5a1" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_a6772851-038b-4789-94f2-9d3083b92aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/NetIncomeLossperOrdinaryShareTables" xlink:type="simple" xlink:href="jazz-20210930.xsd#NetIncomeLossperOrdinaryShareTables"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/NetIncomeLossperOrdinaryShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_f8d756b4-5a9a-4af9-b6fa-0bb87792c1f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_38db55a1-bc64-45a8-82e6-fc7266c555db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f8d756b4-5a9a-4af9-b6fa-0bb87792c1f4" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_38db55a1-bc64-45a8-82e6-fc7266c555db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_46a57520-95a7-4e54-9e77-bab6396b13d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f8d756b4-5a9a-4af9-b6fa-0bb87792c1f4" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_46a57520-95a7-4e54-9e77-bab6396b13d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/NetIncomeLossperOrdinaryShareBasicandDilutedNetIncomeperCommonShareDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#NetIncomeLossperOrdinaryShareBasicandDilutedNetIncomeperCommonShareDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/NetIncomeLossperOrdinaryShareBasicandDilutedNetIncomeperCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b905a6e4-5250-492f-a052-9658f448ad3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_NumeratorAbstract_32c459bc-e324-40da-bf7f-44463374b7bb" xlink:href="jazz-20210930.xsd#jazz_NumeratorAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b905a6e4-5250-492f-a052-9658f448ad3c" xlink:to="loc_jazz_NumeratorAbstract_32c459bc-e324-40da-bf7f-44463374b7bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_49bf18d7-273e-4016-ac1a-8d07a217dd80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_NumeratorAbstract_32c459bc-e324-40da-bf7f-44463374b7bb" xlink:to="loc_us-gaap_NetIncomeLoss_49bf18d7-273e-4016-ac1a-8d07a217dd80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_DenominatorAbstract_89fb0e98-bb44-41f7-ac16-d7c4cbc5289f" xlink:href="jazz-20210930.xsd#jazz_DenominatorAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b905a6e4-5250-492f-a052-9658f448ad3c" xlink:to="loc_jazz_DenominatorAbstract_89fb0e98-bb44-41f7-ac16-d7c4cbc5289f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5b3cba01-28a0-445b-9fd8-847407e6050a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_DenominatorAbstract_89fb0e98-bb44-41f7-ac16-d7c4cbc5289f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5b3cba01-28a0-445b-9fd8-847407e6050a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1300dfbb-721f-4102-b5da-4f6543043960" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_DenominatorAbstract_89fb0e98-bb44-41f7-ac16-d7c4cbc5289f" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1300dfbb-721f-4102-b5da-4f6543043960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f9308457-2ee9-4541-9672-e4b7fe9f915c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_DenominatorAbstract_89fb0e98-bb44-41f7-ac16-d7c4cbc5289f" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f9308457-2ee9-4541-9672-e4b7fe9f915c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract_7cce7913-a326-4981-a139-4fd568bcd1a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b905a6e4-5250-492f-a052-9658f448ad3c" xlink:to="loc_us-gaap_EarningsPerShareReconciliationAbstract_7cce7913-a326-4981-a139-4fd568bcd1a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_f7e051da-cad0-40c0-855a-84ad9adc15a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_7cce7913-a326-4981-a139-4fd568bcd1a5" xlink:to="loc_us-gaap_EarningsPerShareBasic_f7e051da-cad0-40c0-855a-84ad9adc15a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_5f1939f0-7a18-4e50-a755-58a3b28e7c85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_7cce7913-a326-4981-a139-4fd568bcd1a5" xlink:to="loc_us-gaap_EarningsPerShareDiluted_5f1939f0-7a18-4e50-a755-58a3b28e7c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/NetIncomeLossperOrdinaryShareWeightedAverageOrdinarySharesExcludedfromComputationofDilutedNetIncomeperShareDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#NetIncomeLossperOrdinaryShareWeightedAverageOrdinarySharesExcludedfromComputationofDilutedNetIncomeperShareDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/NetIncomeLossperOrdinaryShareWeightedAverageOrdinarySharesExcludedfromComputationofDilutedNetIncomeperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_31433fa7-35ad-4cb8-a2a6-6e5b6012ab54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_59e7c505-4f84-4637-9908-2c795e6835ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_31433fa7-35ad-4cb8-a2a6-6e5b6012ab54" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_59e7c505-4f84-4637-9908-2c795e6835ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5599d094-5e6c-4125-94d2-a5d2cef47510" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_59e7c505-4f84-4637-9908-2c795e6835ab" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5599d094-5e6c-4125-94d2-a5d2cef47510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_00cb5072-b8f0-496c-8cfb-c1325814735d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_5599d094-5e6c-4125-94d2-a5d2cef47510" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_00cb5072-b8f0-496c-8cfb-c1325814735d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_a769f623-7485-408e-9ab7-9f76852ce3c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_00cb5072-b8f0-496c-8cfb-c1325814735d" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_a769f623-7485-408e-9ab7-9f76852ce3c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityUnitPurchaseAgreementsMember_ebb84834-1233-4aa9-bea2-869e296fe9ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityUnitPurchaseAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_00cb5072-b8f0-496c-8cfb-c1325814735d" xlink:to="loc_us-gaap_EquityUnitPurchaseAgreementsMember_ebb84834-1233-4aa9-bea2-869e296fe9ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5482d321-d42c-4313-8a7d-12b878f4ccdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_59e7c505-4f84-4637-9908-2c795e6835ab" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5482d321-d42c-4313-8a7d-12b878f4ccdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7aede90b-b61a-42f0-a36e-9eff5d1733b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5482d321-d42c-4313-8a7d-12b878f4ccdc" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7aede90b-b61a-42f0-a36e-9eff5d1733b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/Revenues" xlink:type="simple" xlink:href="jazz-20210930.xsd#Revenues"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/Revenues" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b0e1548b-55fb-4a1c-8739-dd9ddffb849d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_debed381-92b5-448e-aff5-55e576bb0aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b0e1548b-55fb-4a1c-8739-dd9ddffb849d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_debed381-92b5-448e-aff5-55e576bb0aa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/RevenuesTables" xlink:type="simple" xlink:href="jazz-20210930.xsd#RevenuesTables"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/RevenuesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8ce1f80d-378c-4959-acd3-54bbec6b2e89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_1b25a0e3-ff0d-49ec-a193-8a2c94a0119d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8ce1f80d-378c-4959-acd3-54bbec6b2e89" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_1b25a0e3-ff0d-49ec-a193-8a2c94a0119d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_c003827b-dd8c-4567-9f15-e0e503b8b95a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8ce1f80d-378c-4959-acd3-54bbec6b2e89" xlink:to="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_c003827b-dd8c-4567-9f15-e0e503b8b95a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_83af3009-42d2-4c26-8e39-4ccd4c919cb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8ce1f80d-378c-4959-acd3-54bbec6b2e89" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_83af3009-42d2-4c26-8e39-4ccd4c919cb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/RevenuesSummaryofDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#RevenuesSummaryofDisaggregationofRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/RevenuesSummaryofDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ef3439a9-6c63-4589-a2fe-b9edf392892b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_1d134146-1390-4cf6-b2f5-bbd59c5d9234" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ef3439a9-6c63-4589-a2fe-b9edf392892b" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_1d134146-1390-4cf6-b2f5-bbd59c5d9234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_8d531b57-07ce-4acf-8f88-54aa3ce18038" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1d134146-1390-4cf6-b2f5-bbd59c5d9234" xlink:to="loc_srt_ProductOrServiceAxis_8d531b57-07ce-4acf-8f88-54aa3ce18038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_7a361ff2-9c88-4130-9c3f-2454726abdc9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_8d531b57-07ce-4acf-8f88-54aa3ce18038" xlink:to="loc_srt_ProductsAndServicesDomain_7a361ff2-9c88-4130-9c3f-2454726abdc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ProductAndServicesProductSalesNetOfDeductionsMember_f3dd6ae8-29aa-4f51-8912-36639fd5a027" xlink:href="jazz-20210930.xsd#jazz_ProductAndServicesProductSalesNetOfDeductionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7a361ff2-9c88-4130-9c3f-2454726abdc9" xlink:to="loc_jazz_ProductAndServicesProductSalesNetOfDeductionsMember_f3dd6ae8-29aa-4f51-8912-36639fd5a027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_OncologyMember_b3000fce-ea63-43ca-aaea-39731151be90" xlink:href="jazz-20210930.xsd#jazz_OncologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_ProductAndServicesProductSalesNetOfDeductionsMember_f3dd6ae8-29aa-4f51-8912-36639fd5a027" xlink:to="loc_jazz_OncologyMember_b3000fce-ea63-43ca-aaea-39731151be90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_TotalOxybateMember_ef342b9b-5aac-4e23-839b-3526ae5dd586" xlink:href="jazz-20210930.xsd#jazz_TotalOxybateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_OncologyMember_b3000fce-ea63-43ca-aaea-39731151be90" xlink:to="loc_jazz_TotalOxybateMember_ef342b9b-5aac-4e23-839b-3526ae5dd586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_XyremMember_1c7a0187-348a-453d-a237-f03e7d0fc487" xlink:href="jazz-20210930.xsd#jazz_XyremMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_TotalOxybateMember_ef342b9b-5aac-4e23-839b-3526ae5dd586" xlink:to="loc_jazz_XyremMember_1c7a0187-348a-453d-a237-f03e7d0fc487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_XywavMember_cd533ff8-cf16-49d3-b87e-6f9d22050469" xlink:href="jazz-20210930.xsd#jazz_XywavMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_TotalOxybateMember_ef342b9b-5aac-4e23-839b-3526ae5dd586" xlink:to="loc_jazz_XywavMember_cd533ff8-cf16-49d3-b87e-6f9d22050469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_NeuroscienceMember_cbfce428-3108-427d-9ef8-e2ba0e432175" xlink:href="jazz-20210930.xsd#jazz_NeuroscienceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_OncologyMember_b3000fce-ea63-43ca-aaea-39731151be90" xlink:to="loc_jazz_NeuroscienceMember_cbfce428-3108-427d-9ef8-e2ba0e432175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_EpidiolexEpidyolexMember_94632dbc-4bb6-4037-9d6a-44e7704c3553" xlink:href="jazz-20210930.xsd#jazz_EpidiolexEpidyolexMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_NeuroscienceMember_cbfce428-3108-427d-9ef8-e2ba0e432175" xlink:to="loc_jazz_EpidiolexEpidyolexMember_94632dbc-4bb6-4037-9d6a-44e7704c3553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_SunosiMember_ac53a896-365c-4c97-85f3-f5990b4db576" xlink:href="jazz-20210930.xsd#jazz_SunosiMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_NeuroscienceMember_cbfce428-3108-427d-9ef8-e2ba0e432175" xlink:to="loc_jazz_SunosiMember_ac53a896-365c-4c97-85f3-f5990b4db576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_SativexMember_0c211d7e-55de-4da2-ac20-4d5a4376867c" xlink:href="jazz-20210930.xsd#jazz_SativexMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_NeuroscienceMember_cbfce428-3108-427d-9ef8-e2ba0e432175" xlink:to="loc_jazz_SativexMember_0c211d7e-55de-4da2-ac20-4d5a4376867c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ZepzelcaMember_301e488b-a814-418d-b754-fa4bb76026e8" xlink:href="jazz-20210930.xsd#jazz_ZepzelcaMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_OncologyMember_b3000fce-ea63-43ca-aaea-39731151be90" xlink:to="loc_jazz_ZepzelcaMember_301e488b-a814-418d-b754-fa4bb76026e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_VyxeosMember_6f70ecbc-ebf3-4ee1-b335-5f39d085f1bf" xlink:href="jazz-20210930.xsd#jazz_VyxeosMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_OncologyMember_b3000fce-ea63-43ca-aaea-39731151be90" xlink:to="loc_jazz_VyxeosMember_6f70ecbc-ebf3-4ee1-b335-5f39d085f1bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_DefitelioDefibrotideMember_0e7b1a1a-fa4c-4e87-bfae-3d34e2a088ee" xlink:href="jazz-20210930.xsd#jazz_DefitelioDefibrotideMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_OncologyMember_b3000fce-ea63-43ca-aaea-39731151be90" xlink:to="loc_jazz_DefitelioDefibrotideMember_0e7b1a1a-fa4c-4e87-bfae-3d34e2a088ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_RylazeMember_422e0555-9f0f-4544-b582-0ca91c095b2e" xlink:href="jazz-20210930.xsd#jazz_RylazeMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_OncologyMember_b3000fce-ea63-43ca-aaea-39731151be90" xlink:to="loc_jazz_RylazeMember_422e0555-9f0f-4544-b582-0ca91c095b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ErwinazeAndErwinaseMember_8bf16904-b6d2-4ea7-a9cb-2205ad982eac" xlink:href="jazz-20210930.xsd#jazz_ErwinazeAndErwinaseMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_OncologyMember_b3000fce-ea63-43ca-aaea-39731151be90" xlink:to="loc_jazz_ErwinazeAndErwinaseMember_8bf16904-b6d2-4ea7-a9cb-2205ad982eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_OtherProductsMember_1cda76e5-74a9-487f-af55-eb8af055668c" xlink:href="jazz-20210930.xsd#jazz_OtherProductsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_ProductAndServicesProductSalesNetOfDeductionsMember_f3dd6ae8-29aa-4f51-8912-36639fd5a027" xlink:to="loc_jazz_OtherProductsMember_1cda76e5-74a9-487f-af55-eb8af055668c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ProductAndServicesRoyaltiesAndContractRevenueMember_f99242e8-ca56-484a-8add-62ed77968295" xlink:href="jazz-20210930.xsd#jazz_ProductAndServicesRoyaltiesAndContractRevenueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7a361ff2-9c88-4130-9c3f-2454726abdc9" xlink:to="loc_jazz_ProductAndServicesRoyaltiesAndContractRevenueMember_f99242e8-ca56-484a-8add-62ed77968295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_0a6abf1e-46d0-49db-9b8a-c440890161e8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1d134146-1390-4cf6-b2f5-bbd59c5d9234" xlink:to="loc_srt_StatementGeographicalAxis_0a6abf1e-46d0-49db-9b8a-c440890161e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_75ffde1f-eca1-45cb-8071-1d0d7e6cf1eb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_0a6abf1e-46d0-49db-9b8a-c440890161e8" xlink:to="loc_srt_SegmentGeographicalDomain_75ffde1f-eca1-45cb-8071-1d0d7e6cf1eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_5e6a7caf-4cc6-471f-9b96-7de23d0e56c2" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_75ffde1f-eca1-45cb-8071-1d0d7e6cf1eb" xlink:to="loc_country_US_5e6a7caf-4cc6-471f-9b96-7de23d0e56c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_a42dd986-1c72-4dd7-a8af-185cd92f3ea4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_75ffde1f-eca1-45cb-8071-1d0d7e6cf1eb" xlink:to="loc_srt_EuropeMember_a42dd986-1c72-4dd7-a8af-185cd92f3ea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_OtherCountriesMember_23408507-3e2d-456f-92ff-f91f3615501d" xlink:href="jazz-20210930.xsd#jazz_OtherCountriesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_75ffde1f-eca1-45cb-8071-1d0d7e6cf1eb" xlink:to="loc_jazz_OtherCountriesMember_23408507-3e2d-456f-92ff-f91f3615501d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_5cc96be4-d8c2-4c1d-995a-a0c4cdd00d94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1d134146-1390-4cf6-b2f5-bbd59c5d9234" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_5cc96be4-d8c2-4c1d-995a-a0c4cdd00d94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2ef4c45b-ed08-4ac0-a801-3248ee706e30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_5cc96be4-d8c2-4c1d-995a-a0c4cdd00d94" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2ef4c45b-ed08-4ac0-a801-3248ee706e30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/RevenuesSummaryofthePercentageofTotalRevenuesfromCustomersDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#RevenuesSummaryofthePercentageofTotalRevenuesfromCustomersDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/RevenuesSummaryofthePercentageofTotalRevenuesfromCustomersDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_77913f0c-6f82-4fba-a26c-c29fbcc7164d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_c1afb1ae-8b85-4798-8e3d-3018b2a0f0ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_77913f0c-6f82-4fba-a26c-c29fbcc7164d" xlink:to="loc_us-gaap_ConcentrationRiskTable_c1afb1ae-8b85-4798-8e3d-3018b2a0f0ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_3e3ea48e-98ae-43ba-9fae-1ba43f402136" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_c1afb1ae-8b85-4798-8e3d-3018b2a0f0ae" xlink:to="loc_srt_MajorCustomersAxis_3e3ea48e-98ae-43ba-9fae-1ba43f402136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_1917ed73-33b5-4c2e-a9be-f13111bf6984" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_3e3ea48e-98ae-43ba-9fae-1ba43f402136" xlink:to="loc_srt_NameOfMajorCustomerDomain_1917ed73-33b5-4c2e-a9be-f13111bf6984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ExpressScriptsMember_abc0b582-d74a-4b41-aef9-282ebd2a485a" xlink:href="jazz-20210930.xsd#jazz_ExpressScriptsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_1917ed73-33b5-4c2e-a9be-f13111bf6984" xlink:to="loc_jazz_ExpressScriptsMember_abc0b582-d74a-4b41-aef9-282ebd2a485a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_McKessonCorporationMember_92404579-f6f1-430f-bc8b-209afa00a2a9" xlink:href="jazz-20210930.xsd#jazz_McKessonCorporationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_1917ed73-33b5-4c2e-a9be-f13111bf6984" xlink:to="loc_jazz_McKessonCorporationMember_92404579-f6f1-430f-bc8b-209afa00a2a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5b36c2a2-8194-412b-aa56-1b98d16b4c72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_c1afb1ae-8b85-4798-8e3d-3018b2a0f0ae" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5b36c2a2-8194-412b-aa56-1b98d16b4c72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e6b6dcfa-3481-446e-9d7c-f3627d80d00f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5b36c2a2-8194-412b-aa56-1b98d16b4c72" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e6b6dcfa-3481-446e-9d7c-f3627d80d00f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_92611a27-8bca-4633-bc49-d3ce18c07a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e6b6dcfa-3481-446e-9d7c-f3627d80d00f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_92611a27-8bca-4633-bc49-d3ce18c07a4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_17166cce-1ab6-4c2e-8e10-6e01b8286d01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_c1afb1ae-8b85-4798-8e3d-3018b2a0f0ae" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_17166cce-1ab6-4c2e-8e10-6e01b8286d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_2492e327-b7e3-45ce-a694-e1b8b4fe81ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_17166cce-1ab6-4c2e-8e10-6e01b8286d01" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_2492e327-b7e3-45ce-a694-e1b8b4fe81ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_63e1a876-6540-4882-bf4c-94191b38506a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_2492e327-b7e3-45ce-a694-e1b8b4fe81ec" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_63e1a876-6540-4882-bf4c-94191b38506a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_6d60800a-e9ac-4e1b-9b27-a6afd13cab83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_c1afb1ae-8b85-4798-8e3d-3018b2a0f0ae" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_6d60800a-e9ac-4e1b-9b27-a6afd13cab83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_ddcb3bfb-fa64-40cd-b3fa-9d1d1107661f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6d60800a-e9ac-4e1b-9b27-a6afd13cab83" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_ddcb3bfb-fa64-40cd-b3fa-9d1d1107661f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/RevenuesNarrativeDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#RevenuesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/RevenuesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_fdb66004-ad91-44fd-a641-7cd218df35a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_SummaryOfDeferredRevenueTable_3cdb03e0-8237-43ab-93a3-2344539fc1e0" xlink:href="jazz-20210930.xsd#jazz_SummaryOfDeferredRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_fdb66004-ad91-44fd-a641-7cd218df35a8" xlink:to="loc_jazz_SummaryOfDeferredRevenueTable_3cdb03e0-8237-43ab-93a3-2344539fc1e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_634ed963-678d-474a-8d8b-ba771f8f10c6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_SummaryOfDeferredRevenueTable_3cdb03e0-8237-43ab-93a3-2344539fc1e0" xlink:to="loc_srt_RangeAxis_634ed963-678d-474a-8d8b-ba771f8f10c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_41831d20-2e2f-47a0-848b-0d0e12d03c0a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_634ed963-678d-474a-8d8b-ba771f8f10c6" xlink:to="loc_srt_RangeMember_41831d20-2e2f-47a0-848b-0d0e12d03c0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_deab50ac-e7e5-4494-bbf3-d990439608f1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_41831d20-2e2f-47a0-848b-0d0e12d03c0a" xlink:to="loc_srt_MinimumMember_deab50ac-e7e5-4494-bbf3-d990439608f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_21e07d80-a95d-4d66-a727-c360ff677cb8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_41831d20-2e2f-47a0-848b-0d0e12d03c0a" xlink:to="loc_srt_MaximumMember_21e07d80-a95d-4d66-a727-c360ff677cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_1822435b-23f3-43e4-b283-41ae7791b7d5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_SummaryOfDeferredRevenueTable_3cdb03e0-8237-43ab-93a3-2344539fc1e0" xlink:to="loc_srt_MajorCustomersAxis_1822435b-23f3-43e4-b283-41ae7791b7d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_25313dc3-f64d-4185-93ce-aa191684817a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_1822435b-23f3-43e4-b283-41ae7791b7d5" xlink:to="loc_srt_NameOfMajorCustomerDomain_25313dc3-f64d-4185-93ce-aa191684817a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_NipponShinyakuCo.Ltd.Member_44ac3287-0688-4dd3-b07f-ba09cba3e7ce" xlink:href="jazz-20210930.xsd#jazz_NipponShinyakuCo.Ltd.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_25313dc3-f64d-4185-93ce-aa191684817a" xlink:to="loc_jazz_NipponShinyakuCo.Ltd.Member_44ac3287-0688-4dd3-b07f-ba09cba3e7ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_SummaryOfDeferredRevenueLineItems_8e96a1b9-e10d-4a47-a93a-a493ac443592" xlink:href="jazz-20210930.xsd#jazz_SummaryOfDeferredRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_SummaryOfDeferredRevenueTable_3cdb03e0-8237-43ab-93a3-2344539fc1e0" xlink:to="loc_jazz_SummaryOfDeferredRevenueLineItems_8e96a1b9-e10d-4a47-a93a-a493ac443592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_RevenuePerformanceObligationPaymentTerms_2b1fbc2a-4ccc-4459-ab65-83a33be3eddd" xlink:href="jazz-20210930.xsd#jazz_RevenuePerformanceObligationPaymentTerms"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_SummaryOfDeferredRevenueLineItems_8e96a1b9-e10d-4a47-a93a-a493ac443592" xlink:to="loc_jazz_RevenuePerformanceObligationPaymentTerms_2b1fbc2a-4ccc-4459-ab65-83a33be3eddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_LicensingAgreementNumberOfAgreements_6ad8af28-d959-4f78-ae7b-60ef1fb23a0a" xlink:href="jazz-20210930.xsd#jazz_LicensingAgreementNumberOfAgreements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_SummaryOfDeferredRevenueLineItems_8e96a1b9-e10d-4a47-a93a-a493ac443592" xlink:to="loc_jazz_LicensingAgreementNumberOfAgreements_6ad8af28-d959-4f78-ae7b-60ef1fb23a0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_ab2aea5d-5535-4d47-8dca-c5aefbcf6b32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_SummaryOfDeferredRevenueLineItems_8e96a1b9-e10d-4a47-a93a-a493ac443592" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_ab2aea5d-5535-4d47-8dca-c5aefbcf6b32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_17dc7a67-dd2e-4a60-8568-6e977b38b8cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuePerformanceObligationDescriptionOfTiming"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_SummaryOfDeferredRevenueLineItems_8e96a1b9-e10d-4a47-a93a-a493ac443592" xlink:to="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_17dc7a67-dd2e-4a60-8568-6e977b38b8cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/RevenuesSummaryofContractLiabilitiesDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#RevenuesSummaryofContractLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/RevenuesSummaryofContractLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2873447b-1f1f-47d5-9131-0908f830120b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ChangeInContractWithCustomerLiabilityRollForward_e003cad5-4498-4932-99f3-be6a2c021d38" xlink:href="jazz-20210930.xsd#jazz_ChangeInContractWithCustomerLiabilityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2873447b-1f1f-47d5-9131-0908f830120b" xlink:to="loc_jazz_ChangeInContractWithCustomerLiabilityRollForward_e003cad5-4498-4932-99f3-be6a2c021d38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_84508370-9037-4b6f-9876-36f96d3642d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_ChangeInContractWithCustomerLiabilityRollForward_e003cad5-4498-4932-99f3-be6a2c021d38" xlink:to="loc_us-gaap_ContractWithCustomerLiability_84508370-9037-4b6f-9876-36f96d3642d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ContractWithCustomerLiabilityIncreaseDecreaseForGovernmentalGrant_016950dc-82cc-4d65-a2f8-e74c7aa9dde2" xlink:href="jazz-20210930.xsd#jazz_ContractWithCustomerLiabilityIncreaseDecreaseForGovernmentalGrant"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_ChangeInContractWithCustomerLiabilityRollForward_e003cad5-4498-4932-99f3-be6a2c021d38" xlink:to="loc_jazz_ContractWithCustomerLiabilityIncreaseDecreaseForGovernmentalGrant_016950dc-82cc-4d65-a2f8-e74c7aa9dde2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_f20f32bd-fa05-4438-947a-912f1361371d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_ChangeInContractWithCustomerLiabilityRollForward_e003cad5-4498-4932-99f3-be6a2c021d38" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_f20f32bd-fa05-4438-947a-912f1361371d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_c6f652d1-2b48-4c0f-b1f0-2d2d80b91912" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_ChangeInContractWithCustomerLiabilityRollForward_e003cad5-4498-4932-99f3-be6a2c021d38" xlink:to="loc_us-gaap_ContractWithCustomerLiability_c6f652d1-2b48-4c0f-b1f0-2d2d80b91912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="jazz-20210930.xsd#ShareBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/ShareBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_325f33a4-1466-4ee3-9aaa-b74239adf397" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_d050ce09-3cd6-4331-a3d4-8e4e903d1ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_325f33a4-1466-4ee3-9aaa-b74239adf397" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_d050ce09-3cd6-4331-a3d4-8e4e903d1ab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="jazz-20210930.xsd#ShareBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/ShareBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6efac11a-f9a1-44f9-9a0a-103425bb97cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_9f7a9b29-cb15-4b12-956e-4049f03bac6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6efac11a-f9a1-44f9-9a0a-103425bb97cb" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_9f7a9b29-cb15-4b12-956e-4049f03bac6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_ae09ffd3-5fd0-4dac-a58d-e5654de28597" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6efac11a-f9a1-44f9-9a0a-103425bb97cb" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_ae09ffd3-5fd0-4dac-a58d-e5654de28597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_a6e64d48-dafe-41e5-8f3c-d76a17a762dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6efac11a-f9a1-44f9-9a0a-103425bb97cb" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_a6e64d48-dafe-41e5-8f3c-d76a17a762dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#ShareBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/ShareBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a2fd734c-a910-4035-bc72-a63e7e833a51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_423863b6-0c86-4eb3-bb04-1775e42afa03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a2fd734c-a910-4035-bc72-a63e7e833a51" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_423863b6-0c86-4eb3-bb04-1775e42afa03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_4a569616-7f9b-43f9-ae34-45c19dd7b621" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_423863b6-0c86-4eb3-bb04-1775e42afa03" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_4a569616-7f9b-43f9-ae34-45c19dd7b621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_06179d38-91cd-407a-97f8-214b0666b87d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_4a569616-7f9b-43f9-ae34-45c19dd7b621" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_06179d38-91cd-407a-97f8-214b0666b87d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_0cc76db6-dd3f-4aae-a6d3-2c3be1e41e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_06179d38-91cd-407a-97f8-214b0666b87d" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_0cc76db6-dd3f-4aae-a6d3-2c3be1e41e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_fb71a9ce-e7dc-4d95-977b-647cac914746" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_06179d38-91cd-407a-97f8-214b0666b87d" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_fb71a9ce-e7dc-4d95-977b-647cac914746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_c7c2d069-18ea-4686-ba02-a3d442828dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_06179d38-91cd-407a-97f8-214b0666b87d" xlink:to="loc_us-gaap_CostOfSalesMember_c7c2d069-18ea-4686-ba02-a3d442828dcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_37aa09ca-4b18-435f-927a-3b50f8a2703e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_423863b6-0c86-4eb3-bb04-1775e42afa03" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_37aa09ca-4b18-435f-927a-3b50f8a2703e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_517cfbad-da33-405e-9d43-760d98f97163" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_37aa09ca-4b18-435f-927a-3b50f8a2703e" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_517cfbad-da33-405e-9d43-760d98f97163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_4db99b46-5742-42c9-b489-270480ee698f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_37aa09ca-4b18-435f-927a-3b50f8a2703e" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_4db99b46-5742-42c9-b489-270480ee698f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_98bdf3cc-1c7d-4ed3-b155-4777e91f4cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_37aa09ca-4b18-435f-927a-3b50f8a2703e" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_98bdf3cc-1c7d-4ed3-b155-4777e91f4cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareBasedCompensationWeightedAverageAssumptionsandResultingGrantDateFairValueDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#ShareBasedCompensationWeightedAverageAssumptionsandResultingGrantDateFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/ShareBasedCompensationWeightedAverageAssumptionsandResultingGrantDateFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f6dbaa5c-dae3-4c0a-aeae-6ab1317648ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ScheduleOfWeightedAverageAssumptionsForFairValuesOfStockOptionsTable_fb6f7055-4adb-4486-a8e9-983608520bcb" xlink:href="jazz-20210930.xsd#jazz_ScheduleOfWeightedAverageAssumptionsForFairValuesOfStockOptionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f6dbaa5c-dae3-4c0a-aeae-6ab1317648ce" xlink:to="loc_jazz_ScheduleOfWeightedAverageAssumptionsForFairValuesOfStockOptionsTable_fb6f7055-4adb-4486-a8e9-983608520bcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e3829706-d3d2-4c0f-919c-b3796004907b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_ScheduleOfWeightedAverageAssumptionsForFairValuesOfStockOptionsTable_fb6f7055-4adb-4486-a8e9-983608520bcb" xlink:to="loc_us-gaap_AwardTypeAxis_e3829706-d3d2-4c0f-919c-b3796004907b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_57a44421-8fe2-4e64-bd19-674701c32a89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_e3829706-d3d2-4c0f-919c-b3796004907b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_57a44421-8fe2-4e64-bd19-674701c32a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_8ed2d02f-308c-435b-9b76-f922640ebf2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_57a44421-8fe2-4e64-bd19-674701c32a89" xlink:to="loc_us-gaap_EmployeeStockOptionMember_8ed2d02f-308c-435b-9b76-f922640ebf2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_NominalStrikePriceOptionsMember_b1a471f3-65bf-4ca3-9b37-b7fa57021e3c" xlink:href="jazz-20210930.xsd#jazz_NominalStrikePriceOptionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_57a44421-8fe2-4e64-bd19-674701c32a89" xlink:to="loc_jazz_NominalStrikePriceOptionsMember_b1a471f3-65bf-4ca3-9b37-b7fa57021e3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ScheduleOfWeightedAverageAssumptionsForFairValuesOfStockOptionsLineItems_37956640-e56b-426b-9bc3-ffc8b2071aaa" xlink:href="jazz-20210930.xsd#jazz_ScheduleOfWeightedAverageAssumptionsForFairValuesOfStockOptionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_ScheduleOfWeightedAverageAssumptionsForFairValuesOfStockOptionsTable_fb6f7055-4adb-4486-a8e9-983608520bcb" xlink:to="loc_jazz_ScheduleOfWeightedAverageAssumptionsForFairValuesOfStockOptionsLineItems_37956640-e56b-426b-9bc3-ffc8b2071aaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_92190783-3cf0-4b07-b2c5-e6180326d21d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_ScheduleOfWeightedAverageAssumptionsForFairValuesOfStockOptionsLineItems_37956640-e56b-426b-9bc3-ffc8b2071aaa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_92190783-3cf0-4b07-b2c5-e6180326d21d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_eea94b99-3e44-4821-8a5c-084456791e9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_ScheduleOfWeightedAverageAssumptionsForFairValuesOfStockOptionsLineItems_37956640-e56b-426b-9bc3-ffc8b2071aaa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_eea94b99-3e44-4821-8a5c-084456791e9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_cfb8f62b-5954-4260-86dc-94cfe435c552" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_ScheduleOfWeightedAverageAssumptionsForFairValuesOfStockOptionsLineItems_37956640-e56b-426b-9bc3-ffc8b2071aaa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_cfb8f62b-5954-4260-86dc-94cfe435c552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_e1051a3d-79fa-4ca2-8da6-1bd885aa13ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_ScheduleOfWeightedAverageAssumptionsForFairValuesOfStockOptionsLineItems_37956640-e56b-426b-9bc3-ffc8b2071aaa" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_e1051a3d-79fa-4ca2-8da6-1bd885aa13ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1de06aa0-afec-4f68-9ffd-b7d896ed7248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_ScheduleOfWeightedAverageAssumptionsForFairValuesOfStockOptionsLineItems_37956640-e56b-426b-9bc3-ffc8b2071aaa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1de06aa0-afec-4f68-9ffd-b7d896ed7248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_251e54b3-7643-4f47-88e0-6d17126d1ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_ScheduleOfWeightedAverageAssumptionsForFairValuesOfStockOptionsLineItems_37956640-e56b-426b-9bc3-ffc8b2071aaa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_251e54b3-7643-4f47-88e0-6d17126d1ad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_ee650542-97f2-4b12-ad72-f5aec669b551" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_ScheduleOfWeightedAverageAssumptionsForFairValuesOfStockOptionsLineItems_37956640-e56b-426b-9bc3-ffc8b2071aaa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_ee650542-97f2-4b12-ad72-f5aec669b551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_670d2eed-8b0f-4a29-afd4-e75304fb99a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jazz_ScheduleOfWeightedAverageAssumptionsForFairValuesOfStockOptionsLineItems_37956640-e56b-426b-9bc3-ffc8b2071aaa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_670d2eed-8b0f-4a29-afd4-e75304fb99a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareBasedCompensationRestrictedUnitsDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#ShareBasedCompensationRestrictedUnitsDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/ShareBasedCompensationRestrictedUnitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2f48653a-387b-4a55-badb-d6334aced658" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b9be4166-15a2-4c0a-a973-59c3366a7c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2f48653a-387b-4a55-badb-d6334aced658" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b9be4166-15a2-4c0a-a973-59c3366a7c4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_444ae0a3-7d9e-4ca4-8a3a-a969a2bc690c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b9be4166-15a2-4c0a-a973-59c3366a7c4d" xlink:to="loc_us-gaap_AwardTypeAxis_444ae0a3-7d9e-4ca4-8a3a-a969a2bc690c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d3a5c60f-2a7e-4a54-806a-2fb1fe1794d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_444ae0a3-7d9e-4ca4-8a3a-a969a2bc690c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d3a5c60f-2a7e-4a54-806a-2fb1fe1794d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_2d5d8206-f2aa-44f5-8890-4dc99626c099" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d3a5c60f-2a7e-4a54-806a-2fb1fe1794d2" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_2d5d8206-f2aa-44f5-8890-4dc99626c099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3b815fe3-d99b-4118-bb66-b2b5960526c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b9be4166-15a2-4c0a-a973-59c3366a7c4d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3b815fe3-d99b-4118-bb66-b2b5960526c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_db4d3c92-e142-4931-b052-1a669bb5979c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3b815fe3-d99b-4118-bb66-b2b5960526c1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_db4d3c92-e142-4931-b052-1a669bb5979c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b0a5790c-f5f9-4eb1-bef0-f52c98b5ba75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3b815fe3-d99b-4118-bb66-b2b5960526c1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b0a5790c-f5f9-4eb1-bef0-f52c98b5ba75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a451db19-ebd3-4129-aab1-995c3f326735" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_06cdcaa4-3a0e-4224-9c0d-b29d6d8934c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a451db19-ebd3-4129-aab1-995c3f326735" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_06cdcaa4-3a0e-4224-9c0d-b29d6d8934c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b58a624e-9de0-46a3-8786-81ec036b7056" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_06cdcaa4-3a0e-4224-9c0d-b29d6d8934c3" xlink:to="loc_us-gaap_AwardTypeAxis_b58a624e-9de0-46a3-8786-81ec036b7056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_270cef94-a551-4174-b873-03fbbd8a0b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_b58a624e-9de0-46a3-8786-81ec036b7056" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_270cef94-a551-4174-b873-03fbbd8a0b3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_d02cc1c9-d1f5-4d21-8d70-7759de13698c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_270cef94-a551-4174-b873-03fbbd8a0b3d" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_d02cc1c9-d1f5-4d21-8d70-7759de13698c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_bda898d9-14ae-435e-bc82-49f4a16fb4e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_270cef94-a551-4174-b873-03fbbd8a0b3d" xlink:to="loc_us-gaap_EmployeeStockOptionMember_bda898d9-14ae-435e-bc82-49f4a16fb4e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_PerformanceBasedRestrictedStockUnitsRSUsMember_293b7d84-b9e9-4d31-ad2f-5dea483a0456" xlink:href="jazz-20210930.xsd#jazz_PerformanceBasedRestrictedStockUnitsRSUsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_270cef94-a551-4174-b873-03fbbd8a0b3d" xlink:to="loc_jazz_PerformanceBasedRestrictedStockUnitsRSUsMember_293b7d84-b9e9-4d31-ad2f-5dea483a0456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_091b08a5-52c0-44fc-b17a-b6ac133727d4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_06cdcaa4-3a0e-4224-9c0d-b29d6d8934c3" xlink:to="loc_srt_RangeAxis_091b08a5-52c0-44fc-b17a-b6ac133727d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_489c5908-c448-4050-8cfd-52080ce1538f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_091b08a5-52c0-44fc-b17a-b6ac133727d4" xlink:to="loc_srt_RangeMember_489c5908-c448-4050-8cfd-52080ce1538f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_fae7347e-5f3f-49c3-92d0-228c66f9aae7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_489c5908-c448-4050-8cfd-52080ce1538f" xlink:to="loc_srt_MinimumMember_fae7347e-5f3f-49c3-92d0-228c66f9aae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_eb7ca3a4-7845-4ecf-9be0-8b707f36a871" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_489c5908-c448-4050-8cfd-52080ce1538f" xlink:to="loc_srt_MaximumMember_eb7ca3a4-7845-4ecf-9be0-8b707f36a871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e589870-b55d-4f72-ad48-d76abc31f4ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_06cdcaa4-3a0e-4224-9c0d-b29d6d8934c3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e589870-b55d-4f72-ad48-d76abc31f4ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_a6e38d07-2159-4ddb-bb7d-c0787483b9ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e589870-b55d-4f72-ad48-d76abc31f4ee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_a6e38d07-2159-4ddb-bb7d-c0787483b9ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_ShareBasedCompensationArrangementByShareBasedPaymentAwardAchievementTargetPercentageOfAwardsGranted_65860a0d-6d67-4123-8280-4d84c6a43e5d" xlink:href="jazz-20210930.xsd#jazz_ShareBasedCompensationArrangementByShareBasedPaymentAwardAchievementTargetPercentageOfAwardsGranted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e589870-b55d-4f72-ad48-d76abc31f4ee" xlink:to="loc_jazz_ShareBasedCompensationArrangementByShareBasedPaymentAwardAchievementTargetPercentageOfAwardsGranted_65860a0d-6d67-4123-8280-4d84c6a43e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_PerformanceMetricTargetLevel_474a70d6-f543-4602-9f6f-2b35073886b4" xlink:href="jazz-20210930.xsd#jazz_PerformanceMetricTargetLevel"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e589870-b55d-4f72-ad48-d76abc31f4ee" xlink:to="loc_jazz_PerformanceMetricTargetLevel_474a70d6-f543-4602-9f6f-2b35073886b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_da518fde-e25b-444b-b2bc-8fa24fe03c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e589870-b55d-4f72-ad48-d76abc31f4ee" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_da518fde-e25b-444b-b2bc-8fa24fe03c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_83764dc5-a90a-405b-868b-96e43161a5ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4e589870-b55d-4f72-ad48-d76abc31f4ee" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_83764dc5-a90a-405b-868b-96e43161a5ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/ShareBasedCompensationScheduleofPerformancebasedRSUsDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#ShareBasedCompensationScheduleofPerformancebasedRSUsDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/ShareBasedCompensationScheduleofPerformancebasedRSUsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_50668068-ad20-4a5d-b609-66dbad4e0baf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_52929de3-364c-4e8b-995a-9725d8f83097" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_50668068-ad20-4a5d-b609-66dbad4e0baf" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_52929de3-364c-4e8b-995a-9725d8f83097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2205f433-b8e6-49cb-8ebc-85e9468ca285" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_52929de3-364c-4e8b-995a-9725d8f83097" xlink:to="loc_us-gaap_AwardTypeAxis_2205f433-b8e6-49cb-8ebc-85e9468ca285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fde3b0ee-0e74-45f9-89b7-403ea1004b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_2205f433-b8e6-49cb-8ebc-85e9468ca285" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fde3b0ee-0e74-45f9-89b7-403ea1004b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_PerformanceBasedRestrictedStockUnitsRSUsMember_f861b722-cd20-48f9-bd3f-1fabb8d1b1d3" xlink:href="jazz-20210930.xsd#jazz_PerformanceBasedRestrictedStockUnitsRSUsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fde3b0ee-0e74-45f9-89b7-403ea1004b9b" xlink:to="loc_jazz_PerformanceBasedRestrictedStockUnitsRSUsMember_f861b722-cd20-48f9-bd3f-1fabb8d1b1d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3f417889-8466-4d79-bc70-cae47b13ea89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_52929de3-364c-4e8b-995a-9725d8f83097" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3f417889-8466-4d79-bc70-cae47b13ea89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_f2cd5aa6-35e5-4f2b-89fe-0644ff33af29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3f417889-8466-4d79-bc70-cae47b13ea89" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_f2cd5aa6-35e5-4f2b-89fe-0644ff33af29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_87258c89-b455-4e42-9d3e-8c320f9e6527" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3f417889-8466-4d79-bc70-cae47b13ea89" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_87258c89-b455-4e42-9d3e-8c320f9e6527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/IncomeTaxes" xlink:type="simple" xlink:href="jazz-20210930.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_a0e4af5f-5ed9-4df0-bf64-977b4abfaa35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_8ef0af17-8645-459d-b713-b4690c791d9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a0e4af5f-5ed9-4df0-bf64-977b4abfaa35" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_8ef0af17-8645-459d-b713-b4690c791d9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jazzpharma.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="jazz-20210930.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.jazzpharma.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_b786bb7d-85b1-4ecd-a2ff-52ddc55ba607" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_fff31496-5c53-402e-8a92-fccdde18ed17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b786bb7d-85b1-4ecd-a2ff-52ddc55ba607" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_fff31496-5c53-402e-8a92-fccdde18ed17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_UKFinanceActChangeInTaxRateDeferredTaxLiabilityIncomeTaxExpenseBenefit_b5db1d02-685f-4621-a718-05a263e72120" xlink:href="jazz-20210930.xsd#jazz_UKFinanceActChangeInTaxRateDeferredTaxLiabilityIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b786bb7d-85b1-4ecd-a2ff-52ddc55ba607" xlink:to="loc_jazz_UKFinanceActChangeInTaxRateDeferredTaxLiabilityIncomeTaxExpenseBenefit_b5db1d02-685f-4621-a718-05a263e72120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jazz_IncomeTaxExaminationPenaltiesAndInterestPaid_a4334cbd-9342-48ee-a6e5-d4518b53eb0c" xlink:href="jazz-20210930.xsd#jazz_IncomeTaxExaminationPenaltiesAndInterestPaid"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b786bb7d-85b1-4ecd-a2ff-52ddc55ba607" xlink:to="loc_jazz_IncomeTaxExaminationPenaltiesAndInterestPaid_a4334cbd-9342-48ee-a6e5-d4518b53eb0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
